Form 10-Q

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

0001193125-17-197235.txt : 20170608 0001193125-17-197235.hdr.sgml : 20170608 20170607174908 ACCESSION NUMBER: 0001193125-17-197235 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 85 CONFORMED PERIOD OF REPORT: 20170429 FILED AS OF DATE: 20170608 DATE AS OF CHANGE: 20170607 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AstroNova, Inc. CENTRAL INDEX KEY: 0000008146 STANDARD INDUSTRIAL CLASSIFICATION: COMPUTER PERIPHERAL EQUIPMENT, NEC [3577] IRS NUMBER: 050318215 STATE OF INCORPORATION: RI FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-13200 FILM NUMBER: 17898195 BUSINESS ADDRESS: STREET 1: 600 E GREENWICH AVENUE CITY: WEST WARWICK STATE: RI ZIP: 02893 BUSINESS PHONE: 4018284000 MAIL ADDRESS: STREET 1: 600 E GREENWICH AVENUE CITY: WEST WARWICK STATE: RI ZIP: 02893 FORMER COMPANY: FORMER CONFORMED NAME: ASTRO MED INC /NEW/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ATLAN TOL INDUSTRIES INC DATE OF NAME CHANGE: 19850220 10-Q 1 d379017d10q.htm FORM 10-Q Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 29, 2017

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 0-13200

AstroNova, Inc.

(Exact name of registrant as specified in its charter)


Rhode Island		05-0318215
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

600 East Greenwich Avenue, West Warwick, Rhode Island		02893
(Address of principal executive offices)		(Zip Code)

(401) 828-4000

(Registrant’s telephone number, including area code)

Astro-Med, Inc.

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐.

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Common Stock, $.05 Par Value—6,729,718 shares

(excluding treasury shares) as of June 2, 2017

ASTRONOVA, INC.

INDEX


		Page No.
Part I.	Financial Information
Item 1.	Financial Statements
	Unaudited Condensed Consolidated Balance Sheets—April 29, 2017 and January 31, 2017		3
	Unaudited Condensed Consolidated Statements of Income—Three Months Ended April 29, 2017 and April 30, 2016		4
	Unaudited Condensed Consolidated Statements of Comprehensive Income—Three Months Ended April 29, 2017 and April 30, 2016		5
	Unaudited Condensed Consolidated Statements of Cash Flows—Three Months Ended April 29, 2017 and April 30, 2016		6
	Notes to the Condensed Consolidated Financial Statements (unaudited)		7-21
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		21-26
Item 3.	Quantitative and Qualitative Disclosures about Market Risk		27
Item 4.	Controls and Procedures		27
Part II.	Other Information
Item 1.	Legal Proceedings		28
Item 1A.	Risk Factors		28
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		28
Item 6.	Exhibits		29
Signatures			30

Part I. FINANCIAL INFORMATION

Item 1.

Financial Statements

ASTRONOVA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, Except Share Data)


	April 29, 2017			January 31, 2017
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	$	18,637		$	18,098
Securities Available for Sale		5,185			6,723
Accounts Receivable, net		16,053			15,702
Inventories		20,336			19,506
Prepaid Expenses and Other Current Assets		1,566			1,394

Total Current Assets		61,777			61,423
PROPERTY, PLANT AND EQUIPMENT		40,754			40,378
Less Accumulated Depreciation		(31,520	)		(31,098	)

Property, Plant and Equipment, net		9,234			9,280
OTHER ASSETS
Intangible Assets, net		8,249			5,264
Goodwill		11,958			4,521
Deferred Tax Assets		2,805			2,811
Other		117			366

Total Other Assets		23,129			12,962

TOTAL ASSETS	$	94,140		$	83,665


LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts Payable	$	5,120		$	4,957
Accrued Compensation		2,201			2,936
Other Liabilities and Accrued Expenses		1,954			2,171
Current Portion of Long -Term Debt		1,104			—
Deferred Revenue		370			472
Income Taxes Payable		1,595			1,449

Total Current Liabilities		12,344			11,985
Deferred Tax Liabilities		677			11
Long-Term Debt		7,941			—
Other Liabilities		2,438			1,132

TOTAL LIABILITIES		23,400			13,128
SHAREHOLDERS’ EQUITY
Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 9,886,003 shares and 9,834,906 shares at April 29, 2017 and January 31, 2017, respectively		495			492
Additional Paid-in Capital		48,207			47,524
Retained Earnings		44,341			44,358
Treasury Stock, at Cost, 2,385,534 and 2,375,076 shares at April 29, 2017 and January 31, 2017, respectively		(20,990	)		(20,781	)
Accumulated Other Comprehensive Loss, net of tax		(1,313	)		(1,056	)

TOTAL SHAREHOLDERS’ EQUITY		70,740			70,537

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	94,140		$	83,665

See Notes to condensed consolidated financial statements (unaudited).

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, Except Per Share Data)

(Unaudited)


	Three Months Ended
	April 29, 2017			April 30, 2016
Revenue	$	24,458		$	24,110
Cost of Revenue		15,152			14,637

Gross Profit		9,306			9,473
Operating Expenses:
Selling and Marketing		5,238			4,831
Research and Development		1,505			1,444
General and Administrative		1,856			1,651

Operating Expenses		8,599			7,926

Operating Income, net		707			1,547
Other Expense		(48	)		(52	)

Income before Income Taxes		659			1,495
Income Tax Provision		147			476

Net Income	$	512		$	1,019

Net Income Per Common Share—Basic	$	0.07		$	0.14

Net Income Per Common Share—Diluted	$	0.07		$	0.14

Weighted Average Number of Common Shares Outstanding:
Basic		7,480			7,358
Diluted		7,616			7,524
Dividends Declared Per Common Share	$	0.07		$	0.07

See Notes to condensed consolidated financial statements (unaudited).

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Thousands)

(Unaudited)


	Three Months Ended
	April 29, 2017			April 30, 2016
Net Income	$	512		$	1,019
Other Comprehensive Income, Net of Taxes:
Foreign Currency Translation Adjustments		(221	)		327
Change in value of derivatives designated as cash flow hedges		(259	)		—
Unrealized Holding Gain (Loss) on Securities Available for Sale		12			(2	)
Losses from cash flow hedges reclassified to income statement		211			—

Other Comprehensive Income (Loss)		(257	)		325

Comprehensive Income	$	255		$	1,344

See Notes to condensed consolidated financial statements (unaudited).

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

(Unaudited)


	Three Months Ended
	April 29, 2017			April 30, 2016
Cash Flows from Operating Activities:
Net Income	$	512		$	1,019
Adjustments to Reconcile Net Income to Net Cash Provided (Used) by Operating Activities:
Depreciation and Amortization		715			625
Amortization of Debt Issuance Costs		5			—
Share-Based Compensation		171			314
Deferred Income Tax Provision		7			69
Changes in Assets and Liabilities, Net of Impact of Acquisition:
Accounts Receivable		1,005			443
Inventories		(16	)		(1,588	)
Income Taxes		66			257
Accounts Payable and Accrued Expenses		(3,179	)		1,647
Other		(57	)		128

Net Cash Provided (Used) by Operating Activities		(771	)		2,914
Cash Flows from Investing Activities:
Proceeds from Sales/Maturities of Securities Available for Sale		1,554			1,598
Cash Paid for TrojanLabel Acquisition, net of cash acquired		(9,007	)		—
Payments Received on Line of Credit and Note Receivable		10			188
Additions to Property, Plant and Equipment		(359	)		(195	)

Net Cash Provided (Used) by Investing Activities		(7,802	)		1,591
Cash Flows from Financing Activities:
Cash (used) proceeds from Common Shares Issued Under Employee Benefit Plans and Employee Stock Option Plans, Net of Payment of Minimum Tax Withholdings		306			(40	)
Proceeds from Issuance of Long-Term Debt		9,200			—
Payments of Debt Issuance Costs		(155	)		—
Dividends Paid		(527	)		(516	)

Net Cash Provided (Used) by Financing Activities		8,824			(556	)

Effect of Exchange Rate Changes on Cash and Cash Equivalents		288			542

Net Increase in Cash and Cash Equivalents		539			4,491
Cash and Cash Equivalents, Beginning of Period		18,098			10,043

Cash and Cash Equivalents, End of Period	$	18,637		$	14,534

Supplemental Disclosures of Cash Flow Information:
Cash Paid During the Period for Interest	$	—		$	—
Cash Paid During the Period for Income Taxes, Net of Refunds	$	111		$	170

See Notes to condensed consolidated financial statements (unaudited).

ASTRONOVA, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(1) Overview

Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems. Our products are distributed through our own sales force and authorized dealers in the United States. We also sell to customers outside of the United States primarily through our Company offices in Canada, China, Europe, Mexico and Southeast Asia as well as with independent dealers and representatives. AstroNova, Inc. products are employed around the world in a wide range of aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation applications.

The business consists of two segments, Product Identification (previously known as our QuickLabel segment), which includes specialty printing systems sold under the QuickLabel^® and TrojanLabel^™ brand names, and Test & Measurement which includes test and measurement as well as Aerospace systems sold under the AstroNova™ brand name.

Products sold under the QuickLabel and TrojanLabel brands are used in industrial and commercial product packaging and automatic identification applications to digitally print custom labels and other visual identification marks on demand. Products sold under the AstroNova Test & Measurement brand acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats. In the aerospace market, the Company has a long history of using its data visualization technologies to provide high-resolution airborne printers and networking systems as well as related hardware and supplies.

Unless otherwise indicated, references to “AstroNova,” the “Company,” “we,” “our,” and “us” in this Quarterly Report on Form 10-Q refer to AstroNova, Inc. and its consolidated subsidiaries.

(2) Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with footnotes contained in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2017.

Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year.

The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Some of the more significant estimates relate to the allowances for doubtful accounts and credits, inventory valuation, impairment of long-lived assets and goodwill, income taxes, share-based compensation, accrued expenses and warranty reserves. Management’s estimates are based on the facts and circumstances available at the time estimates are made, historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters. Consequently, actual results could differ from those estimates.

Certain amounts in the prior year financial statements have been reclassified to conform to the current year’s presentation.

(3) Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

(4) Acquisition

On February 1, 2017, our newly-formed wholly-owned Danish subsidiary, ANI ApS, completed the acquisition of the issued and outstanding equity interests of TrojanLabel ApS (TrojanLabel), a Danish private limited liability company, pursuant to the terms of a Share Purchase Agreement dated January 7, 2017. Based in Copenhagen, Denmark, TrojanLabel is a manufacturer of products including digital color label presses and specialty printing systems for a broad range of end markets. Upon the consummation of the acquisition, TrojanLabel became an indirect wholly-owned subsidiary of AstroNova.

The purchase price of this acquisition was 62.9 million Danish Krone (approximately $9.1 million), net of cash acquired of 976,000 Danish Krone (approximately $0.1 million), of which 6.4 million Danish Krone (approximately $0.9 million) was placed in escrow to secure certain post-closing working capital adjustments and indemnification obligations of the sellers. The acquisition was funded using available cash and investment securities.

The sellers of TrojanLabel may be entitled to additional contingent consideration if 80% of specified earnings targets are achieved by TrojanLabel during the seven years following the closing, subject to certain closing working capital adjustments and potential offsets to satisfy the sellers’ indemnification obligations. The contingent consideration consists of potential earn-out payments to the sellers of between 32.5 million Danish Krone (approximately $5.0 million) if 80% of the specified earnings targets are achieved, 40.6 million Danish Krone (approximately $5.8 million) if 100% of the specified earnings targets are achieved, and a maximum of 48.7 million Danish Krone (approximately $7 million) if 120% of the specified earnings targets are achieved.

Total acquisition-related costs were approximately $0.7 million, of which $0.1 million and $0.6 million, are included in the general and administrative expenses in the Company’s consolidated statements of income for the periods ending April 29, 2017 and January 31, 2017, respectively. The acquisition was accounted for under the acquisition method in accordance with the guidance provided by FASB ASC 805, “Business Combinations.”

The US dollar purchase price of the acquisition has been allocated on the basis of fair value as follows:


(In thousands)
Accounts Receivable	$	1,322
Inventory		796
Other Current Assets		166
Property, Plant and Equipment		15
Identifiable Intangible Assets		3,264
Goodwill		7,388
Accounts Payable and Other Current Liabilities		(1,821	)
Other Liability		(114	)
Contingent Liability (Earnout)		(1,314	)
Deferred Tax Liability		(695	)

Total Purchase Price	$	9,007

The fair value of the intangible assets acquired was estimated by applying the income approach, and the fair value of the contingent consideration liability was estimated by applying the real options method. These fair value measurements are based on significant inputs that are not observable in the market and therefore represent a Level 3 measurement as defined in ASC 820, “Fair Value Measurement and Disclosure.” Key assumptions in estimating the fair value of the intangibles include (1) remaining life of existing technology acquired based on estimate of percentage of revenue from 0% -100% for each product, (2) the Company’s internal rate of return of 19.0% and (3) a range of earnings projections from $121,000-$1,070,000. Key assumptions in estimating the fair value of the contingent consideration liability include (1) the estimated earnout targets over the next seven years of $407,000-$1,280,000, (2) the probability of success (achievement of the various contingent events) from 1.6%-87.2% and (3) a risk-adjusted discount rate of approximately 1.77%-3.35% used to adjust the probability-weighted earnout payments to their present value.

Goodwill of $7.4 million, which is not deductible for tax purposes, represents the excess of the purchase price over the estimated fair value assigned to the tangible and identifiable intangible assets acquired and liabilities assumed from TrojanLabel. The goodwill recognized is attributable to synergies which are expected to enhance and expand the Company’s overall product portfolio and opportunities in new and existing markets, future technologies that have yet to be determined and TrojanLabel’s assembled work force. The carrying amount of the goodwill was allocated to the Product Identification segment of the Company.

The following table reflects the fair value of the acquired identifiable intangible assets and related estimated useful lives:


(In thousands)	Fair Value		Useful Life (Years)
Existing Technology	$	2,327		7
Non-Competition Agreement		937		10

Total	$	3,264

Existing Technology intangible asset acquired represents the various technologies TrojanLabel has developed related to its series of printing presses, including hardware components of the presses and the software utilized to optimize their performance.

Beginning February 1, 2017, the results of operations for TrojanLabel have been included in the Company’s statement of income for the period ended April 29, 2017 and are reported as part of the Product Identification segment. Assuming the acquisition of TrojanLabel had occurred on February 1, 2016, the impact on net sales, net income and earnings per share would not have been material to the Company for the period ended April 30, 2016.

(5) Net Income Per Common Share

Basic net income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of shares and, if dilutive, common equivalent shares, determined using the treasury stock method for stock options, restricted stock awards and restricted stock units outstanding during the period. A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:


	Three Months Ended
	April 29, 2017		April 30, 2016
Weighted Average Common Shares Outstanding—Basic		7,480,039		7,357,588
Effect of Dilutive Options and Restricted Stock Units		135,507		166,661

Weighted Average Common Shares Outstanding—Diluted		7,615,546		7,524,249

For the three months ended April 29, 2017 and April 30, 2016, the diluted per share amounts do not reflect common equivalent shares outstanding of 472,214 and 431,133, respectively, because their effect would have been anti-dilutive.

(6) Intangible Assets

Intangible assets are as follows:


	April 29, 2017									January 31, 2017
(In thousands)	Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Miltope:
Customer Contract Relationships	$	3,100	$	(1,190	)		—	$	1,910	$	3,100	$	(1,108	)	$	1,992
RITEC:
Customer Contract Relationships		2,830		(271	)		—		2,559		2,830		(207	)		2,623
Non-Competition Agreement		950		(348	)		—		602		950		(301	)		649
TrojanLabel:
Existing Technology		2,327		(82	)		14		2,259		—		—			—
Non-Competition Agreement		937		(23	)		5		919		—		—			—

Intangible Assets, net	$	10,144	$	(1,914	)		19	$	8,249	$	6,880	$	(1,616	)	$	5,264

There were no impairments to intangible assets during the periods ended April 29, 2017 and April 30, 2016. With respect to the acquired intangibles included in the table above, amortization expense of $298,000 and $179,000, has been included in the condensed consolidated statements of income for the periods ended April 29, 2017 and April 30, 2016, respectively.

(7) Share-Based Compensation

We have two equity incentive plans—the 2007 Equity Incentive Plan (the “2007 Plan”) and the 2015 Equity Incentive Plan (the “2015 Plan”). Under these plans, the Company may grant incentive stock options, non-qualified stock options, stock appreciation rights, time or performance-based restricted stock units (RSUs), restricted stock awards (RSAs), and other stock-based awards to executives, key employees, directors and other eligible individuals. At April 29, 2017, 886 shares were available for grant under the 2007 Plan. The 2007 Plan expires in May 2017. The 2015 Plan authorizes the issuance of up to 500,000 shares (subject to adjustment for stock dividends and stock splits), and at April 29, 2017, 205,983 shares were available for grant under the 2015 Plan. The 2015 Plan will expire in May 2025. Options granted to employees under both plans vest over four years and expire after ten years. The exercise price of each stock option is established at the discretion of the Compensation Committee; however, any incentive stock options granted under the 2007 Plan, and all options granted under the 2015 Plan, must be issued at an exercise price of not less than the fair market value of the Company’s common stock on the date of grant.

Under the plans, each non-employee director receives an automatic annual grant of ten-year options to purchase 5,000 shares of stock upon the adjournment of each annual shareholders meeting. Each such option is exercisable at the fair market value of the Company’s common stock as of the grant date, and vests immediately prior to the next annual shareholders’ meeting.

The Company has a Non-Employee Director Annual Compensation Program (the “Program”) under which each non-employee director receives an automatic grant of RSAs on the first business day of each fiscal quarter. Under the Program, the number of whole shares to be granted each quarter is equal to 25% of the number calculated by dividing the director compensation amount by the fair market value of the Company’s stock on such day. The director annual compensation amount was $55,000 in fiscal year 2017, and $65,000, and $75,000 for fiscal 2018 and 2019, respectively. In addition, the Chairman of the Board receives RSAs with an aggregate value of $6,000, and the Chairs of the Audit and Compensation Committees each receive RSAs with an aggregate value of $4,000, also issued in quarterly installments and calculated in the same manner as the directors’ RSA grants. RSAs granted prior to March 30, 2017 become fully vested on the first anniversary of the date of grant. RSAs granted subsequent to March 30, 2017 become vested three months after the date of grant. A total of 7,233 and 567 shares were awarded to the non-employee directors as compensation under the Program in the first quarter of fiscal 2018 and 2017, respectively.

In April 2013 (fiscal year 2014), the Company granted options and RSUs to officers (“2014 RSUs”). The 2014 RSUs vested as follows: twenty-five percent vested on the third anniversary of the grant date, fifty percent vested upon the Company achieving its cumulative budgeted net revenue target for fiscal years 2014 through 2016 (the “Measurement Period”), and twenty-five percent vested upon the Company achieving a target average annual ORONA (operating income return on net assets as calculated under the Domestic Management Bonus Plan) for the Measurement Period. The grantee may not sell, transfer or otherwise dispose of more than fifty percent of the common stock issued upon vesting of the 2014 RSUs until the first anniversary of the vesting date. In April 2016, 9,300 of the 2014 RSUs vested, as the Company achieved the targeted average annual ORONA, as defined in the plan, for the Measurement Period and another 9,300 vested as a result of the third year anniversary date of the grant. Additionally, on February 1, 2014, the Company accelerated the vesting of 4,166 of the 2014 RSUs held by Everett Pizzuti in connection with his retirement.

In May 2015 (fiscal year 2016), the Company granted an aggregate of 80,000 time-based and 155,000 performance-based RSUs (“2016 RSUs”) to certain officers of the Company. The time-based 2016 RSUs vest in four equal annual installments commencing on the first anniversary of the grant date. The performance-based 2016 RSUs vest over three years based upon the increase in revenue, if any, achieved each fiscal year relative to a three-year revenue increase goal. Performance-based 2016 RSUs that are earned based on organic revenue growth are fully vested when earned, while those earned based on revenue growth via acquisitions vest annually over a three-year period following the fiscal year in which the revenue growth occurs. Any performance-based 2016 RSUs that have not been earned at the end of the three-year performance period will be forfeited. The expense for such shares is recognized in the fiscal year in which the results are achieved, however, the shares are not fully earned until approved by the Compensation Committee in the first quarter of the following fiscal year. 2016 RSUs earned in the first quarter of fiscal 2018 and 2017 were 9,025 and 15,810, respectively.

In March 2015 (fiscal year 2016), the Company granted 50,000 options and 537 RSAs to its CEO pursuant to the CEO Equity Incentive Agreement, and 35,000 options to other key employees.

In March 2016 (fiscal year 2017), the Company granted 50,000 options and 4,030 RSAs to its CEO pursuant to the CEO Equity Incentive Agreement.

In May 2016 (fiscal year 2017) the Company granted 37,000 options to certain key employees. On August 1, 2016 (fiscal year 2017) the Company granted 5,000 options to its Chief Financial Officer.

In March 2017 (fiscal year 2018), the Company granted 50,000 options to the Chief Executive Officer pursuant to the CEO Equity Incentive Agreement and in February and April 2017 (fiscal year 2018) the Company granted 52,189 options to certain other key employees.

The options and RSAs granted March 2015 through March 2017 vest in four equal annual installments commencing on the first anniversary of the grant date.

Share-based compensation expense was recognized as follows:


	Three Months Ended
(In thousands)	April 29, 2017		April 30, 2016
Stock Options	$	94	$	81
Restricted Stock Awards and Restricted Stock Units		74		230
Employee Stock Purchase Plan		3		3

Total	$	171	$	314

Stock Options

The fair value of stock options granted during the three months ended April 29, 2017 and April 30, 2016 was estimated using the following weighted average assumptions:


	Three Months Ended
	April 29, 2017	April 30, 2016
Risk Free Interest Rate	1.7%	1.5%
Expected Volatility	36.6%	24.6%
Expected Life (in years)	7.5	5.0
Dividend Yield	2.1%	1.9%

The weighted average fair value per share for options granted was $4.11 during the three months ended April 29, 2017, compared to $2.86 during the three months ended April 30, 2016.

Aggregated information regarding stock options granted under the plans for the three months ended April 29, 2017, is summarized below:


	Number of Options			Weighted Average Exercise Price
Outstanding at January 31, 2017		685,456		$	11.96
Granted		102,189			13.31
Exercised		(43,125	)		11.50
Forfeited		—			—
Canceled		(19,700	)		11.75

Outstanding at April 29, 2017		724,820		$	12.19

Set forth below is a summary of options outstanding at April 29, 2017:


Outstanding							Exercisable
Range of Exercise prices	Number of Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Number of Shares		Weighted- Average Exercise Price		Weighted Average Remaining Contractual Life
$5.00-10.00		188,056	$	7.84		3.6		188,056	$	7.84		3.6
$10.01-15.00		481,764	$	13.55		7.9		226,275	$	13.20		6.8
$15.01-20.00		55,000	$	15.07		8.9		12,500	$	15.01		8.9

		724,820	$	12.19		6.9		426,831	$	10.89		5.5

As of April 29, 2017, there was approximately $800,000 of unrecognized compensation expense related to stock options which is expected to be recognized over a weighted average period of approximately 2.9 years.

Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs)

Aggregated information regarding RSUs and RSAs granted under the Plan for the three months ended April 29, 2017 is summarized below:


	RSAs & RSUs			Weighted Average Grant Date Fair Value
Unvested at January 31, 2017		213,868		$	14.11
Granted		7,233			13.95
Vested		(10,461	)		13.75
Forfeited		—			—

Unvested at April 29, 2017		210,640		$	14.10

As of April 29, 2017, there was approximately $800,000 of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of 0.8 years.

Employee Stock Purchase Plan

AstroNova has an Employee Stock Purchase Plan allowing eligible employees to purchase shares of common stock at a 15% discount from fair value on the date of purchase. A total of 247,500 shares were reserved for issuance under this plan. During the three months ended April 29, 2017 and April 30, 2016, there were 1,507 and 1,597 shares, respectively, purchased under this plan. As of April 29, 2017, 43,717 shares remain available.

(8) Inventories

Inventories are stated at the lower of cost (first-in, first-out) and net realizable value and include material, labor and manufacturing overhead. The components of inventories are as follows:


(In thousands)	April 29, 2017			January 31, 2017
Materials and Supplies	$	12,082		$	11,865
Work-In-Process		1,168			1,216
Finished Goods		11,184			10,270

		24,434			23,351
Inventory Reserve		(4,098	)		(3,845	)

	$	20,336		$	19,506

(9) Income Taxes

The Company’s effective tax rates for the period, which are based on the projected effective tax rate for the full year, are as follows:


		Three Months Ended
Fiscal 2018		22.3%
Fiscal 2017		31.8%

During the three months ended April 29, 2017, the Company recognized an income tax expense of approximately $147,000. The effective tax rate in this period was directly impacted by a $71,000 tax benefit related to the expiration of the statute of limitations on a previously uncertain tax position and a $14,000 tax benefit arising from windfall tax benefits related to the Company’s stock. During the three months ended April 30, 2016, the Company recognized an income tax expense of approximately $476,000. The effective tax rate in that quarter was directly impacted by a $52,000 tax benefit related to the statute of limitations expiring on a previously uncertain tax position.

As of April 29, 2017, the Company’s cumulative unrecognized tax benefits totaled $673,000 compared to $708,000 as of January 31, 2017. There were no other developments affecting unrecognized tax benefits during the quarter ended April 29, 2017.

(10) Debt

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:


(In thousands)	April 29, 2017			January 31, 2017
USD Term Loan with a rate equal to LIBOR plus a margin of 1.0% to 1.5%, (2.031% as of April 29, 2017), and maturity date of January 31, 2022	$	9,200		$	—
Less:
Debt Issuance Costs, net of accumulated amortization	$	( 155	)	$	—
Current Portion	$	(1,104	)	$	—

Long-Term Debt	$	7,941		$	—

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of April 29, 2017 is as follows:


(In thousands)
Fiscal 2018	$	1,104
Fiscal 2019		1,472
Fiscal 2020		1,840
Fiscal 2021		2,208
Fiscal 2022		2,576

	$	9,200

On February 28, 2017, the Company and the Company’s wholly-owned subsidiary, ANI ApS (together, the “Parties”), entered into a Credit Agreement with Bank of America, N.A. (the “Lender”). The Parties also entered into a related Security and Pledge Agreement with the Lender. The Credit Agreement provides for a term loan to the Parties in the amount of $9.2 million. The Credit Agreement also provides for a $10.0 million revolving credit facility available to the Company for general corporate purposes. Revolving credit loans may be borrowed, at the borrower’s option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Krone.

The term loan bears interest under the Credit Agreement at a rate per annum equal to the LIBOR Rate plus a margin that varies within a range of 1.0% to 1.5% based on the Company’s consolidated leverage ratio. Amounts borrowed under the revolving credit facility bear interest at a rate per annum equal to, at the Company’s option, either (a) the LIBOR Rate (or in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.0% to 1.5% based on the Company’s consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal funds’ rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate or (iii) the LIBOR Rate plus 1.00%, plus a margin that varies within a range of 0.0% to 0.5% based on the Company’s consolidated leverage ratio. In addition to certain other fees and expenses, the Company is required to pay a commitment fee on the undrawn portion of the revolving credit facility at the rate of 0.25% per annum.

In connection with the Credit Agreement, AstroNova and ANI ApS entered into certain hedging arrangements with the Lender to manage the variable interest rate risk and currency risk associated with its payments in respect of the term loan. Refer to Note 11, “Derivative Financial Instruments and Risk Management” for further information about these arrangements.

The Parties must comply with various customary financial and non-financial covenants under the Credit Agreement. The financial covenants consist of a maximum consolidated leverage ratio and a minimum consolidated fixed charge coverage ratio. The Credit Agreement contains limitations, in each case subject to various exceptions and thresholds, on the Company’s and its subsidiaries’ ability to incur future indebtedness, to place liens on assets, to pay dividends or distributions on their capital stock, to repurchase or acquire their capital stock, to conduct mergers or acquisitions, to sell assets, to alter their capital structure, to make investments and loans, to change the nature of their business, and to prepay subordinated indebtedness. The Credit Agreement permits the Company to pay cash dividends on and repurchase shares of its common stock, subject to certain limitations.

The Lender is entitled to accelerate repayment of the loans and to terminate its revolving credit commitment under the Credit Agreement upon the occurrence of any of various customary events of default, which include, among other events, the following: failure to pay when due any principal, interest or other amounts in respect of the loans, breach of any of the Company’s covenants or representations under the loan documents, default under any other of the Company’s or its subsidiaries’ significant indebtedness agreements, a bankruptcy, insolvency or similar event with respect to the Company or any of its subsidiaries, a significant unsatisfied judgment against the Company or any of its subsidiaries, or a change of control of the Company.

The obligations of ANI ApS in respect of the term loan are guaranteed by the Company and TrojanLabel. The Company’s obligations in respect of the revolving credit facility and its guarantee in respect of the term loan are secured by substantially all of the assets of the Company (including a pledge of a portion of the equity interests held by the Company in ANI ApS and the Company’s wholly-owned German subsidiary Astro-Med GmbH), subject to certain exceptions.

As of April 29, 2017, there are no borrowings under the revolving credit facility, and we believe the Company is in compliance with all of the covenants in the Credit Agreement.

Upon entry into the Credit Agreement on February 28, 2017, the Company’s prior Credit Agreement, dated as of September 5, 2014, among the Company, as borrower, and Wells Fargo Bank was terminated. No loans or other amounts were outstanding or owed under that Credit Agreement with Wells Fargo Bank at the time of termination.

(11) Derivative Financial Instruments and Risk Management

As a multinational enterprise, AstroNova is exposed to certain risks relating to our ongoing business operations. We employ a number of practices to manage these risks, including operating and financing activities, and where appropriate, the use of derivative instruments. The primary risks managed by using derivative instruments are interest rate risk and foreign currency exchange rate risk.

ASC 815, “Derivatives and Hedging,” requires the Company to recognize all of its derivative instruments as either assets or liabilities in the statement of financial position at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. For derivative instruments not designated as hedging instruments, the gain or loss is recognized in the statement of income during the current period.

For derivative instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income (OCI) and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings (e.g., in “interest expense” when the hedged transactions are interest cash flows associated with floating-rate debt, or “other income (expense)” for portions reclassified relating to the remeasurement of the debt). The remaining gain or loss on the derivative instrument in excess of the cumulative change in the present value of future cash flows of the hedged item, if any (i.e., the ineffectiveness portion), or hedge components excluded from the assessment of effectiveness, are recognized in the statement of financial income during the current period.

In connection with the Credit Agreement, we entered into a cross-currency interest rate swap to manage the interest rate risk and foreign currency exchange risk associated with the floating-rate foreign currency-denominated borrowing on our Danish Subsidiary and, in accordance to the guidance in ASC 815, have designated this swap as a cash flow hedge of floating-rate borrowings. The cross-currency interest rate swap agreement utilized by the Company effectively modifies the Company’s exposure to interest rate risk and foreign currency exchange rate risk by converting approximately $8.9 million of the Company’s floating-rate debt denominated in U.S. Dollars on our Danish subsidiary’s books to a fixed-rate debt denominated in Danish Krone for the next five years, thus reducing the impact of interest-rate and foreign currency exchange rate changes on future interest expense and principal repayments. This swap involves the receipt of floating rate amounts in U.S. Dollars in exchange for fixed-rate interest payments in Danish Krone, as well as exchanges of principal at the inception spot rate, over the life of the Credit Agreement.

As of April 29, 2017, the total notional amount of the Company’s cross-currency interest rate swap was $8.6 million; the fair value was $393,600.

The following table presents the impact of the derivative instrument in our condensed consolidated financial statements:


Cash Flow Hedge	Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)					Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
Cash Flow Hedge	April 29, 2017			January 31, 2017			April 29, 2017			January 31, 2017
Swap contract	$	(392,636	)	$	—	Other Income (Expense)	$	(320,076	)	$	—

The swap contract resulted in no ineffectiveness for the three months ended April 29, 2017, and no gains or losses were reclassified into earnings as a result of the discontinuance of the swap contract due to the original forecasted transaction no longer being probable of occurring. At April 29, 2017, the Company expects to reclassify $108,200 of net gains on the swap contract from accumulated other comprehensive income to earnings during the next 12 months due to changes in foreign exchange rates and the payment of variable interest associated with the floating-rate debt.

(12) Segment Information

AstroNova reports two segments: Product Identification and Test & Measurement (T&M). The Company evaluates segment performance based on the segment profit before corporate expenses.

Summarized below are the Revenue and Segment Operating Profit for each reporting segment:


	Three Months Ended
	Revenue				Segment Operating Profit
(In thousands)	April 29, 2017		April 30, 2016		April 29, 2017			April 30, 2016
Product Identification	$	18,646	$	16,606	$	2,492		$	1,996
T&M		5,812		7,504		71			1,202

Total	$	24,458	$	24,110		2,563			3,198

Corporate Expenses						1,856			1,651

Operating Income						707			1,547
Other Expense						(48	)		(52	)

Income Before Income Taxes						659			1,495
Income Tax Provision						147			476

Net Income					$	512		$	1,019

(13) Recent Accounting Pronouncements

Goodwill

In January 2017, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2017-04, “Intangibles—Goodwill and Other (Topic 350).” ASU 2017-14 simplifies the subsequent measurement of goodwill impairment. The new guidance eliminates the two-step process that required identification of potential impairment and a separate measure of the actual impairment. Goodwill impairment charges, if any, would be determined by reducing the goodwill balance by the difference between the carrying value and the reporting unit’s fair value (impairment loss is limited to the carrying value). This standard is effective for annual or any interim goodwill impairment tests beginning after December 15, 2019. The Company does not believe the adoption of this guidance will have a material impact on the Company’s consolidated financial statements

Statement of Cash Flows

In August 2016, the FASB issued ASU 2016-15, “Classification of Certain Cash Receipts and Cash Payments (Topic 230).” ASU 2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice for certain cash receipts and cash payments. The standard is effective for annual reporting periods beginning after December 15, 2017 and interim periods within those years (Q1 fiscal 2019 for AstroNova), with early adoption permitted. The Company does not believe the adoption of this guidance will have a material impact on the Company’s consolidated financial statements.

Revenue Recognition

In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 completes the joint effort by the FASB and International Accounting Standards Board to improve financial reporting by creating common revenue recognition guidance for U.S. GAAP and International Financial Reporting Standards. ASU 2014-09 applies to all companies that enter into contracts with customers to transfer goods or services. In August 2015, the FASB modified ASU 2014-09 to be effective for annual reporting periods beginning after December 15, 2017 (Q1 fiscal 2019 for AstroNova), including interim periods within that reporting period. As modified, the FASB permits the adoption of the new revenue standard early, but not before annual periods beginning after December 15, 2016. Entities have the choice to apply ASU 2014-09 either retrospectively to each reporting period presented or by recognizing the cumulative effect of applying ASU 2014-09 at the date of initial application and not adjusting comparative information.

In March 2016, the FASB issued ASU 2016-08, “Revenue from Contracts with Customers (Topic 606)—Principal versus Agent Consideration.” In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606)—Identifying Performance Obligations and Licensing.” In May 2016, the FASB issued ASU 2016-11, “Revenue from Contracts with Customers (Topic 606) and Derivatives and Hedging (Topic 815)—Rescission of SEC Guidance Because of ASU 2014-09 and 2014-16” and ASU 2016-12, “Revenue from Contracts with Customers (Topic 606)—Narrow Scope Improvements and Practical Expedients.” All of these ASUs do not change the core principle of the guidance in Topic 606 (as amended by ASU 2014-09), but rather provide further guidance to improve the operability and understandability of the implementation guidance included in ASU 2014-09. The effective date for all of these ASUs is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those years (Q1 fiscal 2019 for AstroNova). The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements.

Leases

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” ASU 2016-02 supersedes current guidance related to accounting for leases and is intended to increase transparency and comparability among organizations by requiring lessees to recognize assets and liabilities in the balance sheet for operating leases with lease terms greater than twelve months. The update also requires improved disclosures to help users of financial statements better understand the amount, timing and uncertainty of cash flows arising from leases. ASU 2016-02 will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years (Q1 fiscal 2020 for AstroNova), with early adoption permitted. At adoption, this update will be applied using a modified retrospective approach. The Company is currently evaluating the effect of this new guidance on the Company’s consolidated financial statements.

Inventory

In July 2015, the FASB issued ASU 2015-11, “Inventory (Topic 330).” ASU 2015-11 requires inventory to be measured at the lower of cost and net realizable value instead of at lower of cost or market. This guidance does not apply to inventory that is measured using last-in, first out (LIFO) or the retail inventory method but applies to all other inventory, including inventory measured using first-in, first-out (FIFO) or the average cost method. ASU 2015-11 will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years (Q1 fiscal 2018 for AstroNova) and should be applied prospectively. Our adoption of this guidance at the beginning of the first quarter of fiscal 2018 did not have a material effect on our consolidated financial statements.

No other new accounting pronouncements, issued or effective during the first three months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

(14) Securities Available for Sale

Pursuant to our investment policy, securities available for sale include state and municipal securities with various contractual or anticipated maturity dates ranging from 6 to 24 months. Securities available for sale are carried at fair value, with unrealized gains and losses reported as a component of accumulated other comprehensive income (loss) in shareholders’ equity until realized. Realized gains and losses from the sale of available-for-sale securities, if any, are determined on a specific identification basis. A decline in the fair value of any available-for-sale security below cost that is determined to be other than temporary will result in a write-down of its carrying amount to fair value. No such impairment charges were recorded for any period presented. All short-term investment securities have original maturities greater than 90 days.

The fair value, amortized cost and gross unrealized gains and losses of securities available for sale are as follows:


(In thousands) April 29, 2017	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
State and Municipal Obligations	$	5,188	$	—	$	(3	)	$	5,185


January 31, 2017	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
State and Municipal Obligations	$	6,732	$	—	$	(9	)	$	6,723

(15) Fair Value

We measure our financial and nonfinancial assets at fair value on a recurring basis in accordance with the guidance provided in ASC 820, “Fair Value Measurement and Disclosures” which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). In addition, ASC 820 establishes a three-tiered hierarchy for inputs used in management’s determination of fair value of financial instruments that emphasizes the use of observable inputs over the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that reflect management’s belief about the assumptions market participants would use in pricing a financial instrument based on the best information available in the circumstances.

The fair value hierarchy is summarized as follows:

•

Level 1—Quoted prices in active markets for identical assets or liabilities;

•

Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

•

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Cash and cash equivalents, accounts receivable, accounts payable, line of credit receivable, accrued compensation, other liabilities and accrued expenses and income tax payable are reflected in the condensed consolidated balance sheet at carrying value, which approximates fair value due to the short term nature of the these instruments.

Assets and Liabilities Recorded at Fair Value on a Recurring Basis

Fair value is applied to our financial assets and liabilities including money market funds, available for sale securities, derivative instruments consisting of a cross-currency interest rate swap and a contingent consideration liability relating to an earnout payment on future TrojanLabel operating results.

The following tables provide a summary of the financial assets and liabilities that are measured at fair value as of April 29, 2017 and January 31, 2017:


Assets measured at fair value:	Fair value measurement at April 29, 2017								Fair value measurement at January 31, 2017
(in thousands)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Money Market Funds (included in Cash and Cash Equivalents)	$	1,611	$	—	$	—	$	1,611	$	2	$	—	$	—	$	2
State and Municipal Obligations (included in Securities Available for Sale)		—		5,185		—		5,185		—		6,723		—		6,723

Total assets	$	1,611	$	5,185	$	—	$	6,796	$	2	$	6,723	$	—	$	6,725


Liabilities measured at fair value:	Fair value measurement at April 29, 2017								Fair value measurement at January 31, 2017
(in thousands)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Swap Contracts (included in Other Liabilities)	$	—	$	393	$	—	$	393	$	—	$	—	$	—	$	—
Earnout liability (included in Other Liabilities)		—		—		1,322		1,322		—		—		—		—

Total liabilities	$	—	$	393	$	1,322	$	1,715	$	—	$	—	$	—	$	—

For our money market funds and municipal obligations, we utilize the market approach to measure fair value. The market approach is based on using quoted prices for identical or similar assets.

We also use the market approach to measure fair value of our derivative instruments. Our derivative liability is comprised of a cross-currency interest rate swap. This derivative instrument was measured at fair value using readily observable market inputs, such as quotations on interest rates and foreign exchange rates, and is classified as Level 2 because it is an over-the-counter contract with a bank counterparty that is not traded in an active market.

The fair value of the contingent consideration liability was initially determined as of the acquisition date of February 1, 2017, using significant inputs that are not observable in the market and therefore classified as Level 3. Key assumptions in estimating the fair value of the contingent consideration liability included (1) the estimated earnout targets over the next seven years of $407,000-$1,280,000, (2) the probability of success (achievement of the various contingent events) from 1.6%-87.2% and (3) a risk-adjusted discount rate of approximately 1.77%-3.35% used to adjust the probability-weighted earnout payments to their present value. Subsequent to the acquisition date, at each reporting period, the contingent consideration liability is recorded at its fair value with changes reflected in other income in the condensed consolidated statements of operations. The change in fair value for the quarter ended April 29, 2017, was not material.

Assets and Liabilities Not Recorded at Fair Value

As of April 29, 2017, the Company’s long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:


	Fair Value Measurement at April 29, 2017
(In thousands)	Level 1		Level 2		Level 3		Total		Carrying Value
Long-Term debt and related current maturities	$	—	$	9,200	$	—	$	9,200	$	9,200

On February 28, 2017, the Company entered into a term loan in the amount of $9.2 million with the Bank of America. The fair value of the Company’s long-term debt, including the current portion of long-term debt approximates carrying value at April 29, 2017. In subsequent periods, the fair value of the debt will be based on the quoted market prices for the same issues or on the current rates offered for debt of similar remaining maturities.

(16) Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss by component are as follows:


(In thousands)	Foreign Currency Translation Adjustments			Unrealized Holding Gain/(Loss) on Available for Sale Securities			Net Unrealized Gain(Losses) on Cash Flow Hedges			Total
Balance at January 31, 2017	$	(1,048	)	$	(8	)	$	—		$	(1,056	)
Other Comprehensive Income (Loss) before reclassification		(221	)		12			(259	)		(468	)
Amounts reclassified from AOCI to Earnings		—			—			211			211

Other Comprehensive Income (Loss)		(221	)		12			(48	)		(257	)

Balance at April 29, 2017	$	(1,269	)	$	4		$	(48	)	$	(1,313	)

The amounts presented above in other comprehensive income (loss) are net of any applicable taxes.

(17) Subsequent Events

Stock Repurchase Agreement

On May 1, 2017, the Company entered into a stock repurchase agreement with a trust established by Albert W. Ondis to repurchase 826,305 shares of the Company’s common stock held by the trust at a per share price of $13.60, for an aggregate repurchase price of $11.2 million. This stock repurchase was consummated on May 2, 2017 and was funded using existing cash on hand. Following this stock repurchase, the Ondis trust owns 36,000 shares of the Company’s common stock.

April L. Ondis, a director of the Company, is a beneficiary of the trust. The stock repurchase was authorized and approved by the Company’s Audit Committee as a related party transaction. Prior to entering into the agreement, the Company obtained an opinion from an independent investment banking firm that the consideration to be paid by the Company to the trust pursuant to the stock repurchase agreement would be fair to the public stockholders of the Company, other than the trust, from a financial point of view.

Credit Agreement Amendment

In connection with the stock repurchase, the Company entered into a consent and amendment, dated as of May 1, 2017, relating to the Credit Agreement, dated as of February 28, 2017, among the Company, its subsidiaries, ANI ApS and TrojanLabel ApS, and Bank of America, N.A., as lender. Solely for purposes of effecting the stock repurchase, the Amendment increased the aggregate amount of certain repurchases of Company equity interests permitted to be made by the Company under the Credit Agreement in the Company’s fiscal year ending January 31, 2018, from $5,000,000 to $12,000,000, subject to certain conditions. The Amendment prohibits the Company from making other repurchases of Company equity interests under such permission in the fiscal year ending January 31, 2018. The Amendment also provides that the aggregate amount paid in cash by the Company to effect the stock repurchase shall not be deducted from the Company’s consolidated EBITDA for the purposes of calculating the consolidated fixed charge coverage ratio covenant to which the Company is subject under the Credit Agreement with respect to any trailing four-fiscal-quarter measurement period through and including the measurement period ending January 31, 2018.

Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Business Overview

This section should be read in conjunction with the AstroNova condensed consolidated financial statements included elsewhere herein and our Annual Report on Form 10-K for the fiscal year ended January 31, 2017.

AstroNova is a multi-national enterprise that leverages its proprietary data visualization technologies to design, develop, manufacture, distribute and service a broad range of products that acquire, store, analyze and present data in multiple formats. The Company organizes its structure around a core set of competencies, including research and development, manufacturing, service, marketing and distribution. It markets and sells its products and services through the following two segments:

•

Product Identification—offers product identification and label printer hardware, software, servicing contracts, and parts and supplies. Parts and supplies refer to the media (substrate) and ink, toner, ribbon, etc., used with the Company’s printers and the various parts used to maintain the printers.

•

Test and Measurement (T&M)—offers a suite of products and services that acquire and record visual and electronic signal data from local and networked data stream and sensors as well as wired and wireless networks. The recorded data is processed and analyzed and then stored and presented in various visual output formats. The T&M segment also includes a line of aerospace printers that are used to print hard copies of data required for the safe and efficient operation of aircraft, including navigation maps, arrival and departure procedures, flight itineraries, weather maps, performance data, passenger data, and various air traffic control data. Other aerospace products include airborne and rugged networking devices. The Company also markets the media for use with the printers and other devices sold by the T&M segment.

The Company markets and sells its products and services globally through a diverse distribution structure of direct sales personnel, manufacturers’ representatives and authorized dealers that deliver a full complement of branded products and services to customers in our respective markets.

On February 1, 2017, AstroNova completed its acquisition of TrojanLabel ApS (TrojanLabel), a European manufacturer of digital color label presses and specialty printing systems for a broad range of end markets. TrojanLabel is being reported as part of our Product Identification segment beginning with the first quarter of fiscal year 2018. Refer to Note 4, “Acquisition,” in our condensed consolidated financial statements included elsewhere in this report for additional details.

Results of Operations

Three Months Ended April 29, 2017 vs. Three Months Ended April 30, 2016

Revenue by segment and current quarter percentage change over prior year for the three months ended April 29, 2017 and April 30, 2016 were:


(Dollars in thousands)	April 29, 2017		As a % of Revenue			April 30, 2016		As a % of Revenue			% Change Over Prior Year
Product Identification	$	18,646		76.2	%	$	16,606		68.9	%		12.3	%
T&M		5,812		23.8	%		7,504		31.1	%		(22.5	)%

Total	$	24,458		100.0	%	$	24,110		100.0	%		1.4	%

Revenue for the first quarter of the current year was $24.5 million, representing a 1.4% increase compared to the previous year first quarter revenue of $24.1 million. Revenue through domestic channels for the current year first quarter was $15.7 million, a decrease of 6.5% over the prior year’s first quarter. International revenue for the first quarter of the current year was $8.7 million, a 19.2% increase over the previous year first quarter and represents 36% of AstroNova’s first quarter’s revenue. Current year first quarter international revenue includes an unfavorable foreign exchange rate impact of $0.3 million.

Hardware revenue in the current quarter was $7.3 million, a decrease compared to prior year’s first quarter revenue of $8.7 million, primarily due to the decrease in hardware revenue in the Test & Measurement segment. Parts and supplies revenue in the current quarter were $14.8 million, an 11.0% increase over prior year’s first quarter parts and supplies revenue of $13.4 million. The current quarter increase in parts and supplies revenue compared to the first quarter of the prior year is attributable to increases in revenue of both digital color printer supplies and label and tag products within the Product Identification segment.

Service and other revenues of $2.3 million in the current quarter increased 15% from prior year first quarter service and other revenues of $2.0 million, primarily due to an increase in customer demand for parts and repair services during the current year first quarter.

Current year first quarter gross profit was $9.3 million, 1.8% less than prior year first quarter gross profit of $9.5 million. The Company’s current quarter gross profit margin of 38.0% reflects a 1.3 percentage point decrease from the prior year first quarter gross profit margin of 39.3%. The lower gross profit and related profit margin for the current quarter compared to prior year is primarily attributable to product mix, costs associated with the product line integration related to TrojanLabel and lower factory absorption in our manufacturing operations.

Operating expenses for the current quarter were $8.6 million, an increase compared to prior year first quarter operating expenses of $7.9 million. Specifically, selling and marketing expenses for the current quarter increased to $5.2 million compared to $4.8 million in the first quarter of the prior year due primarily to the addition of the TrojanLabel operations and amortization of the identifiable intangibles in connection with the acquisition.

G&A expenses increased in the first quarter to $1.9 million compared to $1.7 million in the prior year first quarter. The increase is primarily due to professional service costs related to the TrojanLabel acquisition. R&D expenses were $1.5 million in the current quarter, compared to $1.4 million in the prior year first quarter. The R&D spending as a percentage of revenue for the current quarter is 6.2% compared to 6.0% for the same period of the prior year.

Other expense during the first quarter was $48 thousand compared to $52 thousand in the first quarter of the previous year. Current year first quarter other expense consists primarily of foreign exchange loss and interest expense, partially offset by investment income. Prior year first quarter other expense consists primarily of foreign exchange loss, partially offset by investment income.

The provision for federal, state and foreign income taxes for the first quarter of the current year was $0.1 million which includes a benefit of $71 thousand related to the statute of limitations expiring on a previous uncertain tax position and a $14 thousand benefit related to windfall tax benefits related to the Company’s stock and reflects an effective tax rate of 22.3%. This compares to the prior year’s first quarter tax provision on income of $0.5 million, which included a benefit of $52 thousand related to the statute of limitations expiring on a previous uncertain tax position and reflected an effective tax rate of 31.8%.

The Company reported net income of $0.5 million for the first quarter of the current year, and earnings of $0.07 per diluted share, compared to the prior year first quarter net income of $1.0 million and related earnings of $0.14 per diluted share. Return on revenue was 2.1% for the first quarter of fiscal 2018 compared to 4.2% for the first quarter in fiscal 2017.

Segment Analysis

The Company reports two segments: Product Identification and Test & Measurement (T&M) and evaluates segment performance based on the segment profit before corporate and financial administration expenses. Summarized below are the Revenue and Segment Operating Profit for each reporting segment:


	Three Months Ended
	Revenue				Segment Operating Profit
(In thousands)	April 29, 2017		April 30, 2016		April 29, 2017			April 30, 2016
Product Identification	$	18,646	$	16,606	$	2,492		$	1,996
T&M		5,812		7,504		71			1,202

Total	$	24,458	$	24,110		2,563			3,198

Corporate Expenses						1,856			1,651

Operating Income						707			1,547
Other Expense						(48	)		(52	)

Income Before Income Taxes						659			1,495
Income Tax Provision						147			476

Net Income					$	512		$	1,019

Product Identification

Revenue from the Product Identification segment increased 12.3% in the first quarter of the current year, with revenue of $18.6 million compared to $16.6 million in the same period of the prior year. Hardware revenue increased 19.0% compared to prior year aided by the contribution of printer revenue from TrojanLabel. Sales of Product Identification’s new QL800 printers also contributed to the increase in current year first quarter hardware revenue. The current year first quarter revenue also received a strong contribution from parts and supplies; revenues from that product line increased 10.9% from the same period in the prior year due to the continued increase in demand for label and tag products, as well as digital color printer supplies, both of which have experienced double-digit growth in the current year first quarter compared to the same period in the prior year. The Product Identification segment current quarter segment operating profit was $2.5 million, reflecting a profit margin of 13.4%. This compares to prior year’s first quarter segment profit of $2.0 million and related profit margin of 12.0 %. The increase in Product Identification current year first quarter segment operating margin is primarily due to higher sales and favorable product mix.

Test & Measurement—T&M

Revenue from the T&M products was $5.8 million for the first quarter of the current fiscal year, representing a 22.5% decrease compared to revenue of $7.5 million for the same period in the prior year. The decrease is due primarily to the decline in revenue in the Aerospace product group as a result of timing on fulfilling orders placed and decreased revenue from certain legacy data recorders.

The T&M segment first quarter segment operating profit of $71 thousand and 1.2% profit margin compared to the prior year segment operating profit of $1.2 million and related operating margin of 16.0%. The lower segment operating profit and related margin were due to lower revenue and unfavorable product mix.

Financial Condition and Liquidity

Based upon our current working capital position, current operating plans and expected business conditions, we expect to fund our short and long-term working capital needs, capital expenditures and acquisition requirements primarily using internal funds, and we believe that cash provided by operations will be sufficient to meet our operating and capital needs for at least the next 12 months.

We may also utilize amounts available under our secured credit facility, as described below, to fund a portion of our capital expenditures, contractual contingent consideration obligations, and future acquisitions.

On February 28, 2017, we entered into a credit agreement with Bank of America, N.A., which provided for a secured credit facility consisting of a $9.2 million term loan and a $10.0 million revolving credit facility. No amount has been drawn under the revolving credit facility as of the filing date of this report, and the entire revolving credit facility is currently available. Refer to Note 10, “Debt,” to our condensed consolidated financial statements included elsewhere in this quarterly report for additional information regarding our new secured credit facility.

The term loan bears interest at a rate per annum equal to the LIBOR rate plus a margin that varies within a range of 1.0% to 1.5% based on the Company’s consolidated leverage ratio. In connection with our entry into the credit agreement, a subsidiary of the Company entered into a hedging arrangement to manage the variable interest rate risk and currency risk associated with its payments in respect of the term loan. Under these arrangements, payments of principal and interest in respect of approximately $8.9 million of the principal of the term loan will be made in Danish Krone, and interest on such principal amount will be payable at a fixed rate of 0.67% per annum for the entire term, subject only to potential increases of 0.25% or 0.50% per annum based on the Company’s consolidated leverage ratio.

Refer to Note 11, “Derivative Financial Instruments and Risk Management,” to our condensed consolidated financial statements included elsewhere in this quarterly report for additional information regarding our hedging arrangements.

The Company’s statements of cash flows for the three months ended April 29, 2017 and April 30, 2016 are included on page 6 of this report. Net cash flows used by operating activities were $0.8 million for the first quarter of fiscal 2018 compared to $2.9 million of cash provided for the same period of the previous year. The decrease in operating cash flow is related to lower net income and higher working capital requirements for the first three months of the current year compared to the same period in the previous year. Excluding the impact of the TrojanLabel acquisition, the accounts receivable balance decreased to $14.7 million at the end of the first quarter compared to $15.7 million at year-end and the accounts receivable collection cycle increased to 53 days from 50 days sales outstanding at year-end. Inventory remained steady at $19.5 million at the end of the first quarter compared to year-end after excluding the TrojanLabel acquisition. Inventory days on hand increased to 121 days on hand at the end of the current quarter from 92 days at year-end.

The Company’s cash, cash equivalents and investments at the end of the first quarter were $23.8 million, compared to $24.8 million at year-end. The decreased cash and investment position at April 29, 2017, resulted from lower net income and cash used to purchase Trojan label, as well as cash used in operations as discussed above, dividends paid of $0.5 million and cash used to acquire property, plant and equipment of $0.4 million, partially offset by proceeds from issuance of long-term debt.

The Company’s backlog increased 3.4% from year-end to $18.2 million at the end of the first quarter of fiscal 2018.

Contractual Obligations, Commitments and Contingencies

Except as set forth below, there have been no material changes to our contractual obligations as disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2017, other than those which occur in the ordinary course of business.

On February 28, 2017, the Company and the Company’s wholly-owned subsidiary, ANI ApS, entered into a Credit Agreement with Bank of America, N.A. which provides for a term loan in the amount of $9.2 million. Future minimum principal and interest payments are approximately $9.7 million through the term loan’s maturity date of January 31, 2022.

Critical Accounting Policies, Commitments and Certain Other Matters

In the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2017, the Company’s most critical accounting policies and estimates upon which our financial status depends were identified as those relating to revenue recognition, warranty claims, bad debts, inventories, income taxes, long-lived assets, goodwill and share-based compensation. We considered the disclosure requirements of Financial Release (“FR”) 60 regarding critical accounting policies and FR-61 regarding liquidity and capital resources, certain trading activities and related party disclosures, and concluded that nothing materially changed during the quarter that would warrant further disclosure under these releases.

Forward-Looking Statements

This Quarterly Report on Form 10-Q may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect our current expectations concerning future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Factors which could cause actual results to differ materially from those anticipated include, but are not limited to (a) general economic, financial and business conditions; (b) declining demand in the test and measurement markets, especially defense and aerospace; (c) competition in the specialty printer industry; (d) ability to develop market acceptance of our products and effective design of customer required features; (e) competition in the data acquisition industry; (f) the impact of changes in foreign currency exchange rates on the results of operations; (g) the ability to successfully integrate acquisitions and realize benefits from divestitures; (h) the business abilities and judgment of personnel and changes in business strategy; (i) the efficacy of research and development investments to develop new products; (j) the launching of significant new products which could result in unanticipated expenses; (k) bankruptcy or other financial problems at major suppliers or customers that could cause disruptions in the Company’s supply chain or difficulty in collecting amounts owed by such customers; and (l) other risks included under “Item 1A-Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2017. We assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We have exposure to financial market risks, including changes in foreign currency exchange rates and interest rates.

Foreign Currency Exchange Risk

The functional currencies of our foreign subsidiaries and branches are the local currencies – the British Pound in the UK, the Canadian Dollar in Canada, the Danish Krone in Denmark and the Euro in France and Germany. Accordingly, the effects of exchange rate fluctuations on the net assets of these foreign subsidiaries’ operations are accounted for as translation gains or losses in accumulated other comprehensive income (loss) within stockholders’ equity. We do not believe that a change of 10% in such foreign currency exchange rates would have a material impact on our consolidated financial position or results of operations.

The Company is also subject to risk from the effects of exchange rate movements in foreign currency through its borrowings, specifically our U.S. dollar borrowing at our Danish Krone functional currency subsidiary. We entered into a cross-currency interest rate swap to hedge the foreign currency cash flow and interest rate exposures related to the U.S. Dollar floating-rate debt included on the books of our Danish subsidiary (functional currency is Danish Krone). A 10% change in the rate of exchange of Danish Krone to U.S. Dollars would result in a change in our debt balance of approximately $0.9 million.

Interest Rate Risk

As of April 29, 2017, the Company’s debt portfolio was comprised of U.S. Dollar, floating-rate borrowings on the books of our Danish subsidiary. We entered into a cross-currency interest rate swap to convert the floating-rate foreign currency debt on our foreign subsidiary, to a fixed-rate functional currency debt. Generally, the fair market value of fixed interest rate debt will increase as interest rates fall and decrease as interest rates rise. If Danish Krone interest rates were to decrease by 50 basis points, the fair value of the Company’s debt would increase by approximately $0.1 million. If interest rates were to increase by 50 basis points, the fair value of the Company’s debt would decrease by approximately $ 0.1 million.

At April 29, 2017, we had cash and cash equivalents of $23.8 million, of which $11.0 million is available for working capital and other operating requirements, $5.7 million is held in foreign bank accounts and $1.9 million is held in highly liquid money market funds with original maturities of 90 days or less. We also have $5.2 million of securities available for sale, which include state and municipal securities with maturities ranging from one month to two years. We do not enter into investments for trading or speculative purposes. We do not believe that we have material exposure to changes in fair value of these investments as a result of changes in interest rates due to the short-term nature of these investments.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management has evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (Exchange Act). Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to have materially affected, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

There are no pending or threatened legal proceedings against the Company believed to be material to the financial position or results of operations of the Company.

Item 1A. Risk Factors

In addition to the other information set forth in this Quarterly Report on Form 10-Q, one should carefully consider the factors discussed in Part I, Item 1A “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2017, which could materially affect our business, financial condition or future operating results. The risks described in our Annual Report on 10-K are not the only risks that could affect our business, as additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results as well as adversely affect the value of our common stock.

There have been no material updates to the risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2017.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the first quarter of fiscal 2018, the Company made the following repurchases of its common stock:


	Total Number of Shares Repurchased			Average Price paid Per Share			Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Maximum Number of Shares That May Be Purchased Under The Plans or Programs
February 1—February 28		—		$	—			—		390,000
March 1—March 31		14,082	(a)(b)(c)	$	14.45	(a)(b)(c)		—		390,000
April 1—April 29		372	(d)	$	14.45	(d)		—		390,000

(a)

Employees of the Company delivered 3,178 shares of the Company’s common stock toward the satisfaction of taxes due with respect to vesting of restricted shares. The shares delivered were valued at an average market value of $12.88 per share and are included with treasury stock in the consolidated balance sheet. This transaction did not impact the number of shares authorized for repurchase under the Company’s current repurchase program.

(b)

The Company’s Chief Executive Officer delivered 446 shares of the Company’s common stock toward the satisfaction of taxes due with respect to vesting of restricted shares. The shares delivered were valued at an average market value of $13.55 per share and are included with treasury stock in the consolidated balance sheet. This transaction did not impact the number of shares authorized for repurchase under the Company’s current repurchase program.

(c)

Employees of the Company delivered 10,458 shares of the Company’s common stock to satisfy the exercise price for 12,400 stock options exercised. The shares delivered were valued at an average market value of $14.97 per share and are included with treasury stock in the consolidated balance sheet. This transaction did not impact the number of shares authorized for repurchase under the Company’s current repurchase program.

(d)

An employee of the Company delivered 372 shares of the Company’s common stock to satisfy the exercise price for 600 stock options exercised. The shares delivered were valued at an average market value of $14.45 per share and are included with treasury stock in the consolidated balance sheet. This transaction did not impact the number of shares authorized for repurchase under the Company’s current repurchase program.

Item 6. Exhibits


3A		Restated Articles of Incorporation of the Company and all amendments thereto (incorporated by reference to Exhibit 3A to the Company’s Quarterly Report on Form 10-Q for the quarter ended April 30, 2016).

3B		By-laws of the Company as amended to date (incorporated by reference to Exhibit 3B to the Company’s Annual Report on Form 10-Q for the fiscal year ended January 31, 2008 (File no. 000-13200)).

10.1		Credit Agreement dated February 28, 2017 among AstroNova, Inc., as the U.S. Borrower, ANI ApS, as the Danish Borrower, certain subsidiaries of the U.S. Borrower, as the Guarantors, and Bank of America, N.A. (incorporated by reference to Exhibit 10.16 to the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2017).

10.2		Security and Pledge Agreement dated February 28, 2017 among AstroNova, Inc., as the U.S. Borrower, and such other parties that become Grantors hereunder after the date thereof and Bank of America, N.A. (incorporated by reference to Exhibit 10.18 to the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2017).

10.3		Stock Purchase Agreement, dated as of May 1, 2017, by and among AstroNova, Inc. and the trust established by Albert W. Ondis by Declaration of Trust dated December 4, 2003, as amended (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, event date May 1, 2017, filed with the SEC on May 5, 2017).

10.4		Consent under Credit Agreement, dated as of May 1, 2017, by and among AstroNova, Inc., ANI ApS, Trojanlabel ApS, and Bank of America, N.A. (incorporated by referenced to Exhibit 10.2 to the Company’s Current Report on Form 8-K, event date May 1, 2017, filed with the SEC on May 5, 2017).

10.5		AstroNova, Inc. Amended and Restated Non-Employee Director Annual Compensation Program, as amended.*

31.1		Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2		Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101		The following materials from Registrant’s Quarterly Report on Form 10-Q for the period ended April 29, 2017, formatted in XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Income, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statements of Cash Flows, and (vi) the Notes to the Condensed Consolidated Financial Statements. Filed electronically herein.

*	Management contract or compensatory plan or arrangement.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	ASTRONOVA, INC. (Registrant)

Date: June 7, 2017	By	/s/ Gregory A. Woods
		Gregory A. Woods,
		President and Chief Executive Officer
		(Principal Executive Officer)

	By	/s/ John P. Jordan
		John P. Jordan,
		Vice President, Chief Financial Officer and Treasurer (Principal
		Accounting Officer and Principal Financial Officer)

EX-10.5 2 d379017dex105.htm EX-10.5 EX-10.5

Exhibit 10.5

ASTRONOVA, INC.

AMENDED AND RESTATED

NON-EMPLOYEE DIRECTOR ANNUAL COMPENSATION PROGRAM

This Amended and Restated Non-Employee Director Annual Compensation Program (the “Program”), effective as of August 1, 2016 (the “Effective Date”), sets forth the annual compensation payable to members of the Board of Directors (the “Board) of AstroNova, Inc. (the “Company”) who are not also officers or other employees of the Company (each a “Non-Employee Director” and collectively, the “Non-Employee Directors”) for their Service as members of the Board. Each Non-Employee Director who is eligible to receive an Award of Restricted Stock under this Program is hereinafter referred to as a “Participant.” Capitalized terms used, but not otherwise defined, in this Program shall have the meanings set forth in the Company’s 2015 Equity Incentive Plan (the “Plan”).

Eligibility and Participation.

(a) A Non-Employee Director of the Company shall automatically become a Participant in the Program as of the later of (i) the Effective Date, or (ii) the date of such person’s initial election to the Board. A Director who is an officer or other employee of the Company is not eligible to participate in the Program.

(b) A Participant shall cease participation in the Program as of the date the Participant (i) fails to be re-elected to the Board, (ii) resigns or otherwise ceases to be a member of the Board, or (iii) becomes an officer or other employee of the Company.

Restricted Stock Awards.

(a) Each Non-Employee Director of the Company shall be automatically granted the following Awards of Restricted Stock: Commencing with the third fiscal quarter of fiscal year 2017, on the first business day of each fiscal quarter of each fiscal year, each Non-Employee Director on such day shall receive a number of whole shares of Restricted Stock equal to twenty-five percent (25%) of the number calculated by dividing the Director Compensation Amount (as hereinafter defined) by the Fair Market Value of the Company’s Stock on such day. The Director Compensation Amount shall be $55,000 for the remainder of fiscal year 2017, $65,000 for fiscal year 2018 and $75,000 for fiscal year 2019.

(b) In addition to the grants specified in Section 2(a), commencing with the third fiscal quarter of fiscal year 2017, and for each fiscal year thereafter, if the Program is still in effect, on the first business day of each fiscal quarter of such fiscal year, a Non-Employee Director shall automatically be granted the following Awards of Restricted Stock, as applicable:

(i) each Non-Employee Director serving as Chairman of the Board on such day shall receive a number of whole shares of Restricted Stock equal to twenty-five percent (25%) of the number calculated by dividing $6,000 by the Fair Market Value of the Company’s Stock on such day;

(ii) each Non-Employee Director serving as Chairman of the Audit Committee on such day shall receive a number of whole shares of Restricted Stock equal to twenty-five percent (25%) of the number calculated by dividing $4,000 by the Fair Market Value of the Company’s Stock on such day; and

(iv) each Non-Employee Director serving as Chairman of the Compensation Committee on such day shall receive a number of whole shares of Restricted Stock equal to twenty-five percent (25%) of the number calculated by dividing $4,000 by the Fair Market Value of the Company’s Stock on such day.

(c) In each of the foregoing calculations, the resulting number shall be rounded down to the nearest whole number of shares of Restricted Stock.

(d) All of the foregoing Awards of Restricted Stock shall be deemed made under the Plan, and all such Awards and this Program shall be subject to all of the provisions of the Plan. In addition to the terms and conditions of the Plan, each such Award of Restricted Stock shall be subject to the terms and conditions of this Program.

(e) If a person becomes a Non-Employee Director, Chairman of the Board or Chairman of the Audit or Compensation Committee other than on the first day of a fiscal quarter of the Company, such person shall receive an Award of Restricted Stock on such day with respect to the balance of such quarter, calculated in accordance with the foregoing provisions of this Section 2 but appropriately prorated to reflect the number of days remaining in the quarter and the total number of days in the quarter.

(f) Awards of Restricted Stock under this Program shall be evidenced by, and subject to the terms of, a Restricted Stock Agreement in a form approved by the Compensation Committee of the Board (the “Compensation Committee”). Restricted Stock Agreements shall comply, as applicable, with and be subject to the terms of the Plan and this Program.

(g) No Non-Employee Director shall receive cash compensation or meeting fees for such person’s Service as a Director, as Chairman of the Board or as Chairman of the Audit or Compensation Committee or Service on any Board Committee. However, each Non-Employee Director will continue to receive reimbursement in accordance with the Company’s policies for appropriate expenses incurred in connection with Service as a member of the Board or any Committee thereof.

Terms and Conditions.

(a) Vesting. Restricted Stock received pursuant to the Program shall become fully vested on the date that is three months following the date of grant, subject to the holder of the Restricted Stock’s continuing Service as a member of the Board. If a Director’s Service as a member of the Board terminates other than for death or Disability, no further Restricted Stock will vest following the date of such termination, and all Restricted Stock which is unvested at the time of such termination will be forfeited. The foregoing notwithstanding, in the event of a Non-Employee Director’s death or Disability or a Change in Control of the Company during such Director’s Service as a member of the Board, all Restricted Stock granted under this Program to

such Non-Employee Director which has not vested before such event shall become immediately vested and no longer subject to restrictions on Transfer hereunder. The Committee may, in its discretion, remove, modify or accelerate the release of restrictions on any Restricted Shares, including upon a Change in Control.

(b) Restrictions on Transfer. Other than as part of a Change in Control, a Non-Employee Director may not sell, transfer, assign, pledge or otherwise encumber (collectively, “Transfer”) any Restricted Stock subject to a Restricted Stock Award or any interest therein until such Restricted Stock has vested. In addition, a Non-Employee Director may not Transfer any Restricted Stock if such Non-Employee Director has not satisfied the requirements of any stock ownership guidelines established for Directors by the Board or if such Transfer would cause the Non-Employee Director to be out of compliance with any such guideline. The periods during which all or any Restricted Stock is subject to forfeiture or restrictions on Transfer as provided in this Section 3 is referred to herein as a “Restricted Period” with respect to such Restricted Stock.

(c) Voting Rights; Dividends. Subject to the other provisions of this Section 3, during the Restricted Period applicable to shares of Restricted Stock subject to a Restricted Stock Award held by a Non-Employee Director, the Non-Employee Director shall have all of the rights of a shareholder of the Company holding shares of Stock, including the right to vote such shares and to receive all dividends and other distributions paid with respect to such shares; provided, however, that if any such dividends or distributions are paid in shares of Stock, such shares shall be subject to the same vesting schedule and restrictions on Transfer as the shares subject to the Restricted Stock Award with respect to which the dividends or distributions were paid.

(d) End of Restricted Period. On the expiration or termination of a Restricted Period, the restrictions on Transfer for the relevant Restricted Stock shall lapse, and it shall be free of all restrictions (except any that may be imposed by law or by any applicable stock ownership guidelines). The ownership by the relevant Non-Employee Director of the shares of Restricted Stock with respect to which the restrictions have lapsed shall be evidenced by either (i) a stock certificate or (ii) a book entry or other appropriate electronic record, registered in the name of the Holder.

(e) Forfeiture of Restricted Stock. In the event of the forfeiture of any Restricted Stock, the Company shall reacquire such Restricted Stock without the payment of consideration in any form to such holder of such Restricted Stock, and the holder of such Restricted Stock shall unconditionally forfeit any right, title or interest to such Restricted Stock. Automatically and without action by any person, all forfeited Restricted Stock and certificates therefor shall be transferred and delivered to the Company. The Committee may, in its sole discretion, waive in writing the Company’s right to reacquire some or all of a holder’s Restricted Stock and any Restricted Stock subject to such a waiver no longer be subject to forfeiture.

(f) Taxes. Each Non-Employee Director will be fully liable for any federal, state or local taxes of any kind owed by him or her with regard to issuance of the Restricted Stock, whether owed at the time of issuance pursuant to the Non-Employee Director having

made an election under Section 83(b) of the Internal Revenue Code of 1986, as amended, or at the time that the Shares vest pursuant to the vesting schedule set forth in this Section 3.

4. Administration. The Program shall be administered by the Compensation Committee of the Board. All questions of interpretation of the Program or of any Award shall be determined by the Committee, and such determinations shall be final and binding upon all persons having an interest in the Program and such Award.

5. Amendment or Termination. The Compensation Committee may terminate or amend this Program. The termination of the Program shall not affect outstanding Restricted Stock, whether or not vested. This Program amends and restates in its entirety the Astro-Med, Inc. Amended and Restated Non-Employee Director Annual Compensation Program, effective as of February 1, 2014, which shall be of no further force or effect on and after the Effective Date.

6. Implied Consent. Every Participant, by acceptance of an Award under this Program, shall be deemed to have consented to be bound, on his or her own behalf and on behalf of his or her heirs, legal representatives, successors and assigns by all of the terms and conditions of this Program.

EX-31.1 3 d379017dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Gregory A. Woods certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of AstroNova, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: June 7, 2017

/s/ Gregory A. Woods

Gregory A. Woods,

President and Chief Executive Officer

(Principal Executive Officer)

EX-31.2 4 d379017dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION

Certification of Chief Financial Officer Section 302 of the Sarbanes-Oxley Act of 2002

I, John P. Jordan, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of AstroNova, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: June 7, 2017

/s/ John P. Jordan

John P. Jordan,

Vice President, Chief Financial Officer and Treasurer (Principal Accounting Officer and Principal Financial Officer)

EX-32.1 5 d379017dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

ASTRONOVA, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of AstroNova, Inc. (the “Company”) on Form 10-Q for the period ended April 29, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregory A. Woods, President and Chief Executive Officer, certify, pursuant to Rule 13a-14(b) and 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: June 7, 2017

/s/ Gregory A. Woods

Gregory A. Woods,

President and Chief Executive Officer

(Principal Executive Officer)

A signed original of this written statement required by Section 906 has been provided to AstroNova, Inc. and will be retained by AstroNova, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 6 d379017dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

ASTRONOVA, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of AstroNova, Inc. (the “Company”) on Form 10-Q for the period ended April 29, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John P. Jordan, Vice President, Chief Financial Officer and Treasurer of the Company, certify, pursuant to Rule 13a-14(b) and 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: June 7, 2017

/s/ John P. Jordan

John P. Jordan,

Vice President, Chief Financial Officer and Treasurer (Principal Accounting Officer and Principal Financial Officer)

EX-101.INS 7 alot-20170429.xml XBRL INSTANCE DOCUMENT

9200000

6729718

5000000

12000000

826305

11200000

36000

14534000

9300

15810

2201000

1611000

10144000

0.05

31520000

6796000

9886003

94140000

61777000

1322000

13000000

48207000

5185000

18637000

2805000

16053000

495000

5120000

370000

-1313000

677000

1954000

7941000

1914000

11184000

24434000

1104000

20336000

1715000

23400000

94140000

8249000

11958000

1168000

2438000

12344000

117000

12082000

23129000

4098000

393000

9234000

40754000

70740000

12.19

10.89

426831

1595000

673000

44341000

12.19

2385534

1566000

20990000

724820

5185000

393000

1322000

1611000

9200000

155000

7941000

9200000

2208000

1104000

2576000

1840000

1104000

1472000

800000

210640

14.10

9025

393600

8600000 8900000

3100000

1190000

1910000

2830000

271000

2559000

950000

348000

602000

3264000

937000

23000

919000

2327000

82000

2259000

43717

205983

500000

886

5188000

5185000

15.01

15.07

12500

55000

7.84

188056

13.20

13.55

226275

481764

-48000

-1269000

4000

-1313000

10043000

2936000

2000

6880000

0.05

31098000

6725000

9834906

83665000

61423000

13000000

47524000

6723000

18098000

2811000

15702000

492000

4957000

472000

-1056000

11000

2171000

1616000

10270000

23351000

19506000

13128000

83665000

5264000

4521000

1216000

1132000

11985000

366000

11865000

12962000

3845000

9280000

40378000

70537000

11.96

1449000

708000

44358000

2375076

1394000

20781000

685456

6723000

2000

213868

14.11

3100000

1108000

1992000

2830000

207000

2623000

950000

301000

649000

6732000

6723000

-1048000

-8000

-1056000

1322000

166000

15000

796000

114000

3264000

695000

1314000

9007000

7388000

6400000 900000 1821000 7400000

32500000

5000000

40600000

5800000

48700000

7000000

10000000

9200000

13.60

5000

19000

108200

5000

14000

4166

976000.0

100000

62900000

9100000

P7Y 0.80 1.00 1.20

52189

537

50000

35000

37000

P3Y

155000

80000

4030

50000

600000

9000

5000

AstroNova, Inc.

472214

10-Q 0000008146

2017-04-29

539000

288000

2018 false

0.07

<div> (16) Accumulated Other Comprehensive Loss The changes in the balance of accumulated other comprehensive loss by component are as follows:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="53%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom" nowrap="nowrap"> (In thousands) </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Foreign Currency Translation Adjustments</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Unrealized Holding Gain/(Loss) on Available for Sale Securities</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Net Unrealized Gain(Losses) on Cash Flow Hedges</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Balance at January 31, 2017 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,048</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(8</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,056</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Other Comprehensive Income (Loss) before reclassification </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(221</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(259</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(468</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Amounts reclassified from AOCI to Earnings </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">211</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">211</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Other Comprehensive Income (Loss) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(221</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(48</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(257</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Balance at April 29, 2017 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,269</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(48</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,313</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> The amounts presented above in other comprehensive income (loss) are net of any applicable taxes. </div>

--01-31

1856000

0.07

<div> (11) Derivative Financial Instruments and Risk Management As a multinational enterprise, AstroNova is exposed to certain risks relating to our ongoing business operations. We employ a number of practices to manage these risks, including operating and financing activities, and where appropriate, the use of derivative instruments. The primary risks managed by using derivative instruments are interest rate risk and foreign currency exchange rate risk. ASC 815, “Derivatives and Hedging,” requires the Company to recognize all of its derivative instruments as either assets or liabilities in the statement of financial position at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. For derivative instruments not designated as hedging instruments, the gain or loss is recognized in the statement of income during the current period. For derivative instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income (OCI) and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings (e.g., in “interest expense” when the hedged transactions are interest cash flows associated with floating-rate debt, or “other income (expense)” for portions reclassified relating to the remeasurement of the debt). The remaining gain or loss on the derivative instrument in excess of the cumulative change in the present value of future cash flows of the hedged item, if any (i.e., the ineffectiveness portion), or hedge components excluded from the assessment of effectiveness, are recognized in the statement of financial income during the current period. In connection with the Credit Agreement, we entered into a cross-currency interest rate swap to manage the interest rate risk and foreign currency exchange risk associated with the floating-rate foreign currency-denominated borrowing on our Danish Subsidiary and, in accordance to the guidance in ASC 815, have designated this swap as a cash flow hedge of floating-rate borrowings. The cross-currency interest rate swap agreement utilized by the Company effectively modifies the Company’s exposure to interest rate risk and foreign currency exchange rate risk by converting approximately $8.9 million of the Company’s floating-rate debt denominated in U.S. Dollars on our Danish subsidiary’s books to a fixed-rate debt denominated in Danish Krone for the next five years, thus reducing the impact of interest-rate and foreign currency exchange rate changes on future interest expense and principal repayments. This swap involves the receipt of floating rate amounts in U.S. Dollars in exchange for fixed-rate interest payments in Danish Krone, as well as exchanges of principal at the inception spot rate, over the life of the Credit Agreement.   As of April 29, 2017, the total notional amount of the Company’s cross-currency interest rate swap was $8.6 million; the fair value was $393,600. The following table presents the impact of the derivative instrument in our condensed consolidated financial statements:   <table style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="36%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom" rowspan="2" nowrap="nowrap"> Cash Flow Hedge </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center">Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" rowspan="2" align="center">Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center">Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">January 31, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">January 31, 2017</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Swap contract </td> <td valign="bottom">  </td> <td valign="top">$</td> <td valign="top" align="right">(392,636</td> <td valign="top" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="top" nowrap="nowrap">$</td> <td valign="top" nowrap="nowrap" align="right"> —  </td> <td valign="top" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" align="center"> Other Income (Expense)</td> <td valign="bottom">  </td> <td valign="top">$</td> <td valign="top" align="right">(320,076</td> <td valign="top" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="top" nowrap="nowrap">$</td> <td valign="top" nowrap="nowrap" align="right"> —  </td> <td valign="top" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> The swap contract resulted in no ineffectiveness for the three months ended April 29, 2017, and no gains or losses were reclassified into earnings as a result of the discontinuance of the swap contract due to the original forecasted transaction no longer being probable of occurring. At April 29, 2017, the Company expects to reclassify $108,200 of net gains on the swap contract from accumulated other comprehensive income to earnings during the next 12 months due to changes in foreign exchange rates and the payment of variable interest associated with the floating-rate debt. </div>

715000

<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> (7) Share-Based Compensation <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> We have two equity incentive plans—the 2007 Equity Incentive Plan (the “2007 Plan”) and the 2015 Equity Incentive Plan (the “2015 Plan”). Under these plans, the Company may grant incentive stock options, non-qualified stock options, stock appreciation rights, time or performance-based restricted stock units (RSUs), restricted stock awards (RSAs), and other stock-based awards to executives, key employees, directors and other eligible individuals. At April 29, 2017, 886 shares were available for grant under the 2007 Plan. The 2007 Plan expires in May 2017. The 2015 Plan authorizes the issuance of up to 500,000 shares (subject to adjustment for stock dividends and stock splits), and at April 29, 2017, 205,983 shares were available for grant under the 2015 Plan. The 2015 Plan will expire in May 2025. Options granted to employees under both plans vest over four years and expire after ten years. The exercise price of each stock option is established at the discretion of the Compensation Committee; however, any incentive stock options granted under the 2007 Plan, and all options granted under the 2015 Plan, must be issued at an exercise price of not less than the fair market value of the Company’s common stock on the date of grant. <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Under the plans, each non-employee director receives an automatic annual grant of ten-year options to purchase 5,000 shares of stock upon the adjournment of each annual shareholders meeting. Each such option is exercisable at the fair market value of the Company’s common stock as of the grant date, and vests immediately prior to the next annual shareholders’ meeting. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> The Company has a Non-Employee Director Annual Compensation Program (the “Program”) under which each non-employee director receives an automatic grant of RSAs on the first business day of each fiscal quarter. Under the Program, the number of whole shares to be granted each quarter is equal to 25% of the number calculated by dividing the director compensation amount by the fair market value of the Company’s stock on such day. The director annual compensation amount was $55,000 in fiscal year 2017, and $65,000, and $75,000 for fiscal 2018 and 2019, respectively. In addition, the Chairman of the Board receives RSAs with an aggregate value of $6,000, and the Chairs of the Audit and Compensation Committees each receive RSAs with an aggregate value of $4,000, also issued in quarterly installments and calculated in the same manner as the directors’ RSA grants. RSAs granted prior to March 30, 2017 become fully vested on the first anniversary of the date of grant. RSAs granted subsequent to March 30, 2017 become vested three months after the date of grant. A total of 7,233 and 567 shares were awarded to the non-employee directors as compensation under the Program in the first quarter of fiscal 2018 and 2017, respectively. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In April 2013 (fiscal year 2014), the Company granted options and RSUs to officers (“2014 RSUs”). The 2014 RSUs vested as follows: twenty-five percent vested on the third anniversary of the grant date, fifty percent vested upon the Company achieving its cumulative budgeted net revenue target for fiscal years 2014 through 2016 (the “Measurement Period”), and twenty-five percent vested upon the Company achieving a target average annual ORONA (operating income return on net assets as calculated under the Domestic Management Bonus Plan) for the Measurement Period. The grantee may not sell, transfer or otherwise dispose of more than fifty percent of the common stock issued upon vesting of the 2014 RSUs until the first anniversary of the vesting date. In April 2016, 9,300 of the 2014 RSUs vested, as the Company achieved the targeted average annual ORONA, as defined in the plan, for the Measurement Period and another 9,300 vested as a result of the third year anniversary date of the grant. Additionally, on February 1, 2014, the Company accelerated the vesting of 4,166 of the 2014 RSUs held by Everett Pizzuti in connection with his retirement. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In May 2015 (fiscal year 2016), the Company granted an aggregate of 80,000 time-based and 155,000 performance-based RSUs (“2016 RSUs”) to certain officers of the Company. The time-based 2016 RSUs vest in four equal annual installments commencing on the first anniversary of the grant date. The performance-based 2016 RSUs vest over three years based upon the increase in revenue, if any, achieved each fiscal year relative to a three-year revenue increase goal. Performance-based 2016 RSUs that are earned based on organic revenue growth are fully vested when earned, while those earned based on revenue growth via acquisitions vest annually over a three-year period following the fiscal year in which the revenue growth occurs. Any performance-based 2016 RSUs that have not been earned at the end of the three-year performance period will be forfeited. The expense for such shares is recognized in the fiscal year in which the results are achieved, however, the shares are not fully earned until approved by the Compensation Committee in the first quarter of the following fiscal year. 2016 RSUs earned in the first quarter of fiscal 2018 and 2017 were 9,025 and 15,810, respectively. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In March 2015 (fiscal year 2016), the Company granted 50,000 options and 537 RSAs to its CEO pursuant to the CEO Equity Incentive Agreement, and 35,000 options to other key employees. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In March 2016 (fiscal year 2017), the Company granted 50,000 options and 4,030 RSAs to its CEO pursuant to the CEO Equity Incentive Agreement. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In May 2016 (fiscal year 2017) the Company granted 37,000 options to certain key employees. On August 1, 2016 (fiscal year 2017) the Company granted 5,000 options to its Chief Financial Officer. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In March 2017 (fiscal year 2018), the Company granted 50,000 options to the Chief Executive Officer pursuant to the CEO Equity Incentive Agreement and in February and April 2017 (fiscal year 2018) the Company granted 52,189 options to certain other key employees. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> The options and RSAs granted March 2015 through March 2017 vest in four equal annual installments commencing on the first anniversary of the grant date. <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Share-based compensation expense was recognized as follows: <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="80%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center">Three Months Ended</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">April 30, 2016</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Stock Options </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">94</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">81</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="top"> Restricted Stock Awards and Restricted Stock Units </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">74</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">230</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Employee Stock Purchase Plan </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="top"> Total </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">171</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">314</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Stock Options <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> The fair value of stock options granted during the three months ended April 29, 2017 and April 30, 2016 was estimated using the following weighted average assumptions: <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="80%"></td> <td valign="bottom" width="7%"></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="3" align="center">Three Months Ended</td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center">April 29, 2017</td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center">April 30, 2016</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Risk Free Interest Rate </td> <td valign="bottom">  </td> <td valign="bottom" align="center">  1.7%</td> <td valign="bottom"> </td> <td valign="bottom" align="center">  1.5%</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="top"> Expected Volatility </td> <td valign="bottom">  </td> <td valign="bottom" align="center">36.6%</td> <td valign="bottom"> </td> <td valign="bottom" align="center">24.6%</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Expected Life (in years) </td> <td valign="bottom">  </td> <td valign="bottom" align="center">  7.5</td> <td valign="bottom"> </td> <td valign="bottom" align="center">  5.0</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="top"> Dividend Yield </td> <td valign="bottom">  </td> <td valign="bottom" align="center">  2.1%</td> <td valign="bottom"> </td> <td valign="bottom" align="center">  1.9%</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> The weighted average fair value per share for options granted was $4.11 during the three months ended April 29, 2017, compared to $2.86 during the three months ended April 30, 2016. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Aggregated information regarding stock options granted under the plans for the three months ended April 29, 2017, is summarized below: <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="70%"></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Number of Options</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Weighted Average Exercise Price</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Outstanding at January 31, 2017 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">685,456</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">11.96</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="top"> Granted </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">102,189</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">13.31</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Exercised </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(43,125</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11.50</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="top"> Forfeited </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Canceled </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(19,700</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11.75</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="top"> Outstanding at April 29, 2017 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">724,820</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12.19</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Set forth below is a summary of options outstanding at April 29, 2017: <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="22%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="12" nowrap="nowrap" align="center"> Outstanding </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="10" align="center">Exercisable</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="bottom" nowrap="nowrap"> Range of Exercise prices </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Number of Shares</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Weighted- Average Exercise Price</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Weighted- Average Remaining Contractual Life</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Number of Shares</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Weighted- Average Exercise Price</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Weighted Average Remaining Contractual Life</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> $5.00-10.00 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">188,056</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7.84</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3.6</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">188,056</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7.84</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3.6</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="top"> $10.01-15.00 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">481,764</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">13.55</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7.9</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">226,275</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">13.20</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6.8</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> $15.01-20.00 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">55,000</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">15.07</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8.9</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12,500</td> <td valign="bottom" nowrap="nowrap"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">15.01</td> <td valign="bottom" nowrap="nowrap"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8.9</td> <td valign="bottom" nowrap="nowrap"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">724,820</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12.19</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6.9</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">426,831</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10.89</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.5</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> As of April 29, 2017, there was approximately $800,000 of unrecognized compensation expense related to stock options which is expected to be recognized over a weighted average period of approximately 2.9 years. <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18px; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs) <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Aggregated information regarding RSUs and RSAs granted under the Plan for the three months ended April 29, 2017 is summarized below: <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="64%"></td> <td valign="bottom" width="12%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="12%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">RSAs & RSUs</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Weighted Average Grant Date Fair Value</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Unvested at January 31, 2017 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">213,868</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">14.11</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="top"> Granted </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,233</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">13.95</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Vested </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(10,461</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">13.75</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="top"> Forfeited </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Unvested at April 29, 2017 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">210,640</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">14.10</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> As of April 29, 2017, there was approximately $800,000 of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of 0.8 years. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Employee Stock Purchase Plan <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> AstroNova has an Employee Stock Purchase Plan allowing eligible employees to purchase shares of common stock at a 15% discount from fair value on the date of purchase. A total of 247,500 shares were reserved for issuance under this plan. During the three months ended April 29, 2017 and April 30, 2016, there were 1,507 and 1,597 shares, respectively, purchased under this plan. As of April 29, 2017, 43,717 shares remain available. </div>

0.07

255000

Accelerated Filer

298000

3000

<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> (15) Fair Value <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> We measure our financial and nonfinancial assets at fair value on a recurring basis in accordance with the guidance provided in ASC 820, “Fair Value Measurement and Disclosures” which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). In addition, ASC 820 establishes a three-tiered hierarchy for inputs used in management’s determination of fair value of financial instruments that emphasizes the use of observable inputs over the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that reflect management’s belief about the assumptions market participants would use in pricing a financial instrument based on the best information available in the circumstances. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> The fair value hierarchy is summarized as follows: <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="break-inside: avoid"> <td width="5%"> </td> <td valign="top" width="2%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Level 1—Quoted prices in active markets for identical assets or liabilities;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="break-inside: avoid"> <td width="5%"> </td> <td valign="top" width="2%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="break-inside: avoid"> <td width="5%"> </td> <td valign="top" width="2%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Cash and cash equivalents, accounts receivable, accounts payable, line of credit receivable, accrued compensation, other liabilities and accrued expenses and income tax payable are reflected in the condensed consolidated balance sheet at carrying value, which approximates fair value due to the short term nature of the these instruments. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Assets and Liabilities Recorded at Fair Value on a Recurring Basis <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Fair value is applied to our financial assets and liabilities including money market funds, available for sale securities, derivative instruments consisting of a cross-currency interest rate swap and a contingent consideration liability relating to an earnout payment on future TrojanLabel operating results. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> The following tables provide a summary of the financial assets and liabilities that are measured at fair value as of April 29, 2017 and January 31, 2017: <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="58%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="bottom" nowrap="nowrap"> Assets measured at fair value: </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="14" align="center">Fair value measurement at April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="14" align="center">Fair value measurement at January 31, 2017</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="bottom"> (in thousands) </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 1</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 2</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 3</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 1</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 2</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 3</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Money Market Funds (included in Cash and Cash Equivalents) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,611</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right">     —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,611</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">    2</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="top"> State and Municipal Obligations (included in Securities Available for Sale) </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,185</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,185</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,723</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,723</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Total assets </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,611</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,185</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,796</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,723</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,725</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <table style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="56%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="bottom" nowrap="nowrap"> Liabilities measured at fair value: </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="14" align="center">Fair value measurement at April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="14" align="center">Fair value measurement at January 31, 2017</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="bottom"> (in thousands) </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 1</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 2</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 3</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 1</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 2</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 3</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Swap Contracts (included in Other Liabilities) </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">393</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">393</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="top"> Earnout liability (included in Other Liabilities) </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,322</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,322</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Total liabilities </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">393</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,322</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,715</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> For our money market funds and municipal obligations, we utilize the market approach to measure fair value. The market approach is based on using quoted prices for identical or similar assets. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> We also use the market approach to measure fair value of our derivative instruments. Our derivative liability is comprised of a cross-currency interest rate swap. This derivative instrument was measured at fair value using readily observable market inputs, such as quotations on interest rates and foreign exchange rates, and is classified as Level 2 because it is an over-the-counter contract with a bank counterparty that is not traded in an active market. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> The fair value of the contingent consideration liability was initially determined as of the acquisition date of February 1, 2017, using significant inputs that are not observable in the market and therefore classified as Level 3. Key assumptions in estimating the fair value of the contingent consideration liability included (1) the estimated earnout targets over the next seven years of $407,000-$1,280,000, (2) the probability of success (achievement of the various contingent events) from 1.6%-87.2% and (3) a risk-adjusted discount rate of approximately 1.77%-3.35% used to adjust the probability-weighted earnout payments to their present value. Subsequent to the acquisition date, at each reporting period, the contingent consideration liability is recorded at its fair value with changes reflected in other income in the condensed consolidated statements of operations. The change in fair value for the quarter ended April 29, 2017, was not material. <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Assets and Liabilities Not Recorded at Fair Value <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> As of April 29, 2017, the Company’s long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below: <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">   <table style="FONT-SIZE: 8pt; FONT-FAMILY: "Times New Roman"; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="74%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="14" align="center">Fair Value Measurement at April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid"> <td valign="bottom" nowrap="nowrap"> (In thousands) </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 1</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 2</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Level 3</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center">Carrying Value</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; break-inside: avoid" bgcolor="#CCEEFF"> <td valign="top"> Long-Term debt and related current maturities </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,200</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,200</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,200</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> On February 28, 2017, the Company entered into a term loan in the amount of $9.2 million with the Bank of America. The fair value of the Company’s long-term debt, including the current portion of long-term debt approximates carrying value at April 29, 2017. In subsequent periods, the fair value of the debt will be based on the quoted market prices for the same issues or on the current rates offered for debt of similar remaining maturities. </div>

7000

15152000

<div> (5) Net Income Per Common Share Basic net income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of shares and, if dilutive, common equivalent shares, determined using the treasury stock method for stock options, restricted stock awards and restricted stock units outstanding during the period. A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Three Months Ended</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">April 30, 2016</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Weighted Average Common Shares Outstanding—Basic </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,480,039</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,357,588</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Effect of Dilutive Options and Restricted Stock Units </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">135,507</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">166,661</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Weighted Average Common Shares Outstanding—Diluted </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,615,546</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,524,249</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> For the three months ended April 29, 2017 and April 30, 2016, the diluted per share amounts do not reflect common equivalent shares outstanding of 472,214 and 431,133, respectively, because their effect would have been anti-dilutive. </div>

0.223

24458000

66000

<div> (8) Inventories Inventories are stated at the lower of cost (first-in, first-out) and net realizable value and include material, labor and manufacturing overhead. The components of inventories are as follows:   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center"> <tr> <td width="70%"></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"> April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"> January 31, 2017</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Materials and Supplies </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,082</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">11,865</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Work-In-Process </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,168</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,216</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Finished Goods </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,184</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10,270</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">24,434</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">23,351</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Inventory Reserve </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4,098</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,845</td> <td nowrap="nowrap" valign="bottom">) </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">20,336</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">19,506</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

-48000

1554000

<div> (6) Intangible Assets Intangible assets are as follows:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="49%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="14" align="center">April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="10" align="center">January 31, 2017</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Gross Carrying Amount</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Accumulated Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Currency Translation Adjustment</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Net Carrying Amount</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Gross Carrying Amount</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Accumulated Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Net Carrying Amount</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Miltope: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Customer Contract Relationships </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,100</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,190</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,910</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,100</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,108</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,992</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> RITEC: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Customer Contract Relationships </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,830</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(271</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,559</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,830</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(207</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,623</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Non-Competition Agreement </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">950</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(348</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">602</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">950</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(301</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">649</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> TrojanLabel: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Existing Technology </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,327</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(82</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,259</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Non-Competition Agreement </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">937</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(23</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">919</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Intangible Assets, net </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,144</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,914</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">    19</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,249</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,880</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,616</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,264</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> There were no impairments to intangible assets during the periods ended April 29, 2017 and April 30, 2016. With respect to the acquired intangibles included in the table above, amortization expense of $298,000 and $179,000, has been included in the condensed consolidated statements of income for the periods ended April 29, 2017 and April 30, 2016, respectively. </div>

9306000

<div> (9) Income Taxes The Company’s effective tax rates for the period, which are based on the projected effective tax rate for the full year, are as follows:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="77%"></td> <td valign="bottom" width="20%"></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" align="center">Three Months Ended</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Fiscal 2018 </td> <td valign="bottom">  </td> <td valign="bottom" align="center">22.3%</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Fiscal 2017 </td> <td valign="bottom">  </td> <td valign="bottom" align="center">31.8%</td> </tr> </table> During the three months ended April 29, 2017, the Company recognized an income tax expense of approximately $147,000. The effective tax rate in this period was directly impacted by a $71,000 tax benefit related to the expiration of the statute of limitations on a previously uncertain tax position and a $14,000 tax benefit arising from windfall tax benefits related to the Company’s stock. During the three months ended April 30, 2016, the Company recognized an income tax expense of approximately $476,000. The effective tax rate in that quarter was directly impacted by a $52,000 tax benefit related to the statute of limitations expiring on a previously uncertain tax position. As of April 29, 2017, the Company’s cumulative unrecognized tax benefits totaled $673,000 compared to $708,000 as of January 31, 2017. There were no other developments affecting unrecognized tax benefits during the quarter ended April 29, 2017. </div>

8599000

512000

-211000

659000

-7802000

-221000

155000

10000

-1005000

-259000

9007000

<div> (13) Recent Accounting Pronouncements Goodwill In January 2017, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2017-04, “Intangibles—Goodwill and Other (Topic 350).” ASU 2017-14 simplifies the subsequent measurement of goodwill impairment. The new guidance eliminates the two-step process that required identification of potential impairment and a separate measure of the actual impairment. Goodwill impairment charges, if any, would be determined by reducing the goodwill balance by the difference between the carrying value and the reporting unit’s fair value (impairment loss is limited to the carrying value). This standard is effective for annual or any interim goodwill impairment tests beginning after December 15, 2019. The Company does not believe the adoption of this guidance will have a material impact on the Company’s consolidated financial statements Statement of Cash Flows In August 2016, the FASB issued ASU 2016-15, “Classification of Certain Cash Receipts and Cash Payments (Topic 230).” ASU 2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice for certain cash receipts and cash payments. The standard is effective for annual reporting periods beginning after December 15, 2017 and interim periods within those years (Q1 fiscal 2019 for AstroNova), with early adoption permitted. The Company does not believe the adoption of this guidance will have a material impact on the Company’s consolidated financial statements. Revenue Recognition In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 completes the joint effort by the FASB and International Accounting Standards Board to improve financial reporting by creating common revenue recognition guidance for U.S. GAAP and International Financial Reporting Standards. ASU 2014-09 applies to all companies that enter into contracts with customers to transfer goods or services. In August 2015, the FASB modified ASU 2014-09 to be effective for annual reporting periods beginning after December 15, 2017 (Q1 fiscal 2019 for AstroNova), including interim periods within that reporting period. As modified, the FASB permits the adoption of the new revenue standard early, but not before annual periods beginning after December 15, 2016. Entities have the choice to apply ASU 2014-09 either retrospectively to each reporting period presented or by recognizing the cumulative effect of applying ASU 2014-09 at the date of initial application and not adjusting comparative information. In March 2016, the FASB issued ASU 2016-08, “Revenue from Contracts with Customers (Topic 606)—Principal versus Agent Consideration.” In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606)—Identifying Performance Obligations and Licensing.” In May 2016, the FASB issued ASU 2016-11, “Revenue from Contracts with Customers (Topic 606) and Derivatives and Hedging (Topic 815)—Rescission of SEC Guidance Because of ASU 2014-09 and 2014-16” and ASU 2016-12, “Revenue from Contracts with Customers (Topic 606)—Narrow Scope Improvements and Practical Expedients.” All of these ASUs do not change the core principle of the guidance in Topic 606 (as amended by ASU 2014-09), but rather provide further guidance to improve the operability and understandability of the implementation guidance included in ASU 2014-09. The effective date for all of these ASUs is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those years (Q1 fiscal 2019 for AstroNova). The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements. Leases In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” ASU 2016-02 supersedes current guidance related to accounting for leases and is intended to increase transparency and comparability among organizations by requiring lessees to recognize assets and liabilities in the balance sheet for operating leases with lease terms greater than twelve months. The update also requires improved disclosures to help users of financial statements better understand the amount, timing and uncertainty of cash flows arising from leases. ASU 2016-02 will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years (Q1 fiscal 2020 for AstroNova), with early adoption permitted. At adoption, this update will be applied using a modified retrospective approach. The Company is currently evaluating the effect of this new guidance on the Company’s consolidated financial statements.   Inventory In July 2015, the FASB issued ASU 2015-11, “Inventory (Topic 330).” ASU 2015-11 requires inventory to be measured at the lower of cost and net realizable value instead of at lower of cost or market. This guidance does not apply to inventory that is measured using last-in, first out (LIFO) or the retail inventory method but applies to all other inventory, including inventory measured using first-in, first-out (FIFO) or the average cost method. ASU 2015-11 will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years (Q1 fiscal 2018 for AstroNova) and should be applied prospectively. Our adoption of this guidance at the beginning of the first quarter of fiscal 2018 did not have a material effect on our consolidated financial statements. No other new accounting pronouncements, issued or effective during the first three months of the current year, have had or are expected to have a material impact on our consolidated financial statements. </div>

<div> (3) Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. </div>

<div> Recent Accounting Pronouncements Goodwill In January 2017, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2017-04, “Intangibles—Goodwill and Other (Topic 350).” ASU 2017-14 simplifies the subsequent measurement of goodwill impairment. The new guidance eliminates the two-step process that required identification of potential impairment and a separate measure of the actual impairment. Goodwill impairment charges, if any, would be determined by reducing the goodwill balance by the difference between the carrying value and the reporting unit’s fair value (impairment loss is limited to the carrying value). This standard is effective for annual or any interim goodwill impairment tests beginning after December 15, 2019. The Company does not believe the adoption of this guidance will have a material impact on the Company’s consolidated financial statements Statement of Cash Flows In August 2016, the FASB issued ASU 2016-15, “Classification of Certain Cash Receipts and Cash Payments (Topic 230).” ASU 2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice for certain cash receipts and cash payments. The standard is effective for annual reporting periods beginning after December 15, 2017 and interim periods within those years (Q1 fiscal 2019 for AstroNova), with early adoption permitted. The Company does not believe the adoption of this guidance will have a material impact on the Company’s consolidated financial statements. Revenue Recognition In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 completes the joint effort by the FASB and International Accounting Standards Board to improve financial reporting by creating common revenue recognition guidance for U.S. GAAP and International Financial Reporting Standards. ASU 2014-09 applies to all companies that enter into contracts with customers to transfer goods or services. In August 2015, the FASB modified ASU 2014-09 to be effective for annual reporting periods beginning after December 15, 2017 (Q1 fiscal 2019 for AstroNova), including interim periods within that reporting period. As modified, the FASB permits the adoption of the new revenue standard early, but not before annual periods beginning after December 15, 2016. Entities have the choice to apply ASU 2014-09 either retrospectively to each reporting period presented or by recognizing the cumulative effect of applying ASU 2014-09 at the date of initial application and not adjusting comparative information. In March 2016, the FASB issued ASU 2016-08, “Revenue from Contracts with Customers (Topic 606)—Principal versus Agent Consideration.” In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606)—Identifying Performance Obligations and Licensing.” In May 2016, the FASB issued ASU 2016-11, “Revenue from Contracts with Customers (Topic 606) and Derivatives and Hedging (Topic 815)—Rescission of SEC Guidance Because of ASU 2014-09 and 2014-16” and ASU 2016-12, “Revenue from Contracts with Customers (Topic 606)—Narrow Scope Improvements and Practical Expedients.” All of these ASUs do not change the core principle of the guidance in Topic 606 (as amended by ASU 2014-09), but rather provide further guidance to improve the operability and understandability of the implementation guidance included in ASU 2014-09. The effective date for all of these ASUs is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those years (Q1 fiscal 2019 for AstroNova). The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements. Leases In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” ASU 2016-02 supersedes current guidance related to accounting for leases and is intended to increase transparency and comparability among organizations by requiring lessees to recognize assets and liabilities in the balance sheet for operating leases with lease terms greater than twelve months. The update also requires improved disclosures to help users of financial statements better understand the amount, timing and uncertainty of cash flows arising from leases. ASU 2016-02 will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years (Q1 fiscal 2020 for AstroNova), with early adoption permitted. At adoption, this update will be applied using a modified retrospective approach. The Company is currently evaluating the effect of this new guidance on the Company’s consolidated financial statements.   Inventory In July 2015, the FASB issued ASU 2015-11, “Inventory (Topic 330).” ASU 2015-11 requires inventory to be measured at the lower of cost and net realizable value instead of at lower of cost or market. This guidance does not apply to inventory that is measured using last-in, first out (LIFO) or the retail inventory method but applies to all other inventory, including inventory measured using first-in, first-out (FIFO) or the average cost method. ASU 2015-11 will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years (Q1 fiscal 2018 for AstroNova) and should be applied prospectively. Our adoption of this guidance at the beginning of the first quarter of fiscal 2018 did not have a material effect on our consolidated financial statements. No other new accounting pronouncements, issued or effective during the first three months of the current year, have had or are expected to have a material impact on our consolidated financial statements. </div>

-257000

16000

707000

527000

8824000

12000

-3179000

111000

<div> (14) Securities Available for Sale Pursuant to our investment policy, securities available for sale include state and municipal securities with various contractual or anticipated maturity dates ranging from 6 to 24 months. Securities available for sale are carried at fair value, with unrealized gains and losses reported as a component of accumulated other comprehensive income (loss) in shareholders’ equity until realized. Realized gains and losses from the sale of available-for-sale securities, if any, are determined on a specific identification basis. A decline in the fair value of any available-for-sale security below cost that is determined to be other than temporary will result in a write-down of its carrying amount to fair value. No such impairment charges were recorded for any period presented. All short-term investment securities have original maturities greater than 90 days.   The fair value, amortized cost and gross unrealized gains and losses of securities available for sale are as follows:   <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" align="center"> <tr> <td width="60%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td valign="bottom" nowrap="nowrap"> (In thousands) April 29, 2017 </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"> Amortized Cost</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">Gross Unrealized Gains</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">Gross Unrealized Losses</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">Fair Value</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> State and Municipal Obligations </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,188</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td nowrap="nowrap" valign="bottom">$</td> <td nowrap="nowrap" valign="bottom" align="right"> —  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,185</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="font-size:1pt"> <td height="16"></td> <td height="16" colspan="4"></td> <td height="16" colspan="4"></td> <td height="16" colspan="4"></td> <td height="16" colspan="4"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td valign="bottom" nowrap="nowrap"> January 31, 2017 </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"> Amortized Cost</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">Gross Unrealized Gains</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">Gross Unrealized Losses</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">Fair Value</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> State and Municipal Obligations </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,732</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td nowrap="nowrap" valign="bottom">$</td> <td nowrap="nowrap" valign="bottom" align="right"> —  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(9</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,723</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> (2) Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with footnotes contained in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2017. Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year. The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Some of the more significant estimates relate to the allowances for doubtful accounts and credits, inventory valuation, impairment of long-lived assets and goodwill, income taxes, share-based compensation, accrued expenses and warranty reserves. Management’s estimates are based on the facts and circumstances available at the time estimates are made, historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters. Consequently, actual results could differ from those estimates. Certain amounts in the prior year financial statements have been reclassified to conform to the current year’s presentation. </div>

147000

<div> (1) Overview Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems. Our products are distributed through our own sales force and authorized dealers in the United States. We also sell to customers outside of the United States primarily through our Company offices in Canada, China, Europe, Mexico and Southeast Asia as well as with independent dealers and representatives. AstroNova, Inc. products are employed around the world in a wide range of aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation applications. The business consists of two segments, Product Identification (previously known as our QuickLabel segment), which includes specialty printing systems sold under the QuickLabel® and TrojanLabel™ brand names, and Test & Measurement which includes test and measurement as well as Aerospace systems sold under the AstroNova™ brand name. Products sold under the QuickLabel and TrojanLabel brands are used in industrial and commercial product packaging and automatic identification applications to digitally print custom labels and other visual identification marks on demand. Products sold under the AstroNova Test & Measurement brand acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats. In the aerospace market, the Company has a long history of using its data visualization technologies to provide high-resolution airborne printers and networking systems as well as related hardware and supplies. Unless otherwise indicated, references to “AstroNova,” the “Company,” “we,” “our,” and “us” in this Quarterly Report on Form 10-Q refer to AstroNova, Inc. and its consolidated subsidiaries. </div>

-771000

359000

43125

7615546

<div> The changes in the balance of accumulated other comprehensive loss by component are as follows:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"> <tr> <td width="53%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom" nowrap="nowrap"> (In thousands) </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Foreign Currency Translation Adjustments</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Unrealized Holding Gain/(Loss) on Available for Sale Securities</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Net Unrealized Gain(Losses) on Cash Flow Hedges</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Balance at January 31, 2017 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,048</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(8</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,056</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Other Comprehensive Income (Loss) before reclassification </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(221</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(259</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(468</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Amounts reclassified from AOCI to Earnings </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">211</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">211</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Other Comprehensive Income (Loss) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(221</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(48</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(257</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Balance at April 29, 2017 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,269</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(48</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,313</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> The fair value, amortized cost and gross unrealized gains and losses of securities available for sale are as follows:   <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" align="center"> <tr> <td width="60%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td valign="bottom" nowrap="nowrap"> (In thousands) April 29, 2017 </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"> Amortized Cost</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">Gross Unrealized Gains</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">Gross Unrealized Losses</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">Fair Value</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> State and Municipal Obligations </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,188</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td nowrap="nowrap" valign="bottom">$</td> <td nowrap="nowrap" valign="bottom" align="right"> —  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,185</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="font-size:1pt"> <td height="16"></td> <td height="16" colspan="4"></td> <td height="16" colspan="4"></td> <td height="16" colspan="4"></td> <td height="16" colspan="4"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td valign="bottom" nowrap="nowrap"> January 31, 2017 </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"> Amortized Cost</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">Gross Unrealized Gains</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">Gross Unrealized Losses</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">Fair Value</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> State and Municipal Obligations </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,732</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td nowrap="nowrap" valign="bottom">$</td> <td nowrap="nowrap" valign="bottom" align="right"> —  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(9</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,723</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> Inventories are stated at the lower of cost (first-in, first-out) and net realizable value and include material, labor and manufacturing overhead. The components of inventories are as follows:   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center"> <tr> <td width="70%"></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"> April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"> January 31, 2017</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Materials and Supplies </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,082</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">11,865</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Work-In-Process </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,168</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,216</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Finished Goods </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,184</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10,270</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">24,434</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">23,351</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Inventory Reserve </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4,098</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,845</td> <td nowrap="nowrap" valign="bottom">) </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">20,336</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">19,506</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

0.021

13.31

135507

<div> Set forth below is a summary of options outstanding at April 29, 2017:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="22%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="12" nowrap="nowrap" align="center"> Outstanding </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="10" align="center">Exercisable</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom" nowrap="nowrap"> Range of Exercise prices </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Number of Shares</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Weighted- Average Exercise Price</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Weighted- Average Remaining Contractual Life</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Number of Shares</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Weighted- Average Exercise Price</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Weighted Average Remaining Contractual Life</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> $5.00-10.00 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">188,056</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7.84</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3.6</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">188,056</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7.84</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3.6</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> $10.01-15.00 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">481,764</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">13.55</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7.9</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">226,275</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">13.20</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6.8</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> $15.01-20.00 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">55,000</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">15.07</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8.9</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12,500</td> <td valign="bottom" nowrap="nowrap"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">15.01</td> <td valign="bottom" nowrap="nowrap"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8.9</td> <td valign="bottom" nowrap="nowrap"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">724,820</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12.19</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6.9</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">426,831</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10.89</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.5</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> Intangible assets are as follows:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="49%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="14" align="center">April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="10" align="center">January 31, 2017</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Gross Carrying Amount</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Accumulated Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Currency Translation Adjustment</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Net Carrying Amount</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Gross Carrying Amount</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Accumulated Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Net Carrying Amount</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Miltope: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Customer Contract Relationships </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,100</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,190</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,910</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,100</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,108</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,992</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> RITEC: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Customer Contract Relationships </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,830</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(271</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,559</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,830</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(207</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,623</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Non-Competition Agreement </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">950</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(348</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">602</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">950</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(301</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">649</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> TrojanLabel: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Existing Technology </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,327</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(82</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,259</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Non-Competition Agreement </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">937</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(23</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">919</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Intangible Assets, net </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,144</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,914</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">    19</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,249</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,880</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,616</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,264</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

P5Y6M0D

<div> The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of April 29, 2017 is as follows:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="89%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Fiscal 2018 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,104</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Fiscal 2019 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,472</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Fiscal 2020 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,840</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Fiscal 2021 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,208</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Fiscal 2022 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,576</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,200</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

11.50

7480039

ALOT

71000

1505000

9200000

<div> (12) Segment Information AstroNova reports two segments: Product Identification and Test & Measurement (T&M). The Company evaluates segment performance based on the segment profit before corporate expenses. Summarized below are the Revenue and Segment Operating Profit for each reporting segment:   <table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center"> <tr> <td width="66%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="14" align="center" style="border-bottom:1.00pt solid #000000">Three Months Ended</td> <td valign="bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1.00pt solid #000000">Revenue</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1.00pt solid #000000"> Segment Operating Profit</td> <td valign="bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td valign="bottom" nowrap="nowrap"> (In thousands) </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">April 30, 2016</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">April 30, 2016</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Product Identification </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">18,646</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,606</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,492</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,996</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> T&M </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,812</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,504</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">71</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,202</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Total </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">24,458</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">24,110</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,563</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,198</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Corporate Expenses </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,856</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,651</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Operating Income </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">707</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,547</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Other Expense </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(48</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(52</td> <td nowrap="nowrap" valign="bottom">) </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Income Before Income Taxes </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">659</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,495</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Income Tax Provision </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">147</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">476</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Net Income </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">512</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,019</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

0.366

94000

<div> Share-based compensation expense was recognized as follows:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="80%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Three Months Ended</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">April 30, 2016</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Stock Options </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">94</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">81</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Restricted Stock Awards and Restricted Stock Units </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">74</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">230</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Employee Stock Purchase Plan </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Total </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">171</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">314</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> Summarized below are the Revenue and Segment Operating Profit for each reporting segment:   <table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center"> <tr> <td width="66%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="14" align="center" style="border-bottom:1.00pt solid #000000">Three Months Ended</td> <td valign="bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1.00pt solid #000000">Revenue</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1.00pt solid #000000"> Segment Operating Profit</td> <td valign="bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td valign="bottom" nowrap="nowrap"> (In thousands) </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">April 30, 2016</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">April 30, 2016</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Product Identification </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">18,646</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,606</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,492</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,996</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> T&M </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,812</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,504</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">71</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,202</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Total </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">24,458</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">24,110</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,563</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,198</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Corporate Expenses </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,856</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,651</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Operating Income </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">707</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,547</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Other Expense </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(48</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(52</td> <td nowrap="nowrap" valign="bottom">) </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Income Before Income Taxes </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">659</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,495</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Income Tax Provision </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">147</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">476</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Net Income </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">512</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,019</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> Aggregated information regarding stock options granted under the plans for the three months ended April 29, 2017, is summarized below:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="70%"></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Number of Options</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Weighted Average Exercise Price</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Outstanding at January 31, 2017 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">685,456</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">11.96</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Granted </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">102,189</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">13.31</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Exercised </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(43,125</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11.50</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Forfeited </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Canceled </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(19,700</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11.75</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Outstanding at April 29, 2017 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">724,820</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12.19</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

102189

4.11

5238000

0.017

171000

P7Y6M

19700

<div> The following table presents the impact of the derivative instrument in our condensed consolidated financial statements:   <table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" align="center"> <tr> <td width="36%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td valign="bottom" rowspan="2" nowrap="nowrap"> Cash Flow Hedge </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1.00pt solid #000000">Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000">Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)</td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1.00pt solid #000000">Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)</td> <td valign="bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"> January 31, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">January 31, 2017</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td valign="top"> Swap contract </td> <td valign="bottom">  </td> <td valign="top">$</td> <td valign="top" align="right">(392,636</td> <td nowrap="nowrap" valign="top">) </td> <td valign="bottom">  </td> <td nowrap="nowrap" valign="top">$</td> <td nowrap="nowrap" valign="top" align="right"> —  </td> <td nowrap="nowrap" valign="top"> </td> <td valign="bottom">  </td> <td valign="bottom" align="center"> Other Income (Expense)</td> <td valign="bottom">  </td> <td valign="top">$</td> <td valign="top" align="right">(320,076</td> <td nowrap="nowrap" valign="top">) </td> <td valign="bottom">  </td> <td nowrap="nowrap" valign="top">$</td> <td nowrap="nowrap" valign="top" align="right"> —  </td> <td nowrap="nowrap" valign="top"> </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Three Months Ended</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">April 29, 2017</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">April 30, 2016</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Weighted Average Common Shares Outstanding—Basic </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,480,039</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,357,588</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Effect of Dilutive Options and Restricted Stock Units </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">135,507</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">166,661</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Weighted Average Common Shares Outstanding—Diluted </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,615,546</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,524,249</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

74000

11.75

P6Y10M25D

<div> (17) Subsequent Events Stock Repurchase Agreement On May 1, 2017, the Company entered into a stock repurchase agreement with a trust established by Albert W. Ondis to repurchase 826,305 shares of the Company’s common stock held by the trust at a per share price of $13.60, for an aggregate repurchase price of $11.2 million. This stock repurchase was consummated on May 2, 2017 and was funded using existing cash on hand. Following this stock repurchase, the Ondis trust owns 36,000 shares of the Company’s common stock. April L. Ondis, a director of the Company, is a beneficiary of the trust. The stock repurchase was authorized and approved by the Company’s Audit Committee as a related party transaction. Prior to entering into the agreement, the Company obtained an opinion from an independent investment banking firm that the consideration to be paid by the Company to the trust pursuant to the stock repurchase agreement would be fair to the public stockholders of the Company, other than the trust, from a financial point of view. Credit Agreement Amendment In connection with the stock repurchase, the Company entered into a consent and amendment, dated as of May 1, 2017, relating to the Credit Agreement, dated as of February 28, 2017, among the Company, its subsidiaries, ANI ApS and TrojanLabel ApS, and Bank of America, N.A., as lender. Solely for purposes of effecting the stock repurchase, the Amendment increased the aggregate amount of certain repurchases of Company equity interests permitted to be made by the Company under the Credit Agreement in the Company’s fiscal year ending January 31, 2018, from $5,000,000 to $12,000,000, subject to certain conditions. The Amendment prohibits the Company from making other repurchases of Company equity interests under such permission in the fiscal year ending January 31, 2018. The Amendment also provides that the aggregate amount paid in cash by the Company to effect the stock repurchase shall not be deducted from the Company’s consolidated EBITDA for the purposes of calculating the consolidated fixed charge coverage ratio covenant to which the Company is subject under the Credit Agreement with respect to any trailing four-fiscal-quarter measurement period through and including the measurement period ending January 31, 2018. </div>

57000

247500 <div> The Company’s effective tax rates for the period, which are based on the projected effective tax rate for the full year, are as follows:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="77%"></td> <td valign="bottom" width="20%"></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" align="center">Three Months Ended</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Fiscal 2018 </td> <td valign="bottom">  </td> <td valign="bottom" align="center">22.3%</td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Fiscal 2017 </td> <td valign="bottom">  </td> <td valign="bottom" align="center">31.8%</td> </tr> </table> </div> 0.50 2 306000 14000

1856000

2563000

5812000

71000

18646000

2492000

0.0025

0.000

0.010

0.005

0.015

0.0050

0.0100

2022-01-31

0.010

0.015

0.02031

LIBOR plus a margin of 1.0% to 1.5%, (2.031% as of April 29, 2017), and maturity date of January 31, 2022

-320076

Other Income (Expense)

-392636

P2Y10M25D

P4Y

P10Y

P4Y

P10Y

P0Y9M18D

0.25 0.25 0.50 2014 through 2016

13.95

10461

13.75

7233

P10Y

5000

7233

P5Y

700000

<div> The following table reflects the fair value of the acquired identifiable intangible assets and related estimated useful lives:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="77%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom" nowrap="nowrap"> (In thousands) </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Fair Value</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Useful Life (Years)</td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Existing Technology </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,327</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Non-Competition Agreement </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">937</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Total </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,264</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> </div>

<div> The US dollar purchase price of the acquisition has been allocated on the basis of fair value as follows:   <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"> <tr> <td width="88%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Accounts Receivable </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,322</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Inventory </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">796</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Other Current Assets </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">166</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Property, Plant and Equipment </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">15</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Identifiable Intangible Assets </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,264</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Goodwill </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,388</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Accounts Payable and Other Current Liabilities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,821</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Other Liability </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(114</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Contingent Liability (Earnout) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,314</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"> <td valign="top"> Deferred Tax Liability </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(695</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"> <td valign="top"> Total Purchase Price </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,007</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

100000

P10Y

P7Y

P90D P6M 121000 0.00

0.0177

0.016 P24M 1070000 1.00

0.0335

0.872

0.15

1507

2017-05 2025-05

3000

Key assumptions in estimating the fair value of the intangibles include (1) remaining life of existing technology acquired based on estimate of percentage of revenue from 0% -100% for each product, (2) the Company's internal rate of return of 19.0% and (3) a range of earnings projections from $121,000-$1,070,000.

0.190

P7Y

P8Y10M25D

15.01

P8Y10M25D

P3Y7M6D

5.00

P3Y7M6D

P6Y9M18D

10.01

P7Y10M25D

6000 55000 65000 75000 0.25 4000

407000

1280000

Key assumptions in estimating the fair value of the contingent consideration liability include (1) the estimated earnout targets over the next seven years of $407,000-$1,280,000, (2) the probability of success (achievement of the various contingent events) from 1.6%-87.2% and (3) a risk-adjusted discount rate of approximately 1.77%-3.35% used to adjust the probability-weighted earnout payments to their present value.

P7Y

-259000

-48000

-211000

-221000

12000

-468000

-257000

-211000

431133

4491000

542000

0.07

1651000

0.14

625000

0.14

1344000

179000

3000

69000

14637000

0.318

24110000

257000

-52000

1598000

9473000

7926000

1019000

1495000

1591000

327000

188000

-443000

325000

1588000

1547000

516000

-556000

-2000

1647000

170000

476000

2914000

195000

7524249

0.019

166661

7357588

52000

1444000

0.246

81000

2.86

4831000

0.015

314000

P5Y

230000

-128000

-40000

1651000

3198000

7504000

1202000

16606000

1996000

567

1597

0000008146 alot:EmployeeStockPurchasePlanMember 2016-02-01 2016-04-30 0000008146 alot:EquityIncentivePlanMemberalot:NonEmployeeDirectorMember 2016-02-01 2016-04-30 0000008146 us-gaap:OperatingSegmentsMemberalot:ProductIdentificationMember 2016-02-01 2016-04-30 0000008146 us-gaap:OperatingSegmentsMemberalot:TestAndMeasurementMember 2016-02-01 2016-04-30 0000008146 us-gaap:OperatingSegmentsMember 2016-02-01 2016-04-30 0000008146 us-gaap:CorporateNonSegmentMember 2016-02-01 2016-04-30 0000008146 2016-02-01 2016-04-30 0000008146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-02-01 2017-04-29 0000008146 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-02-01 2017-04-29 0000008146 us-gaap:AccumulatedTranslationAdjustmentMember 2017-02-01 2017-04-29 0000008146 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-02-01 2017-04-29 0000008146 us-gaap:ContingentConsiderationClassifiedAsEquityMember 2017-02-01 2017-04-29 0000008146 alot:ChairsOfAuditAndCompensationCommitteesMember 2017-02-01 2017-04-29 0000008146 alot:NonEmployeeDirectorMember 2017-02-01 2017-04-29 0000008146 us-gaap:BoardOfDirectorsChairmanMember 2017-02-01 2017-04-29 0000008146 alot:RangeFourMember 2017-02-01 2017-04-29 0000008146 alot:RangeThreeMember 2017-02-01 2017-04-29 0000008146 alot:RangeFiveMember 2017-02-01 2017-04-29 0000008146 us-gaap:FiniteLivedIntangibleAssetsMemberus-gaap:ContingentConsiderationClassifiedAsEquityMember 2017-02-01 2017-04-29 0000008146 us-gaap:FiniteLivedIntangibleAssetsMember 2017-02-01 2017-04-29 0000008146 alot:StateAndMunicipalObligationsMember 2017-02-01 2017-04-29 0000008146 alot:TwoThousandFifteenEquityIncentivePlanMember 2017-02-01 2017-04-29 0000008146 alot:TwoThousandSevenEquityIncentivePlanMember 2017-02-01 2017-04-29 0000008146 alot:EmployeeStockPurchasePlanMember 2017-02-01 2017-04-29 0000008146 us-gaap:MaximumMemberus-gaap:ContingentConsiderationClassifiedAsEquityMember 2017-02-01 2017-04-29 0000008146 us-gaap:FiniteLivedIntangibleAssetsMemberus-gaap:MaximumMember 2017-02-01 2017-04-29 0000008146 us-gaap:MaximumMember 2017-02-01 2017-04-29 0000008146 us-gaap:MinimumMemberus-gaap:ContingentConsiderationClassifiedAsEquityMember 2017-02-01 2017-04-29 0000008146 us-gaap:FiniteLivedIntangibleAssetsMemberus-gaap:MinimumMember 2017-02-01 2017-04-29 0000008146 us-gaap:MinimumMember 2017-02-01 2017-04-29 0000008146 alot:TrojanlabelApSMemberalot:ExistingTechnologyMember 2017-02-01 2017-04-29 0000008146 alot:TrojanlabelApSMemberus-gaap:NoncompeteAgreementsMember 2017-02-01 2017-04-29 0000008146 alot:TrojanlabelApSMemberus-gaap:GeneralAndAdministrativeExpenseMember 2017-02-01 2017-04-29 0000008146 alot:TrojanlabelApSMember 2017-02-01 2017-04-29 0000008146 us-gaap:CrossCurrencyInterestRateContractMember 2017-02-01 2017-04-29 0000008146 alot:EquityIncentivePlanMemberalot:NonEmployeeDirectorMember 2017-02-01 2017-04-29 0000008146 alot:RestrictedStockAwardAndRestrictedStockUnitMember 2017-02-01 2017-04-29 0000008146 us-gaap:RestrictedStockUnitsRSUMemberus-gaap:OfficerMember 2017-02-01 2017-04-29 0000008146 us-gaap:RestrictedStockUnitsRSUMemberus-gaap:OfficerMemberalot:NetSalesTargetMember 2017-02-01 2017-04-29 0000008146 us-gaap:RestrictedStockUnitsRSUMemberus-gaap:OfficerMemberalot:ThirdAnniversaryMember 2017-02-01 2017-04-29 0000008146 us-gaap:RestrictedStockUnitsRSUMemberus-gaap:OfficerMemberalot:OronaTargetMember 2017-02-01 2017-04-29 0000008146 us-gaap:RestrictedStockUnitsRSUMember 2017-02-01 2017-04-29 0000008146 us-gaap:EmployeeStockOptionMemberalot:TwoThousandFifteenEquityIncentivePlanMember 2017-02-01 2017-04-29 0000008146 us-gaap:EmployeeStockOptionMemberalot:TwoThousandSevenEquityIncentivePlanMember 2017-02-01 2017-04-29 0000008146 us-gaap:EmployeeStockOptionMember 2017-02-01 2017-04-29 0000008146 us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMember 2017-02-01 2017-04-29 0000008146 alot:TermLoanMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2017-02-01 2017-04-29 0000008146 alot:TermLoanMemberus-gaap:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2017-02-01 2017-04-29 0000008146 alot:TermLoanMemberus-gaap:MinimumMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2017-02-01 2017-04-29 0000008146 alot:TermLoanMember 2017-02-01 2017-04-29 0000008146 us-gaap:RevolvingCreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2017-02-01 2017-04-29 0000008146 us-gaap:RevolvingCreditFacilityMemberus-gaap:FederalFundsEffectiveSwapRateMember 2017-02-01 2017-04-29 0000008146 us-gaap:RevolvingCreditFacilityMemberus-gaap:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2017-02-01 2017-04-29 0000008146 us-gaap:RevolvingCreditFacilityMemberus-gaap:MaximumMember 2017-02-01 2017-04-29 0000008146 us-gaap:RevolvingCreditFacilityMemberus-gaap:MinimumMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2017-02-01 2017-04-29 0000008146 us-gaap:RevolvingCreditFacilityMemberus-gaap:MinimumMember 2017-02-01 2017-04-29 0000008146 us-gaap:RevolvingCreditFacilityMember 2017-02-01 2017-04-29 0000008146 us-gaap:OperatingSegmentsMemberalot:ProductIdentificationMember 2017-02-01 2017-04-29 0000008146 us-gaap:OperatingSegmentsMemberalot:TestAndMeasurementMember 2017-02-01 2017-04-29 0000008146 us-gaap:OperatingSegmentsMember 2017-02-01 2017-04-29 0000008146 us-gaap:CorporateNonSegmentMember 2017-02-01 2017-04-29 0000008146 2017-02-01 2017-04-29 0000008146 alot:StateAndMunicipalObligationsMember 2016-02-01 2017-01-31 0000008146 alot:TrojanlabelApSMemberus-gaap:GeneralAndAdministrativeExpenseMember 2016-02-01 2017-01-31 0000008146 us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMember 2016-02-01 2017-01-31 0000008146 us-gaap:ChiefExecutiveOfficerMember 2017-03-01 2017-03-31 0000008146 alot:RestrictedStockAndStockOptionMember 2017-03-01 2017-03-31 0000008146 us-gaap:ChiefExecutiveOfficerMember 2016-03-01 2016-03-31 0000008146 us-gaap:RestrictedStockMemberus-gaap:ChiefExecutiveOfficerMember 2016-03-01 2016-03-31 0000008146 alot:TimeBasedRestrictedStockUnitsMember 2015-05-01 2015-05-31 0000008146 us-gaap:PerformanceSharesMember 2015-05-01 2015-05-31 0000008146 alot:CertainKeyEmployeesMember 2016-05-01 2016-05-31 0000008146 alot:OtherKeyEmployeesMember 2015-03-01 2015-03-31 0000008146 us-gaap:ChiefExecutiveOfficerMember 2015-03-01 2015-03-31 0000008146 us-gaap:RestrictedStockMemberus-gaap:ChiefExecutiveOfficerMember 2015-03-01 2015-03-31 0000008146 alot:CertainOtherKeyEmployeesMember 2017-04-01 2017-04-30 0000008146 alot:CertainOtherKeyEmployeesMember 2017-02-01 2017-02-28 0000008146 alot:TrojanlabelApSMemberalot:EarnOutPaymentsIfHundredAndTwentyPercentageOfSpecifiedEarningsTargetsAreAchievedMember 2017-02-01 2017-02-01 0000008146 alot:TrojanlabelApSMemberalot:EarnOutPaymentsIfHundredPercentageOfSpecifiedEarningsTargetsAreAchievedMember 2017-02-01 2017-02-01 0000008146 alot:TrojanlabelApSMemberalot:EarnOutPaymentsIfEightyPercentageOfSpecifiedEarningsTargetsAreAchievedMember 2017-02-01 2017-02-01 0000008146 alot:TrojanlabelApSMember 2017-02-01 2017-02-01 0000008146 us-gaap:RestrictedStockUnitsRSUMember 2014-02-01 2014-02-01 0000008146 alot:TrojanlabelApSMemberalot:ExistingTechnologyMember 2017-04-29 2017-04-29 0000008146 alot:TrojanlabelApSMemberus-gaap:NoncompeteAgreementsMember 2017-04-29 2017-04-29 0000008146 us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-04-29 2017-04-29 0000008146 2017-04-29 2017-04-29 0000008146 us-gaap:ChiefFinancialOfficerMember 2016-08-01 2016-08-01 0000008146 alot:StockRepurchaseAgreementMemberus-gaap:SubsequentEventMember 2017-05-01 2017-05-01 0000008146 alot:TermLoanMemberalot:BankOfAmericaMember 2017-02-28 0000008146 us-gaap:RevolvingCreditFacilityMemberalot:BankOfAmericaMember 2017-02-28 0000008146 alot:TrojanlabelApSMemberalot:EarnOutPaymentsIfHundredAndTwentyPercentageOfSpecifiedEarningsTargetsAreAchievedMember 2017-02-01 0000008146 alot:TrojanlabelApSMemberalot:EarnOutPaymentsIfHundredPercentageOfSpecifiedEarningsTargetsAreAchievedMember 2017-02-01 0000008146 alot:TrojanlabelApSMemberalot:EarnOutPaymentsIfEightyPercentageOfSpecifiedEarningsTargetsAreAchievedMember 2017-02-01 0000008146 alot:TrojanlabelApSMember 2017-02-01 0000008146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-31 0000008146 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-01-31 0000008146 us-gaap:AccumulatedTranslationAdjustmentMember 2017-01-31 0000008146 alot:StateAndMunicipalObligationsMember 2017-01-31 0000008146 alot:RuggedInformationTechnologyEquipmentCorporationMemberus-gaap:NoncompeteAgreementsMember 2017-01-31 0000008146 alot:RuggedInformationTechnologyEquipmentCorporationMemberus-gaap:CustomerContractsMember 2017-01-31 0000008146 alot:MiltopeCorporationMemberus-gaap:CustomerContractsMember 2017-01-31 0000008146 alot:RestrictedStockAwardAndRestrictedStockUnitMember 2017-01-31 0000008146 us-gaap:FairValueInputsLevel1Member 2017-01-31 0000008146 us-gaap:FairValueInputsLevel2Member 2017-01-31 0000008146 2017-01-31 0000008146 2016-01-31 0000008146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-04-29 0000008146 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-04-29 0000008146 us-gaap:AccumulatedTranslationAdjustmentMember 2017-04-29 0000008146 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-04-29 0000008146 alot:RangeFourMember 2017-04-29 0000008146 alot:RangeThreeMember 2017-04-29 0000008146 alot:RangeFiveMember 2017-04-29 0000008146 alot:StateAndMunicipalObligationsMember 2017-04-29 0000008146 alot:TwoThousandFifteenEquityIncentivePlanMember 2017-04-29 0000008146 alot:TwoThousandSevenEquityIncentivePlanMemberus-gaap:ChiefExecutiveOfficerMember 2017-04-29 0000008146 alot:TwoThousandSevenEquityIncentivePlanMember 2017-04-29 0000008146 alot:EmployeeStockPurchasePlanMember 2017-04-29 0000008146 alot:TrojanlabelApSMemberalot:ExistingTechnologyMember 2017-04-29 0000008146 alot:TrojanlabelApSMemberus-gaap:NoncompeteAgreementsMember 2017-04-29 0000008146 alot:TrojanlabelApSMember 2017-04-29 0000008146 alot:RuggedInformationTechnologyEquipmentCorporationMemberus-gaap:NoncompeteAgreementsMember 2017-04-29 0000008146 alot:RuggedInformationTechnologyEquipmentCorporationMemberus-gaap:CustomerContractsMember 2017-04-29 0000008146 alot:MiltopeCorporationMemberus-gaap:CustomerContractsMember 2017-04-29 0000008146 us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:SwapMember 2017-04-29 0000008146 us-gaap:CrossCurrencyInterestRateContractMember 2017-04-29 0000008146 alot:PerformanceBasedRestrictedStockUnitsRsusMember 2017-04-29 0000008146 alot:RestrictedStockAwardAndRestrictedStockUnitMember 2017-04-29 0000008146 us-gaap:RestrictedStockUnitsRSUMember 2017-04-29 0000008146 us-gaap:EmployeeStockOptionMember 2017-04-29 0000008146 alot:TermLoanMember 2017-04-29 0000008146 us-gaap:RevolvingCreditFacilityMemberalot:WellsFargoBankMember 2017-04-29 0000008146 us-gaap:FairValueInputsLevel1Member 2017-04-29 0000008146 us-gaap:FairValueInputsLevel3Member 2017-04-29 0000008146 us-gaap:FairValueInputsLevel2Member 2017-04-29 0000008146 2017-04-29 0000008146 alot:PerformanceBasedRestrictedStockUnitsRsusMember 2016-04-30 0000008146 us-gaap:RestrictedStockUnitsRSUMemberalot:ThirdAnniversaryMember 2016-04-30 0000008146 us-gaap:RestrictedStockUnitsRSUMember 2016-04-30 0000008146 2016-04-30 0000008146 alot:StockRepurchaseAgreementMemberus-gaap:SubsequentEventMember 2017-05-01 0000008146 alot:CreditAgreementAmendmentMemberus-gaap:SubsequentEventMember 2017-05-01 0000008146 alot:CreditAgreementAmendmentMemberus-gaap:SubsequentEventMember 2017-04-30 0000008146 2017-06-02 0000008146 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2017-03-29 0000008146 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-03-29 0000008146 us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-03-29 iso4217:USD shares iso4217:USD shares iso4217:DKK pure alot:Installment alot:Segment alot:Segments alot:Equity_Plan EX-101.SCH 8 alot-20170429.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 103 - Statement - Condensed Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 105 - Statement - Condensed Consolidated Statements of Income link:calculationLink link:presentationLink link:definitionLink 106 - Statement - Condensed Consolidated Statements of Comprehensive Income link:calculationLink link:presentationLink link:definitionLink 107 - Statement - Condensed Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 108 - Disclosure - Overview link:calculationLink link:presentationLink link:definitionLink 109 - Disclosure - Basis of Presentation link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - Principles of Consolidation link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - Acquisition link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - Net Income Per Common Share link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - Intangible Assets link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - Share-Based Compensation link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - Inventories link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - Debt link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - Derivative Financial Instruments and Risk Management link:calculationLink link:presentationLink link:definitionLink 119 - Disclosure - Segment Information link:calculationLink link:presentationLink link:definitionLink 120 - Disclosure - Recent Accounting Pronouncements link:calculationLink link:presentationLink link:definitionLink 121 - Disclosure - Securities Available for Sale link:calculationLink link:presentationLink link:definitionLink 122 - Disclosure - Fair Value link:calculationLink link:presentationLink link:definitionLink 123 - Disclosure - Accumulated Other Comprehensive Loss link:calculationLink link:presentationLink link:definitionLink 124 - Disclosure - Subsequent Events link:calculationLink link:presentationLink link:definitionLink 125 - Disclosure - Recent Accounting Pronouncements (Policies) link:calculationLink link:presentationLink link:definitionLink 126 - Disclosure - Acquisition (Tables) link:calculationLink link:presentationLink link:definitionLink 127 - Disclosure - Net Income Per Common Share (Tables) link:calculationLink link:presentationLink link:definitionLink 128 - Disclosure - Intangible Assets (Tables) link:calculationLink link:presentationLink link:definitionLink 129 - Disclosure - Share-Based Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 130 - Disclosure - Inventories (Tables) link:calculationLink link:presentationLink link:definitionLink 131 - Disclosure - Income Taxes (Tables) link:calculationLink link:presentationLink link:definitionLink 132 - Disclosure - Debt (Tables) link:calculationLink link:presentationLink link:definitionLink 133 - Disclosure - Derivative Financial Instruments and Risk Management (Tables) link:calculationLink link:presentationLink link:definitionLink 134 - Disclosure - Segment Information (Tables) link:calculationLink link:presentationLink link:definitionLink 135 - Disclosure - Securities Available for Sale (Tables) link:calculationLink link:presentationLink link:definitionLink 136 - Disclosure - Fair Value (Tables) link:calculationLink link:presentationLink link:definitionLink 137 - Disclosure - Accumulated Other Comprehensive Loss (Tables) link:calculationLink link:presentationLink link:definitionLink 138 - Disclosure - Overview - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 139 - Disclosure - Acquisition - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 140 - Disclosure - Acquisition - Purchase Price of Acquisition Allocated on Basis of Fair Value (Detail) link:calculationLink link:presentationLink link:definitionLink 141 - Disclosure - Acquisition - Fair Value of the Acquired Identifiable Intangible Assets and Related Estimated Useful Lives (Detail) link:calculationLink link:presentationLink link:definitionLink 142 - Disclosure - Net Income Per Common Share - Reconciliation of Shares Used in Calculating Basic and Diluted (Detail) link:calculationLink link:presentationLink link:definitionLink 143 - Disclosure - Net Income Per Common Share - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 144 - Disclosure - Intangible Assets - Fair Value of Acquired Identifiable Intangible Assets and Related Estimated Useful Lives (Detail) link:calculationLink link:presentationLink link:definitionLink 145 - Disclosure - Intangible Assets - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 146 - Disclosure - Share-Based Compensation - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 147 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (Detail) link:calculationLink link:presentationLink link:definitionLink 148 - Disclosure - Share-Based Compensation - Fair Value of Stock Options Granted (Detail) link:calculationLink link:presentationLink link:definitionLink 149 - Disclosure - Share-Based Compensation - Aggregated Information Regarding Stock Options Granted (Detail) link:calculationLink link:presentationLink link:definitionLink 150 - Disclosure - Share-Based Compensation - Summary of Options Outstanding (Detail) link:calculationLink link:presentationLink link:definitionLink 151 - Disclosure - Share-Based Compensation - Aggregated Information Regarding RSUs and RSAs Granted (Detail) link:calculationLink link:presentationLink link:definitionLink 152 - Disclosure - Inventories - Components of Inventories (Detail) link:calculationLink link:presentationLink link:definitionLink 153 - Disclosure - Income Taxes - Projected Effective Tax Rate for Periods (Detail) link:calculationLink link:presentationLink link:definitionLink 154 - Disclosure - Income Taxes - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 155 - Disclosure - Debt - Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets (Detail) link:calculationLink link:presentationLink link:definitionLink 156 - Disclosure - Debt - Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 157 - Disclosure - Debt - Schedule of Required Principal Payments Remaining on Long Term Debt Outstanding (Detail) link:calculationLink link:presentationLink link:definitionLink 158 - Disclosure - Debt - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 159 - Disclosure - Derivative Financial Instruments and Risk Management - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 160 - Disclosure - Derivative Financial Instruments and Risk Management - Schedule of Impact of the Derivative Instrument in the Condensed Consolidated Financial Statements (Detail) link:calculationLink link:presentationLink link:definitionLink 161 - Disclosure - Segment Information - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 162 - Disclosure - Segment Information - Net Sales and Segment Operating Profit for Each Reporting Segment (Detail) link:calculationLink link:presentationLink link:definitionLink 163 - Disclosure - Securities Available for Sale - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 164 - Disclosure - Securities Available for Sale - Fair Value, Amortized Cost and Gross Unrealized Gains and Losses of the Securities (Detail) link:calculationLink link:presentationLink link:definitionLink 165 - Disclosure - Fair Value - Summary of Financial Assets and Liabilities Measured at Fair Value (Detail) link:calculationLink link:presentationLink link:definitionLink 166 - Disclosure - Fair Value - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 167 - Disclosure - Fair Value - Schedule of Company's Long-Term Debt Including the Current Portion Not Reflected in Financial Statements at Fair Value (Detail) link:calculationLink link:presentationLink link:definitionLink 168 - Disclosure - Accumulated Other Comprehensive Loss - Changes in Balance of Accumulated Other Comprehensive Loss (Detail) link:calculationLink link:presentationLink link:definitionLink 169 - Disclosure - Subsequent Events - Additional information (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 9 alot-20170429_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 alot-20170429_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 alot-20170429_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Accounting Changes and Error Corrections [Abstract] Accounting Changes and Error Corrections [Abstract] Accounting Policies [Abstract] Accounting Policies [Abstract] Accounts Payable, Current Accounts Payable Accounts Receivable, Net, Current Accounts Receivable, net Accrued Liabilities, Current Other Liabilities and Accrued Expenses Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less Accumulated Depreciation Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Net Unrealized Gain (Losses) on Cash Flow Hedges Translation Adjustments [Member] Accumulated Net Investment Gain (Loss) Attributable to Parent [Member] Unrealized Holding Gain/ (Loss) on Available for Sale Securities [Member] Accumulated Other Comprehensive Income (Loss), Net of Tax Ending Balance Beginning Balance Accumulated Other Comprehensive Loss, net of tax AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Foreign Currency Translation Adjustments [Member] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Useful Life Additional Paid in Capital, Common Stock Additional Paid-in Capital Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to Reconcile Net Income to Net Cash Provided (Used) by Operating Activities: Amendment Flag Amendment Flag Amortization of Debt Issuance Costs Amortization of Debt Issuance Costs Amortization of Intangible Assets Amortization expense Amortized Cost and Fair Value Debt Securities [Abstract] Amortized Cost and Fair Value Debt Securities [Abstract] Amortized Cost and Fair Value Debt Securities [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Number of common equivalent shares Assets TOTAL ASSETS Assets [Abstract] ASSETS Assets, Current Total Current Assets Assets, Current [Abstract] CURRENT ASSETS Assets, Fair Value Disclosure, Recurring Total assets Available-for-sale Securities, Amortized Cost Basis Amortized Cost Available-for-sale Securities, Current State and Municipal Obligations (included in Securities Available for Sale) Fair Value Securities Available for Sale Available For Sale Securities Expected Maturity Period Available For Sale Securities Expected Maturity Period Anticipated maturity period Available-for-sale Securities, Gross Unrealized Gain Gross Unrealized Gains Available-for-sale Securities, Gross Unrealized Loss Gross Unrealized Losses Award Type [Axis] Award Type [Axis] Bank of America. Bank Of America [Member] Bank of America, N.A. [Member] Board of Directors Chairman [Member] Chairman of Board [Member] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition [Axis] Business Acquisition [Axis] Business acquisition contingent consideration percentage of achievement. Business Acquisition Contingent Consideration Percentage Of Achievement Minimum percentage required to entitle additional contingent consideration Business acquisition contingent consideration period. Business Acquisition Contingent Consideration Period Additional contingent consideration period Business Acquisition [Line Items] Business Acquisition [Line Items] Business acquisition purchase price allocation goodwill expected tax not deductible amount. Business Acquisition Purchase Price Allocation Goodwill Expected Tax Not Deductible Amount Goodwill not deductible for tax purposes Business acquisition purchase price amount held in escrow to secure indemnification obligations. Business Acquisition Purchase Price Amount Held in Escrow to Secure Indemnification Obligations Purchase price of acquisition amount held in escrow Business Combination, Acquisition Related Costs General and administrative expense Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High Estimated earnout targets Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, Low Estimated earnout targets Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Business acquisition contingent consideration potential earn-out payments Business Combination, Contingent Consideration, Liability Earnout liability (included in Other Liabilities) Business Combination Disclosure [Text Block] Acquisition Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability Contingent Liability (Earnout) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Other Current Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Accounts Receivable Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accounts payable and other current liabilities. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts payable and other current liabilities Accounts Payable and Other Current Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Deferred Tax Liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Fair Value Identifiable Intangible Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Other Liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Property, Plant and Equipment Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Total Purchase Price Business Combinations [Abstract] Business Combinations [Abstract] Reported Value Measurement [Member] Carrying Value [Member] Cash Acquired from Acquisition Cash acquired from acquisition Cash and Cash Equivalents, at Carrying Value Cash and Cash Equivalents, End of Period Cash and Cash Equivalents, Beginning of Period Cash and Cash Equivalents Cash and Cash Equivalents, Fair Value Disclosure Money Market Funds (included in Cash and Cash Equivalents) Cash and Cash Equivalents, Period Increase (Decrease) Net Increase in Cash and Cash Equivalents Cash Flow Hedging [Member] Cash Flow Hedge [Member] Certain key employees. Certain Key Employees [Member] Certain Key Employees [Member] certain other key employees. Certain Other Key Employees [Member] Certain Other Key Employees [Member] Chairs of audit and compensation committees. Chairs Of Audit And Compensation Committees [Member] Chairs of Audit and Compensation Committees [Member] Chief Executive Officer [Member] Chief Executive Officer [Member] Chief Financial Officer [Member] Chief Financial Officer [Member] Common Stock, Dividends, Per Share, Declared Dividends Declared Per Common Share Common stock held in former employee trust. Common Stock, Shares Held in Former Employee Trust Common stock owned by trust, shares Common Stock, Par or Stated Value Per Share Common Stock, Par Value Common Stock, Shares Authorized Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares Issued Common Stock, Value, Issued Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 9,886,003 shares and 9,834,906 shares at April 29, 2017 and January 31, 2017, respectively Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive Income Comprehensive Income (Loss) Note [Text Block] Accumulated Other Comprehensive Loss Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Contingent Consideration Classified as Equity [Member] Contingent Consideration Liability [Member] Corporate, Non-Segment [Member] Corporate Expenses [Member] Cost of Revenue Cost of Revenue Credit Agreement Amendment [Member] Credit Agreement Amendment [Member] Credit Agreement Amendment [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Cross Currency Interest Rate Contract [Member] Cross Currency Interest Rate Contract [Member] Cumulative budgeted net sales target measurement period. Cumulative Budgeted Net Sales Target Measurement Period Cumulative budgeted net sales target measurement period Current Fiscal Year End Date Current Fiscal Year End Date Customer Contracts [Member] Customer Contract Relationships [Member] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Debt Disclosure [Text Block] Debt Debt instrument additional basis spread. Debt Instrument Additional Basis Spread Percentage added to variable rate Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Basis Spread on Variable Rate Interest rate Long-term Debt, Gross Credit facility, maximum borrowing capacity USD Term Loan with a rate equal to LIBOR plus a margin of 1.0% to 1.5%, (2.031% as of April 29, 2017), and maturity date of January 31, 2022 Debt Instrument, Description of Variable Rate Basis Debt instrument, description of variable rate basis Debt Instrument [Line Items] Debt Instrument [Line Items] Debt Instrument, Maturity Date Debt instrument, maturity date Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Debt instrument unamortized discount premium debt issuance costs and current portion adjustment. Debt instrument unamortized discount premium debt issuance costs and current portion adjustment [abstract] Less: Debt Issuance Costs, Net Debt Issuance Costs, net of accumulated amortization Deferred Income Taxes and Tax Credits Deferred Income Tax Provision Deferred Revenue, Current Deferred Revenue Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Deferred Tax Assets Deferred Tax Liabilities, Net, Noncurrent Deferred Tax Liabilities Depreciation, Depletion and Amortization Depreciation and Amortization Derivative Contract [Domain] Derivative Contract [Domain] Derivative Liability, Fair Value, Gross Liability Derivative fair value Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative Financial Instruments and Risk Management Hedging Relationship [Axis] Hedging Relationship [Axis] Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Amount of Gain Reclassified from Accumulated OCI into Income (Effective Portion) Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion) Derivative Instruments, Income Statement Location of Gain (Loss) Reclassified from Accumulated OCI Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Derivative, Notional Amount Amount of debt conversion Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Share-Based Compensation Document and entity information. Document And Entity Information [Abstract] Document And Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Period End Date Document Period End Date Document Type Document Type Earnings Per Share [Abstract] Earnings Per Share [Abstract] Earnings Per Share, Basic Net Income Per Common Share-Basic Earnings Per Share, Diluted Net Income Per Common Share-Diluted Earnings Per Share [Text Block] Net Income Per Common Share Earn out payments if eighty percentage of specified earnings targets are achieved. Earn Out Payments if Eighty Percentage of Specified Earnings Targets are Achieved [Member] Earn-Out Payments, if 80% of Specified Earnings Targets are Achieved [Member] Earn out payments if hundred and twenty percentage of specified earnings targets are achieved. Earn Out Payments if Hundred and Twenty Percentage of Specified Earnings Targets are Achieved [Member] Earn-Out Payments, if 120% of Specified Earnings Targets are Achieved [Member] Earn out payments if hundred percentage of specified earnings targets are achieved. Earn Out Payments if Hundred Percentage of Specified Earnings Targets are Achieved [Member] Earn-Out Payments, if 100% of Specified Earnings Targets are Achieved [Member] Effective Income Tax Rate Reconciliation, Percent Effective tax rates for income from continuing operations Effect of Exchange Rate on Cash and Cash Equivalents Effect of Exchange Rate Changes on Cash and Cash Equivalents Employee-related Liabilities, Current Accrued Compensation Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Unrecognized compensation expense to be recognized, Weighted average period Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options Unrecognized compensation expense related to RSUs and RSAs Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Unrecognized compensation expense related to options Employee Stock Option [Member] Stock Options [Member] Employee Stock Ownership Plan (ESOP), Compensation Expense Employee Stock Purchase Plan Employee stock purchase plan. Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan [Member] Entity Central Index Key Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Filer Category Entity Filer Category Entity Registrant Name Entity Registrant Name Equity [Abstract] Equity [Abstract] Equity Component [Domain] Equity Component [Domain] Equity incentive plan. Equity Incentive Plan [Member] Equity Incentive Plan [Member] Estimate of Fair Value Measurement [Member] Fair Value [Member] Existing technology. Existing Technology [Member] Existing Technology [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair value assumptions earnings projections. Fair Value Assumptions Earnings Projections Fair value assumptions, Earnings projections Fair Value Assumptions, Expected Term Estimated target period Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Measurement Basis [Axis] Measurement Basis [Axis] Fair Value by Shareholders' Equity Class [Domain] Fair Value by Shareholders' Equity Class [Domain] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value Fair Value Inputs Assets Liabilities Quantitative Information [Line Items] Fair Value Inputs Assets Liabilities Quantitative Information [Line Items] Fair Value Inputs Assets Liabilities Quantitative Information [Line Items] Fair value inputs assets liabilities quantitative information. Fair Value Inputs Assets Liabilities Quantitative Information [Table] Fair Value Inputs Assets Liabilities Quantitative Information [Table] Fair Value Inputs, Discount Rate Fair value assumptions, risk-adjusted discount rate Fair Value, Inputs, Level 1 [Member] Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Level 3 [Member] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Fair Value Measurements, Significant Assumptions Fair value key assumptions Federal Funds Effective Swap Rate [Member] Federal Funds Effective Swap Rate [Member] Financial Instrument [Axis] Financial Instrument [Axis] Finite-Lived Intangible Assets, Accumulated Amortization Accumulated Amortization Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Currency Translation Adjustment Finite-Lived Intangible Assets, Gross Gross Carrying Amount Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets [Member] Intangible Assets [Member] Finite-Lived Intangible Assets, Net Intangible Assets, net Net Carrying Amount Foreign Currency Contracts, Liability, Fair Value Disclosure Swap Contracts (included in Other Liabilities) General and Administrative Expense Corporate Expenses General and Administrative General and Administrative Expense [Member] General and Administrative Expense [Member] Goodwill Goodwill Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Gross Profit Gross Profit Hedging Relationship [Domain] Hedging Relationship [Domain] Impairment of Intangible Assets (Excluding Goodwill) [Abstract] Impairment of Intangible Assets (Excluding Goodwill) [Abstract] Impairment of Intangible Assets, Finite-lived Impairments of intangible assets Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income Before Income Taxes Income before Income Taxes Income Statement [Abstract] Income Statement [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] EX-101.PRE 12 alot-20170429_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 13 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Apr. 29, 2017	Jun. 02, 2017
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Apr. 29, 2017
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q1
Trading Symbol	ALOT
Entity Registrant Name	AstroNova, Inc.
Entity Central Index Key	0000008146
Current Fiscal Year End Date	--01-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		6,729,718

XML 14 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 29, 2017	Jan. 31, 2017
CURRENT ASSETS
Cash and Cash Equivalents	$ 18,637	$ 18,098
Securities Available for Sale	5,185	6,723
Accounts Receivable, net	16,053	15,702
Inventories	20,336	19,506
Prepaid Expenses and Other Current Assets	1,566	1,394
Total Current Assets	61,777	61,423
PROPERTY, PLANT AND EQUIPMENT	40,754	40,378
Less Accumulated Depreciation	(31,520)	(31,098)
Property, Plant and Equipment, net	9,234	9,280
OTHER ASSETS
Intangible Assets, net	8,249	5,264
Goodwill	11,958	4,521
Deferred Tax Assets	2,805	2,811
Other	117	366
Total Other Assets	23,129	12,962
TOTAL ASSETS	94,140	83,665
CURRENT LIABILITIES
Accounts Payable	5,120	4,957
Accrued Compensation	2,201	2,936
Other Liabilities and Accrued Expenses	1,954	2,171
Current Portion of Long -Term Debt	1,104
Deferred Revenue	370	472
Income Taxes Payable	1,595	1,449
Total Current Liabilities	12,344	11,985
Deferred Tax Liabilities	677	11
Long-Term Debt	7,941
Other Liabilities	2,438	1,132
TOTAL LIABILITIES	23,400	13,128
SHAREHOLDERS' EQUITY
Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 9,886,003 shares and 9,834,906 shares at April 29, 2017 and January 31, 2017, respectively	495	492
Additional Paid-in Capital	48,207	47,524
Retained Earnings	44,341	44,358
Treasury Stock, at Cost, 2,385,534 and 2,375,076 shares at April 29, 2017 and January 31, 2017, respectively	(20,990)	(20,781)
Accumulated Other Comprehensive Loss, net of tax	(1,313)	(1,056)
TOTAL SHAREHOLDERS' EQUITY	70,740	70,537
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 94,140	$ 83,665

XML 15 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Apr. 29, 2017	Jan. 31, 2017
Statement of Financial Position [Abstract]
Common Stock, Par Value	$ 0.05	$ 0.05
Common Stock, Shares Authorized	13,000,000	13,000,000
Common Stock, Shares Issued	9,886,003	9,834,906
Treasury Stock, Shares	2,385,534	2,375,076

XML 16 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Income Statement [Abstract]
Revenue	$ 24,458	$ 24,110
Cost of Revenue	15,152	14,637
Gross Profit	9,306	9,473
Operating Expenses:
Selling and Marketing	5,238	4,831
Research and Development	1,505	1,444
General and Administrative	1,856	1,651
Operating Expenses	8,599	7,926
Operating Income, net	707	1,547
Other Expense	(48)	(52)
Income before Income Taxes	659	1,495
Income Tax Provision	147	476
Net Income	$ 512	$ 1,019
Net Income Per Common Share-Basic	$ 0.07	$ 0.14
Net Income Per Common Share-Diluted	$ 0.07	$ 0.14
Weighted Average Number of Common Shares Outstanding:
Basic	7,480,039	7,357,588
Diluted	7,615,546	7,524,249
Dividends Declared Per Common Share	$ 0.07	$ 0.07

XML 17 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Statement of Comprehensive Income [Abstract]
Net Income	$ 512	$ 1,019
Other Comprehensive Income, Net of Taxes:
Foreign Currency Translation Adjustments	(221)	327
Change in value of derivatives designated as cash flow hedges	(259)
Unrealized Holding Gain (Loss) on Securities Available for Sale	12	(2)
Losses from cash flow hedges reclassified to income statement	211
Other Comprehensive Income (Loss)	(257)	325
Comprehensive Income	$ 255	$ 1,344

XML 18 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Cash Flows from Operating Activities:
Net Income	$ 512	$ 1,019
Adjustments to Reconcile Net Income to Net Cash Provided (Used) by Operating Activities:
Depreciation and Amortization	715	625
Amortization of Debt Issuance Costs	5
Share-Based Compensation	171	314
Deferred Income Tax Provision	7	69
Changes in Assets and Liabilities, Net of Impact of Acquisition:
Accounts Receivable	1,005	443
Inventories	(16)	(1,588)
Income Taxes	66	257
Accounts Payable and Accrued Expenses	(3,179)	1,647
Other	(57)	128
Net Cash Provided (Used) by Operating Activities	(771)	2,914
Cash Flows from Investing Activities:
Proceeds from Sales/Maturities of Securities Available for Sale	1,554	1,598
Cash Paid for TrojanLabel Acquisition, net of cash acquired	(9,007)
Payments Received on Line of Credit and Note Receivable	10	188
Additions to Property, Plant and Equipment	(359)	(195)
Net Cash Provided (Used) by Investing Activities	(7,802)	1,591
Cash Flows from Financing Activities:
Cash (used) proceeds from Common Shares Issued Under Employee Benefit Plans and Employee Stock Option Plans, Net of Payment of Minimum Tax Withholdings	306	(40)
Proceeds from Issuance of Long-Term Debt	9,200
Payments of Debt Issuance Costs	(155)
Dividends Paid	(527)	(516)
Net Cash Provided (Used) by Financing Activities	8,824	(556)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	288	542
Net Increase in Cash and Cash Equivalents	539	4,491
Cash and Cash Equivalents, Beginning of Period	18,098	10,043
Cash and Cash Equivalents, End of Period	18,637	14,534
Supplemental Disclosures of Cash Flow Information:
Cash Paid During the Period for Interest	0	0
Cash Paid During the Period for Income Taxes, Net of Refunds	$ 111	$ 170

XML 19 R7.htm IDEA: XBRL DOCUMENT

Overview	3 Months Ended
Overview	Apr. 29, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Overview	(1) Overview Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems. Our products are distributed through our own sales force and authorized dealers in the United States. We also sell to customers outside of the United States primarily through our Company offices in Canada, China, Europe, Mexico and Southeast Asia as well as with independent dealers and representatives. AstroNova, Inc. products are employed around the world in a wide range of aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation applications. The business consists of two segments, Product Identification (previously known as our QuickLabel segment), which includes specialty printing systems sold under the QuickLabel^® and TrojanLabel^™ brand names, and Test & Measurement which includes test and measurement as well as Aerospace systems sold under the AstroNova™ brand name. Products sold under the QuickLabel and TrojanLabel brands are used in industrial and commercial product packaging and automatic identification applications to digitally print custom labels and other visual identification marks on demand. Products sold under the AstroNova Test & Measurement brand acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats. In the aerospace market, the Company has a long history of using its data visualization technologies to provide high-resolution airborne printers and networking systems as well as related hardware and supplies. Unless otherwise indicated, references to “AstroNova,” the “Company,” “we,” “our,” and “us” in this Quarterly Report on Form 10-Q refer to AstroNova, Inc. and its consolidated subsidiaries.

XML 20 R8.htm IDEA: XBRL DOCUMENT

Basis of Presentation	3 Months Ended
Basis of Presentation	Apr. 29, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	(2) Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with footnotes contained in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2017. Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year. The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Some of the more significant estimates relate to the allowances for doubtful accounts and credits, inventory valuation, impairment of long-lived assets and goodwill, income taxes, share-based compensation, accrued expenses and warranty reserves. Management’s estimates are based on the facts and circumstances available at the time estimates are made, historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters. Consequently, actual results could differ from those estimates. Certain amounts in the prior year financial statements have been reclassified to conform to the current year’s presentation.

XML 21 R9.htm IDEA: XBRL DOCUMENT

Principles of Consolidation	3 Months Ended
Principles of Consolidation	Apr. 29, 2017
Accounting Policies [Abstract]
Principles of Consolidation	(3) Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

XML 22 R10.htm IDEA: XBRL DOCUMENT

Acquisition

3 Months Ended

Apr. 29, 2017

Business Combinations [Abstract]

Acquisition

(4) Acquisition

The US dollar purchase price of the acquisition has been allocated on the basis of fair value as follows:


(In thousands)
Accounts Receivable	$	1,322
Inventory		796
Other Current Assets		166
Property, Plant and Equipment		15
Identifiable Intangible Assets		3,264
Goodwill		7,388
Accounts Payable and Other Current Liabilities		(1,821	)
Other Liability		(114	)
Contingent Liability (Earnout)		(1,314	)
Deferred Tax Liability		(695	)

Total Purchase Price	$	9,007

The following table reflects the fair value of the acquired identifiable intangible assets and related estimated useful lives:


(In thousands)	Fair Value		Useful Life (Years)
Existing Technology	$	2,327		7
Non-Competition Agreement		937		10

Total	$	3,264

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1524-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4922-128472

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4934-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4926-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=73530397&loc=SL65897772-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

+ Details

XML 23 R11.htm IDEA: XBRL DOCUMENT

Net Income Per Common Share

3 Months Ended

Apr. 29, 2017

Earnings Per Share [Abstract]

Net Income Per Common Share

(5) Net Income Per Common Share


	Three Months Ended
	April 29, 2017		April 30, 2016
Weighted Average Common Shares Outstanding—Basic		7,480,039		7,357,588
Effect of Dilutive Options and Restricted Stock Units		135,507		166,661

Weighted Average Common Shares Outstanding—Diluted		7,615,546		7,524,249

XML 24 R12.htm IDEA: XBRL DOCUMENT

Intangible Assets

3 Months Ended

Apr. 29, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

(6) Intangible Assets

Intangible assets are as follows:


	April 29, 2017									January 31, 2017
(In thousands)	Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Miltope:
Customer Contract Relationships	$	3,100	$	(1,190	)		—	$	1,910	$	3,100	$	(1,108	)	$	1,992
RITEC:
Customer Contract Relationships		2,830		(271	)		—		2,559		2,830		(207	)		2,623
Non-Competition Agreement		950		(348	)		—		602		950		(301	)		649
TrojanLabel:
Existing Technology		2,327		(82	)		14		2,259		—		—			—
Non-Competition Agreement		937		(23	)		5		919		—		—			—

Intangible Assets, net	$	10,144	$	(1,914	)		19	$	8,249	$	6,880	$	(1,616	)	$	5,264

XML 25 R13.htm IDEA: XBRL DOCUMENT

Share-Based Compensation

3 Months Ended

Apr. 29, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Compensation

(7) Share-Based Compensation

In March 2015 (fiscal year 2016), the Company granted 50,000 options and 537 RSAs to its CEO pursuant to the CEO Equity Incentive Agreement, and 35,000 options to other key employees.

In March 2016 (fiscal year 2017), the Company granted 50,000 options and 4,030 RSAs to its CEO pursuant to the CEO Equity Incentive Agreement.

In May 2016 (fiscal year 2017) the Company granted 37,000 options to certain key employees. On August 1, 2016 (fiscal year 2017) the Company granted 5,000 options to its Chief Financial Officer.

The options and RSAs granted March 2015 through March 2017 vest in four equal annual installments commencing on the first anniversary of the grant date.

Share-based compensation expense was recognized as follows:


	Three Months Ended
(In thousands)	April 29, 2017		April 30, 2016
Stock Options	$	94	$	81
Restricted Stock Awards and Restricted Stock Units		74		230
Employee Stock Purchase Plan		3		3

Total	$	171	$	314

Stock Options

The fair value of stock options granted during the three months ended April 29, 2017 and April 30, 2016 was estimated using the following weighted average assumptions:


	Three Months Ended
	April 29, 2017	April 30, 2016
Risk Free Interest Rate	1.7%	1.5%
Expected Volatility	36.6%	24.6%
Expected Life (in years)	7.5	5.0
Dividend Yield	2.1%	1.9%

The weighted average fair value per share for options granted was $4.11 during the three months ended April 29, 2017, compared to $2.86 during the three months ended April 30, 2016.

Aggregated information regarding stock options granted under the plans for the three months ended April 29, 2017, is summarized below:


	Number of Options			Weighted Average Exercise Price
Outstanding at January 31, 2017		685,456		$	11.96
Granted		102,189			13.31
Exercised		(43,125	)		11.50
Forfeited		—			—
Canceled		(19,700	)		11.75

Outstanding at April 29, 2017		724,820		$	12.19

Set forth below is a summary of options outstanding at April 29, 2017:


Outstanding							Exercisable
Range of Exercise prices	Number of Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Number of Shares		Weighted- Average Exercise Price		Weighted Average Remaining Contractual Life
$5.00-10.00		188,056	$	7.84		3.6		188,056	$	7.84		3.6
$10.01-15.00		481,764	$	13.55		7.9		226,275	$	13.20		6.8
$15.01-20.00		55,000	$	15.07		8.9		12,500	$	15.01		8.9

		724,820	$	12.19		6.9		426,831	$	10.89		5.5

Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs)

Aggregated information regarding RSUs and RSAs granted under the Plan for the three months ended April 29, 2017 is summarized below:


	RSAs & RSUs			Weighted Average Grant Date Fair Value
Unvested at January 31, 2017		213,868		$	14.11
Granted		7,233			13.95
Vested		(10,461	)		13.75
Forfeited		—			—

Unvested at April 29, 2017		210,640		$	14.10

As of April 29, 2017, there was approximately $800,000 of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of 0.8 years.

Employee Stock Purchase Plan

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

XML 26 R14.htm IDEA: XBRL DOCUMENT

Inventories

3 Months Ended

Apr. 29, 2017

Inventory Disclosure [Abstract]

Inventories

(8) Inventories

Inventories are stated at the lower of cost (first-in, first-out) and net realizable value and include material, labor and manufacturing overhead. The components of inventories are as follows:


(In thousands)	April 29, 2017			January 31, 2017
Materials and Supplies	$	12,082		$	11,865
Work-In-Process		1,168			1,216
Finished Goods		11,184			10,270

		24,434			23,351
Inventory Reserve		(4,098	)		(3,845	)

	$	20,336		$	19,506

XML 27 R15.htm IDEA: XBRL DOCUMENT

Income Taxes

3 Months Ended

Apr. 29, 2017

Income Tax Disclosure [Abstract]

Income Taxes

(9) Income Taxes

The Company’s effective tax rates for the period, which are based on the projected effective tax rate for the full year, are as follows:


		Three Months Ended
Fiscal 2018		22.3%
Fiscal 2017		31.8%

XML 28 R16.htm IDEA: XBRL DOCUMENT

Debt

3 Months Ended

Apr. 29, 2017

Debt Disclosure [Abstract]

Debt

(10) Debt

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:


(In thousands)	April 29, 2017			January 31, 2017
USD Term Loan with a rate equal to LIBOR plus a margin of 1.0% to 1.5%, (2.031% as of April 29, 2017), and maturity date of January 31, 2022	$	9,200		$	—
Less:
Debt Issuance Costs, net of accumulated amortization	$	( 155	)	$	—
Current Portion	$	(1,104	)	$	—

Long-Term Debt	$	7,941		$	—

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of April 29, 2017 is as follows:


(In thousands)
Fiscal 2018	$	1,104
Fiscal 2019		1,472
Fiscal 2020		1,840
Fiscal 2021		2,208
Fiscal 2022		2,576

	$	9,200

As of April 29, 2017, there are no borrowings under the revolving credit facility, and we believe the Company is in compliance with all of the covenants in the Credit Agreement.

XML 29 R17.htm IDEA: XBRL DOCUMENT

Derivative Financial Instruments and Risk Management

3 Months Ended

Apr. 29, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments and Risk Management

(11) Derivative Financial Instruments and Risk Management

As of April 29, 2017, the total notional amount of the Company’s cross-currency interest rate swap was $8.6 million; the fair value was $393,600.

The following table presents the impact of the derivative instrument in our condensed consolidated financial statements:


Cash Flow Hedge	Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)					Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
Cash Flow Hedge	April 29, 2017			January 31, 2017			April 29, 2017			January 31, 2017
Swap contract	$	(392,636	)	$	—	Other Income (Expense)	$	(320,076	)	$	—

- Definition

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

XML 30 R18.htm IDEA: XBRL DOCUMENT

Segment Information

3 Months Ended

Apr. 29, 2017

Segment Reporting [Abstract]

Segment Information

(12) Segment Information

AstroNova reports two segments: Product Identification and Test & Measurement (T&M). The Company evaluates segment performance based on the segment profit before corporate expenses.

Summarized below are the Revenue and Segment Operating Profit for each reporting segment:


	Three Months Ended
	Revenue				Segment Operating Profit
(In thousands)	April 29, 2017		April 30, 2016		April 29, 2017			April 30, 2016
Product Identification	$	18,646	$	16,606	$	2,492		$	1,996
T&M		5,812		7,504		71			1,202

Total	$	24,458	$	24,110		2,563			3,198

Corporate Expenses						1,856			1,651

Operating Income						707			1,547
Other Expense						(48	)		(52	)

Income Before Income Taxes						659			1,495
Income Tax Provision						147			476

Net Income					$	512		$	1,019

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

+ Details

XML 31 R19.htm IDEA: XBRL DOCUMENT

Recent Accounting Pronouncements	3 Months Ended
Recent Accounting Pronouncements	Apr. 29, 2017
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	(13) Recent Accounting Pronouncements Goodwill In January 2017, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2017-04, “Intangibles—Goodwill and Other (Topic 350).” ASU 2017-14 simplifies the subsequent measurement of goodwill impairment. The new guidance eliminates the two-step process that required identification of potential impairment and a separate measure of the actual impairment. Goodwill impairment charges, if any, would be determined by reducing the goodwill balance by the difference between the carrying value and the reporting unit’s fair value (impairment loss is limited to the carrying value). This standard is effective for annual or any interim goodwill impairment tests beginning after December 15, 2019. The Company does not believe the adoption of this guidance will have a material impact on the Company’s consolidated financial statements Statement of Cash Flows In August 2016, the FASB issued ASU 2016-15, “Classification of Certain Cash Receipts and Cash Payments (Topic 230).” ASU 2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice for certain cash receipts and cash payments. The standard is effective for annual reporting periods beginning after December 15, 2017 and interim periods within those years (Q1 fiscal 2019 for AstroNova), with early adoption permitted. The Company does not believe the adoption of this guidance will have a material impact on the Company’s consolidated financial statements. Revenue Recognition In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 completes the joint effort by the FASB and International Accounting Standards Board to improve financial reporting by creating common revenue recognition guidance for U.S. GAAP and International Financial Reporting Standards. ASU 2014-09 applies to all companies that enter into contracts with customers to transfer goods or services. In August 2015, the FASB modified ASU 2014-09 to be effective for annual reporting periods beginning after December 15, 2017 (Q1 fiscal 2019 for AstroNova), including interim periods within that reporting period. As modified, the FASB permits the adoption of the new revenue standard early, but not before annual periods beginning after December 15, 2016. Entities have the choice to apply ASU 2014-09 either retrospectively to each reporting period presented or by recognizing the cumulative effect of applying ASU 2014-09 at the date of initial application and not adjusting comparative information. In March 2016, the FASB issued ASU 2016-08, “Revenue from Contracts with Customers (Topic 606)—Principal versus Agent Consideration.” In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606)—Identifying Performance Obligations and Licensing.” In May 2016, the FASB issued ASU 2016-11, “Revenue from Contracts with Customers (Topic 606) and Derivatives and Hedging (Topic 815)—Rescission of SEC Guidance Because of ASU 2014-09 and 2014-16” and ASU 2016-12, “Revenue from Contracts with Customers (Topic 606)—Narrow Scope Improvements and Practical Expedients.” All of these ASUs do not change the core principle of the guidance in Topic 606 (as amended by ASU 2014-09), but rather provide further guidance to improve the operability and understandability of the implementation guidance included in ASU 2014-09. The effective date for all of these ASUs is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those years (Q1 fiscal 2019 for AstroNova). The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements. Leases In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” ASU 2016-02 supersedes current guidance related to accounting for leases and is intended to increase transparency and comparability among organizations by requiring lessees to recognize assets and liabilities in the balance sheet for operating leases with lease terms greater than twelve months. The update also requires improved disclosures to help users of financial statements better understand the amount, timing and uncertainty of cash flows arising from leases. ASU 2016-02 will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years (Q1 fiscal 2020 for AstroNova), with early adoption permitted. At adoption, this update will be applied using a modified retrospective approach. The Company is currently evaluating the effect of this new guidance on the Company’s consolidated financial statements. Inventory In July 2015, the FASB issued ASU 2015-11, “Inventory (Topic 330).” ASU 2015-11 requires inventory to be measured at the lower of cost and net realizable value instead of at lower of cost or market. This guidance does not apply to inventory that is measured using last-in, first out (LIFO) or the retail inventory method but applies to all other inventory, including inventory measured using first-in, first-out (FIFO) or the average cost method. ASU 2015-11 will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years (Q1 fiscal 2018 for AstroNova) and should be applied prospectively. Our adoption of this guidance at the beginning of the first quarter of fiscal 2018 did not have a material effect on our consolidated financial statements. No other new accounting pronouncements, issued or effective during the first three months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

- Definition

The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6507316

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Direct Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=66092750

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22583-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Indirect Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6515603

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22580-107794

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.10-01.(b)(6))
-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Accounting Change
-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22499-107794

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Retrospective Application
-URI http://asc.fasb.org/extlink&oid=6523989

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305

+ Details

XML 32 R20.htm IDEA: XBRL DOCUMENT

Securities Available for Sale

3 Months Ended

Apr. 29, 2017

Investments, Debt and Equity Securities [Abstract]

Securities Available for Sale

(14) Securities Available for Sale

The fair value, amortized cost and gross unrealized gains and losses of securities available for sale are as follows:


(In thousands) April 29, 2017	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
State and Municipal Obligations	$	5,188	$	—	$	(3	)	$	5,185


January 31, 2017	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
State and Municipal Obligations	$	6,732	$	—	$	(9	)	$	6,723

- Definition

The entire disclosure for investments in certain debt and equity securities.

+ References + Details

XML 33 R21.htm IDEA: XBRL DOCUMENT

Fair Value

3 Months Ended

Apr. 29, 2017

Fair Value Disclosures [Abstract]

Fair Value

(15) Fair Value

The fair value hierarchy is summarized as follows:

•

Level 1—Quoted prices in active markets for identical assets or liabilities;

•

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Assets and Liabilities Recorded at Fair Value on a Recurring Basis

The following tables provide a summary of the financial assets and liabilities that are measured at fair value as of April 29, 2017 and January 31, 2017:


Assets measured at fair value:	Fair value measurement at April 29, 2017								Fair value measurement at January 31, 2017
(in thousands)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Money Market Funds (included in Cash and Cash Equivalents)	$	1,611	$	—	$	—	$	1,611	$	2	$	—	$	—	$	2
State and Municipal Obligations (included in Securities Available for Sale)		—		5,185		—		5,185		—		6,723		—		6,723

Total assets	$	1,611	$	5,185	$	—	$	6,796	$	2	$	6,723	$	—	$	6,725


Liabilities measured at fair value:	Fair value measurement at April 29, 2017								Fair value measurement at January 31, 2017
(in thousands)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Swap Contracts (included in Other Liabilities)	$	—	$	393	$	—	$	393	$	—	$	—	$	—	$	—
Earnout liability (included in Other Liabilities)		—		—		1,322		1,322		—		—		—		—

Total liabilities	$	—	$	393	$	1,322	$	1,715	$	—	$	—	$	—	$	—

For our money market funds and municipal obligations, we utilize the market approach to measure fair value. The market approach is based on using quoted prices for identical or similar assets.

Assets and Liabilities Not Recorded at Fair Value

As of April 29, 2017, the Company’s long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:


	Fair Value Measurement at April 29, 2017
(In thousands)	Level 1		Level 2		Level 3		Total		Carrying Value
Long-Term debt and related current maturities	$	—	$	9,200	$	—	$	9,200	$	9,200

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 34 R22.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Loss

3 Months Ended

Apr. 29, 2017

Equity [Abstract]

Accumulated Other Comprehensive Loss

(16) Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss by component are as follows:


(In thousands)	Foreign Currency Translation Adjustments			Unrealized Holding Gain/(Loss) on Available for Sale Securities			Net Unrealized Gain(Losses) on Cash Flow Hedges			Total
Balance at January 31, 2017	$	(1,048	)	$	(8	)	$	—		$	(1,056	)
Other Comprehensive Income (Loss) before reclassification		(221	)		12			(259	)		(468	)
Amounts reclassified from AOCI to Earnings		—			—			211			211

Other Comprehensive Income (Loss)		(221	)		12			(48	)		(257	)

Balance at April 29, 2017	$	(1,269	)	$	4		$	(48	)	$	(1,313	)

The amounts presented above in other comprehensive income (loss) are net of any applicable taxes.

- Definition

The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e640-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e716-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e709-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e681-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Reclassification Adjustments
-URI http://asc.fasb.org/extlink&oid=6522872

+ Details

XML 35 R23.htm IDEA: XBRL DOCUMENT

Subsequent Events	3 Months Ended
Subsequent Events	Apr. 29, 2017
Subsequent Events [Abstract]
Subsequent Events	(17) Subsequent Events Stock Repurchase Agreement On May 1, 2017, the Company entered into a stock repurchase agreement with a trust established by Albert W. Ondis to repurchase 826,305 shares of the Company’s common stock held by the trust at a per share price of $13.60, for an aggregate repurchase price of $11.2 million. This stock repurchase was consummated on May 2, 2017 and was funded using existing cash on hand. Following this stock repurchase, the Ondis trust owns 36,000 shares of the Company’s common stock. April L. Ondis, a director of the Company, is a beneficiary of the trust. The stock repurchase was authorized and approved by the Company’s Audit Committee as a related party transaction. Prior to entering into the agreement, the Company obtained an opinion from an independent investment banking firm that the consideration to be paid by the Company to the trust pursuant to the stock repurchase agreement would be fair to the public stockholders of the Company, other than the trust, from a financial point of view. Credit Agreement Amendment In connection with the stock repurchase, the Company entered into a consent and amendment, dated as of May 1, 2017, relating to the Credit Agreement, dated as of February 28, 2017, among the Company, its subsidiaries, ANI ApS and TrojanLabel ApS, and Bank of America, N.A., as lender. Solely for purposes of effecting the stock repurchase, the Amendment increased the aggregate amount of certain repurchases of Company equity interests permitted to be made by the Company under the Credit Agreement in the Company’s fiscal year ending January 31, 2018, from $5,000,000 to $12,000,000, subject to certain conditions. The Amendment prohibits the Company from making other repurchases of Company equity interests under such permission in the fiscal year ending January 31, 2018. The Amendment also provides that the aggregate amount paid in cash by the Company to effect the stock repurchase shall not be deducted from the Company’s consolidated EBITDA for the purposes of calculating the consolidated fixed charge coverage ratio covenant to which the Company is subject under the Credit Agreement with respect to any trailing four-fiscal-quarter measurement period through and including the measurement period ending January 31, 2018.

XML 36 R24.htm IDEA: XBRL DOCUMENT

Recent Accounting Pronouncements (Policies)	3 Months Ended
Recent Accounting Pronouncements (Policies)	Apr. 29, 2017
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements Goodwill In January 2017, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2017-04, “Intangibles—Goodwill and Other (Topic 350).” ASU 2017-14 simplifies the subsequent measurement of goodwill impairment. The new guidance eliminates the two-step process that required identification of potential impairment and a separate measure of the actual impairment. Goodwill impairment charges, if any, would be determined by reducing the goodwill balance by the difference between the carrying value and the reporting unit’s fair value (impairment loss is limited to the carrying value). This standard is effective for annual or any interim goodwill impairment tests beginning after December 15, 2019. The Company does not believe the adoption of this guidance will have a material impact on the Company’s consolidated financial statements Statement of Cash Flows In August 2016, the FASB issued ASU 2016-15, “Classification of Certain Cash Receipts and Cash Payments (Topic 230).” ASU 2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice for certain cash receipts and cash payments. The standard is effective for annual reporting periods beginning after December 15, 2017 and interim periods within those years (Q1 fiscal 2019 for AstroNova), with early adoption permitted. The Company does not believe the adoption of this guidance will have a material impact on the Company’s consolidated financial statements. Revenue Recognition In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 completes the joint effort by the FASB and International Accounting Standards Board to improve financial reporting by creating common revenue recognition guidance for U.S. GAAP and International Financial Reporting Standards. ASU 2014-09 applies to all companies that enter into contracts with customers to transfer goods or services. In August 2015, the FASB modified ASU 2014-09 to be effective for annual reporting periods beginning after December 15, 2017 (Q1 fiscal 2019 for AstroNova), including interim periods within that reporting period. As modified, the FASB permits the adoption of the new revenue standard early, but not before annual periods beginning after December 15, 2016. Entities have the choice to apply ASU 2014-09 either retrospectively to each reporting period presented or by recognizing the cumulative effect of applying ASU 2014-09 at the date of initial application and not adjusting comparative information. In March 2016, the FASB issued ASU 2016-08, “Revenue from Contracts with Customers (Topic 606)—Principal versus Agent Consideration.” In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606)—Identifying Performance Obligations and Licensing.” In May 2016, the FASB issued ASU 2016-11, “Revenue from Contracts with Customers (Topic 606) and Derivatives and Hedging (Topic 815)—Rescission of SEC Guidance Because of ASU 2014-09 and 2014-16” and ASU 2016-12, “Revenue from Contracts with Customers (Topic 606)—Narrow Scope Improvements and Practical Expedients.” All of these ASUs do not change the core principle of the guidance in Topic 606 (as amended by ASU 2014-09), but rather provide further guidance to improve the operability and understandability of the implementation guidance included in ASU 2014-09. The effective date for all of these ASUs is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those years (Q1 fiscal 2019 for AstroNova). The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements. Leases In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” ASU 2016-02 supersedes current guidance related to accounting for leases and is intended to increase transparency and comparability among organizations by requiring lessees to recognize assets and liabilities in the balance sheet for operating leases with lease terms greater than twelve months. The update also requires improved disclosures to help users of financial statements better understand the amount, timing and uncertainty of cash flows arising from leases. ASU 2016-02 will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years (Q1 fiscal 2020 for AstroNova), with early adoption permitted. At adoption, this update will be applied using a modified retrospective approach. The Company is currently evaluating the effect of this new guidance on the Company’s consolidated financial statements. Inventory In July 2015, the FASB issued ASU 2015-11, “Inventory (Topic 330).” ASU 2015-11 requires inventory to be measured at the lower of cost and net realizable value instead of at lower of cost or market. This guidance does not apply to inventory that is measured using last-in, first out (LIFO) or the retail inventory method but applies to all other inventory, including inventory measured using first-in, first-out (FIFO) or the average cost method. ASU 2015-11 will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years (Q1 fiscal 2018 for AstroNova) and should be applied prospectively. Our adoption of this guidance at the beginning of the first quarter of fiscal 2018 did not have a material effect on our consolidated financial statements. No other new accounting pronouncements, issued or effective during the first three months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

XML 37 R25.htm IDEA: XBRL DOCUMENT

Acquisition (Tables) - TrojanLabel ApS [Member]

3 Months Ended

Apr. 29, 2017

Purchase Price of Acquisition Allocated on Basis of Fair Value

The US dollar purchase price of the acquisition has been allocated on the basis of fair value as follows:


(In thousands)
Accounts Receivable	$	1,322
Inventory		796
Other Current Assets		166
Property, Plant and Equipment		15
Identifiable Intangible Assets		3,264
Goodwill		7,388
Accounts Payable and Other Current Liabilities		(1,821	)
Other Liability		(114	)
Contingent Liability (Earnout)		(1,314	)
Deferred Tax Liability		(695	)

Total Purchase Price	$	9,007

Fair Value of the Acquired Identifiable Intangible Assets and Related Estimated Useful Lives

The following table reflects the fair value of the acquired identifiable intangible assets and related estimated useful lives:


(In thousands)	Fair Value		Useful Life (Years)
Existing Technology	$	2,327		7
Non-Competition Agreement		937		10

Total	$	3,264

XML 38 R26.htm IDEA: XBRL DOCUMENT

Net Income Per Common Share (Tables)

3 Months Ended

Apr. 29, 2017

Earnings Per Share [Abstract]

Reconciliation of Shares Used in Calculating Basic and Diluted

A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:


	Three Months Ended
	April 29, 2017		April 30, 2016
Weighted Average Common Shares Outstanding—Basic		7,480,039		7,357,588
Effect of Dilutive Options and Restricted Stock Units		135,507		166,661

Weighted Average Common Shares Outstanding—Diluted		7,615,546		7,524,249

XML 39 R27.htm IDEA: XBRL DOCUMENT

Intangible Assets (Tables)

3 Months Ended

Apr. 29, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Fair Value of Acquired Identifiable Intangible Assets and Related Estimated Useful Lives

Intangible assets are as follows:


	April 29, 2017									January 31, 2017
(In thousands)	Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Miltope:
Customer Contract Relationships	$	3,100	$	(1,190	)		—	$	1,910	$	3,100	$	(1,108	)	$	1,992
RITEC:
Customer Contract Relationships		2,830		(271	)		—		2,559		2,830		(207	)		2,623
Non-Competition Agreement		950		(348	)		—		602		950		(301	)		649
TrojanLabel:
Existing Technology		2,327		(82	)		14		2,259		—		—			—
Non-Competition Agreement		937		(23	)		5		919		—		—			—

Intangible Assets, net	$	10,144	$	(1,914	)		19	$	8,249	$	6,880	$	(1,616	)	$	5,264

XML 40 R28.htm IDEA: XBRL DOCUMENT

Share-Based Compensation (Tables)

3 Months Ended

Apr. 29, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Compensation Expense

Share-based compensation expense was recognized as follows:


	Three Months Ended
(In thousands)	April 29, 2017		April 30, 2016
Stock Options	$	94	$	81
Restricted Stock Awards and Restricted Stock Units		74		230
Employee Stock Purchase Plan		3		3

Total	$	171	$	314

Fair Value of Stock Options Granted

The fair value of stock options granted during the three months ended April 29, 2017 and April 30, 2016 was estimated using the following weighted average assumptions:


	Three Months Ended
	April 29, 2017	April 30, 2016
Risk Free Interest Rate	1.7%	1.5%
Expected Volatility	36.6%	24.6%
Expected Life (in years)	7.5	5.0
Dividend Yield	2.1%	1.9%

Aggregated Information Regarding Stock Options Granted

Aggregated information regarding stock options granted under the plans for the three months ended April 29, 2017, is summarized below:


	Number of Options			Weighted Average Exercise Price
Outstanding at January 31, 2017		685,456		$	11.96
Granted		102,189			13.31
Exercised		(43,125	)		11.50
Forfeited		—			—
Canceled		(19,700	)		11.75

Outstanding at April 29, 2017		724,820		$	12.19

Summary of Options Outstanding

Set forth below is a summary of options outstanding at April 29, 2017:


Outstanding							Exercisable
Range of Exercise prices	Number of Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Number of Shares		Weighted- Average Exercise Price		Weighted Average Remaining Contractual Life
$5.00-10.00		188,056	$	7.84		3.6		188,056	$	7.84		3.6
$10.01-15.00		481,764	$	13.55		7.9		226,275	$	13.20		6.8
$15.01-20.00		55,000	$	15.07		8.9		12,500	$	15.01		8.9

		724,820	$	12.19		6.9		426,831	$	10.89		5.5

Aggregated Information Regarding RSUs and RSAs Granted

Aggregated information regarding RSUs and RSAs granted under the Plan for the three months ended April 29, 2017 is summarized below:


	RSAs & RSUs			Weighted Average Grant Date Fair Value
Unvested at January 31, 2017		213,868		$	14.11
Granted		7,233			13.95
Vested		(10,461	)		13.75
Forfeited		—			—

Unvested at April 29, 2017		210,640		$	14.10

XML 41 R29.htm IDEA: XBRL DOCUMENT

Inventories (Tables)

3 Months Ended

Apr. 29, 2017

Inventory Disclosure [Abstract]

Components of Inventories

Inventories are stated at the lower of cost (first-in, first-out) and net realizable value and include material, labor and manufacturing overhead. The components of inventories are as follows:


(In thousands)	April 29, 2017			January 31, 2017
Materials and Supplies	$	12,082		$	11,865
Work-In-Process		1,168			1,216
Finished Goods		11,184			10,270

		24,434			23,351
Inventory Reserve		(4,098	)		(3,845	)

	$	20,336		$	19,506

XML 42 R30.htm IDEA: XBRL DOCUMENT

Income Taxes (Tables)

3 Months Ended

Apr. 29, 2017

Income Tax Disclosure [Abstract]

Projected Effective Tax Rate for Periods

The Company’s effective tax rates for the period, which are based on the projected effective tax rate for the full year, are as follows:


		Three Months Ended
Fiscal 2018		22.3%
Fiscal 2017		31.8%

XML 43 R31.htm IDEA: XBRL DOCUMENT

Debt (Tables)

3 Months Ended

Apr. 29, 2017

Debt Disclosure [Abstract]

Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:


(In thousands)	April 29, 2017			January 31, 2017
USD Term Loan with a rate equal to LIBOR plus a margin of 1.0% to 1.5%, (2.031% as of April 29, 2017), and maturity date of January 31, 2022	$	9,200		$	—
Less:
Debt Issuance Costs, net of accumulated amortization	$	( 155	)	$	—
Current Portion	$	(1,104	)	$	—

Long-Term Debt	$	7,941		$	—

Schedule of Required Principal Payments Remaining on Long Term Debt Outstanding

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of April 29, 2017 is as follows:


(In thousands)
Fiscal 2018	$	1,104
Fiscal 2019		1,472
Fiscal 2020		1,840
Fiscal 2021		2,208
Fiscal 2022		2,576

	$	9,200

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

+ Details

XML 44 R32.htm IDEA: XBRL DOCUMENT

Derivative Financial Instruments and Risk Management (Tables)

3 Months Ended

Apr. 29, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Impact of the Derivative Instrument in the Condensed Consolidated Financial Statements

The following table presents the impact of the derivative instrument in our condensed consolidated financial statements:


Cash Flow Hedge	Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)					Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
Cash Flow Hedge	April 29, 2017			January 31, 2017			April 29, 2017			January 31, 2017
Swap contract	$	(392,636	)	$	—	Other Income (Expense)	$	(320,076	)	$	—

XML 45 R33.htm IDEA: XBRL DOCUMENT

Segment Information (Tables)

3 Months Ended

Apr. 29, 2017

Segment Reporting [Abstract]

Net Sales and Segment Operating Profit for Each Reporting Segment

Summarized below are the Revenue and Segment Operating Profit for each reporting segment:


	Three Months Ended
	Revenue				Segment Operating Profit
(In thousands)	April 29, 2017		April 30, 2016		April 29, 2017			April 30, 2016
Product Identification	$	18,646	$	16,606	$	2,492		$	1,996
T&M		5,812		7,504		71			1,202

Total	$	24,458	$	24,110		2,563			3,198

Corporate Expenses						1,856			1,651

Operating Income						707			1,547
Other Expense						(48	)		(52	)

Income Before Income Taxes						659			1,495
Income Tax Provision						147			476

Net Income					$	512		$	1,019

XML 46 R34.htm IDEA: XBRL DOCUMENT

Securities Available for Sale (Tables)

3 Months Ended

Apr. 29, 2017

Investments, Debt and Equity Securities [Abstract]

Fair Value, Amortized Cost and Gross Unrealized Gains and Losses of the Securities

The fair value, amortized cost and gross unrealized gains and losses of securities available for sale are as follows:


(In thousands) April 29, 2017	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
State and Municipal Obligations	$	5,188	$	—	$	(3	)	$	5,185


January 31, 2017	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
State and Municipal Obligations	$	6,732	$	—	$	(9	)	$	6,723

XML 47 R35.htm IDEA: XBRL DOCUMENT

Fair Value (Tables)

3 Months Ended

Apr. 29, 2017

Fair Value Disclosures [Abstract]

Summary of Financial Assets and Liabilities Measured at Fair Value

The following tables provide a summary of the financial assets and liabilities that are measured at fair value as of April 29, 2017 and January 31, 2017:


Assets measured at fair value:	Fair value measurement at April 29, 2017								Fair value measurement at January 31, 2017
(in thousands)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Money Market Funds (included in Cash and Cash Equivalents)	$	1,611	$	—	$	—	$	1,611	$	2	$	—	$	—	$	2
State and Municipal Obligations (included in Securities Available for Sale)		—		5,185		—		5,185		—		6,723		—		6,723

Total assets	$	1,611	$	5,185	$	—	$	6,796	$	2	$	6,723	$	—	$	6,725


Liabilities measured at fair value:	Fair value measurement at April 29, 2017								Fair value measurement at January 31, 2017
(in thousands)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Swap Contracts (included in Other Liabilities)	$	—	$	393	$	—	$	393	$	—	$	—	$	—	$	—
Earnout liability (included in Other Liabilities)		—		—		1,322		1,322		—		—		—		—

Total liabilities	$	—	$	393	$	1,322	$	1,715	$	—	$	—	$	—	$	—

chedule of Company's Long-Term Debt Including the Current Portion Not Reflected in Financial Statements at Fair Value

As of April 29, 2017, the Company’s long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:


	Fair Value Measurement at April 29, 2017
(In thousands)	Level 1		Level 2		Level 3		Total		Carrying Value
Long-Term debt and related current maturities	$	—	$	9,200	$	—	$	9,200	$	9,200

XML 48 R36.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Loss (Tables)

3 Months Ended

Apr. 29, 2017

Equity [Abstract]

Changes in Balance of Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss by component are as follows:


(In thousands)	Foreign Currency Translation Adjustments			Unrealized Holding Gain/(Loss) on Available for Sale Securities			Net Unrealized Gain(Losses) on Cash Flow Hedges			Total
Balance at January 31, 2017	$	(1,048	)	$	(8	)	$	—		$	(1,056	)
Other Comprehensive Income (Loss) before reclassification		(221	)		12			(259	)		(468	)
Amounts reclassified from AOCI to Earnings		—			—			211			211

Other Comprehensive Income (Loss)		(221	)		12			(48	)		(257	)

Balance at April 29, 2017	$	(1,269	)	$	4		$	(48	)	$	(1,313	)

XML 49 R37.htm IDEA: XBRL DOCUMENT

Overview - Additional Information (Detail)	3 Months Ended
Overview - Additional Information (Detail)	Apr. 29, 2017 Segments
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating segments	2

XML 50 R38.htm IDEA: XBRL DOCUMENT

Acquisition - Additional Information (Detail)			3 Months Ended	12 Months Ended
Acquisition - Additional Information (Detail)	Feb. 01, 2017 USD ($)	Feb. 01, 2017 DKK	Apr. 29, 2017 USD ($)	Jan. 31, 2017 USD ($)	Feb. 01, 2017 DKK
Contingent Consideration Liability [Member]
Business Acquisition [Line Items]
Fair value key assumptions			Key assumptions in estimating the fair value of the contingent consideration liability include (1) the estimated earnout targets over the next seven years of $407,000-$1,280,000, (2) the probability of success (achievement of the various contingent events) from 1.6%-87.2% and (3) a risk-adjusted discount rate of approximately 1.77%-3.35% used to adjust the probability-weighted earnout payments to their present value.
Estimated target period			7 years
Estimated earnout targets			$ 1,280,000
Estimated earnout targets			$ 407,000
Intangible Assets [Member]
Business Acquisition [Line Items]
Internal rate of return			19.00%
Fair value key assumptions			Key assumptions in estimating the fair value of the intangibles include (1) remaining life of existing technology acquired based on estimate of percentage of revenue from 0% -100% for each product, (2) the Company's internal rate of return of 19.0% and (3) a range of earnings projections from $121,000-$1,070,000.
Intangible Assets [Member] \| Contingent Consideration Liability [Member]
Business Acquisition [Line Items]
Estimated target period			7 years
TrojanLabel ApS [Member]
Business Acquisition [Line Items]
Purchase price of acquisition	$ 9,100,000	DKK 62,900,000
Purchase price of acquisition amount held in escrow	900,000				DKK 6,400,000
Cash acquired from acquisition	$ 100,000	DKK 976,000.0
Additional contingent consideration period	7 years	7 years
General and administrative expense			$ 700,000
Goodwill not deductible for tax purposes	$ 7,400,000
TrojanLabel ApS [Member] \| General and Administrative Expense [Member]
Business Acquisition [Line Items]
General and administrative expense			$ 100,000	$ 600,000
TrojanLabel ApS [Member] \| Earn-Out Payments, if 80% of Specified Earnings Targets are Achieved [Member]
Business Acquisition [Line Items]
Minimum percentage required to entitle additional contingent consideration	80.00%	80.00%
Business acquisition contingent consideration potential earn-out payments	$ 5,000,000				32,500,000
TrojanLabel ApS [Member] \| Earn-Out Payments, if 100% of Specified Earnings Targets are Achieved [Member]
Business Acquisition [Line Items]
Minimum percentage required to entitle additional contingent consideration	100.00%	100.00%
Business acquisition contingent consideration potential earn-out payments	$ 5,800,000				40,600,000
TrojanLabel ApS [Member] \| Earn-Out Payments, if 120% of Specified Earnings Targets are Achieved [Member]
Business Acquisition [Line Items]
Minimum percentage required to entitle additional contingent consideration	120.00%	120.00%
Business acquisition contingent consideration potential earn-out payments	$ 7,000,000				DKK 48,700,000
Minimum [Member] \| Contingent Consideration Liability [Member]
Business Acquisition [Line Items]
Probability of success			1.60%
Fair value assumptions, risk-adjusted discount rate			1.77%
Minimum [Member] \| Intangible Assets [Member]
Business Acquisition [Line Items]
Percentage of revenue on existing technology			0.00%
Fair value assumptions, Earnings projections			$ 121,000
Maximum [Member] \| Contingent Consideration Liability [Member]
Business Acquisition [Line Items]
Probability of success			87.20%
Fair value assumptions, risk-adjusted discount rate			3.35%
Maximum [Member] \| Intangible Assets [Member]
Business Acquisition [Line Items]
Percentage of revenue on existing technology			100.00%
Fair value assumptions, Earnings projections			$ 1,070,000

XML 51 R39.htm IDEA: XBRL DOCUMENT

Acquisition - Purchase Price of Acquisition Allocated on Basis of Fair Value (Detail) - USD ($) $ in Thousands	Apr. 29, 2017	Feb. 01, 2017	Jan. 31, 2017
Business Acquisition [Line Items]
Goodwill	$ 11,958		$ 4,521
TrojanLabel ApS [Member]
Business Acquisition [Line Items]
Accounts Receivable		$ 1,322
Inventory		796
Other Current Assets		166
Property, Plant and Equipment		15
Identifiable Intangible Assets	$ 3,264	3,264
Goodwill		7,388
Accounts Payable and Other Current Liabilities		(1,821)
Other Liability		(114)
Contingent Liability (Earnout)		(1,314)
Deferred Tax Liability		(695)
Total Purchase Price		$ 9,007

XML 52 R40.htm IDEA: XBRL DOCUMENT

Acquisition - Fair Value of the Acquired Identifiable Intangible Assets and Related Estimated Useful Lives (Detail) - TrojanLabel ApS [Member] - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Feb. 01, 2017
Acquired Finite-Lived Intangible Assets [Line Items]
Fair Value	$ 3,264	$ 3,264
Existing Technology [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Fair Value	$ 2,327
Useful Life	7 years
Non-Competition Agreement [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Fair Value	$ 937
Useful Life	10 years

XML 53 R41.htm IDEA: XBRL DOCUMENT

Net Income Per Common Share - Reconciliation of Shares Used in Calculating Basic and Diluted (Detail) - shares	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Earnings Per Share [Abstract]
Weighted Average Common Shares Outstanding-Basic	7,480,039	7,357,588
Effect of Dilutive Options and Restricted Stock Units	135,507	166,661
Weighted Average Common Shares Outstanding-Diluted	7,615,546	7,524,249

XML 54 R42.htm IDEA: XBRL DOCUMENT

Net Income Per Common Share - Additional Information (Detail) - shares	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Earnings Per Share [Abstract]
Number of common equivalent shares	472,214	431,133

XML 55 R43.htm IDEA: XBRL DOCUMENT

Intangible Assets - Fair Value of Acquired Identifiable Intangible Assets and Related Estimated Useful Lives (Detail) - USD ($) $ in Thousands	Apr. 29, 2017	Jan. 31, 2017
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 10,144	$ 6,880
Accumulated Amortization	(1,914)	(1,616)
Net Carrying Amount	8,249	5,264
Currency Translation Adjustment	19
Customer Contract Relationships [Member] \| Miltope [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	3,100	3,100
Accumulated Amortization	(1,190)	(1,108)
Net Carrying Amount	1,910	1,992
Customer Contract Relationships [Member] \| RITEC [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,830	2,830
Accumulated Amortization	(271)	(207)
Net Carrying Amount	2,559	2,623
Non-Competition Agreement [Member] \| RITEC [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	950	950
Accumulated Amortization	(348)	(301)
Net Carrying Amount	602	$ 649
Non-Competition Agreement [Member] \| TrojanLabel ApS [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	937
Accumulated Amortization	(23)
Net Carrying Amount	919
Currency Translation Adjustment	5
Existing Technology [Member] \| TrojanLabel ApS [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,327
Accumulated Amortization	(82)
Net Carrying Amount	2,259
Currency Translation Adjustment	$ 14

XML 56 R44.htm IDEA: XBRL DOCUMENT

Intangible Assets - Additional Information (Detail) - USD ($)	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Impairment of Intangible Assets (Excluding Goodwill) [Abstract]
Impairments of intangible assets	$ 0	$ 0
Amortization expense	$ 298,000	$ 179,000

XML 57 R45.htm IDEA: XBRL DOCUMENT

Share-Based Compensation - Additional Information (Detail)			1 Months Ended							3 Months Ended
	Aug. 01, 2016 shares	Feb. 01, 2014 shares	Apr. 30, 2017 shares	Mar. 31, 2017 Installment shares	Feb. 28, 2017 shares	May 31, 2016 shares	Mar. 31, 2016 shares	May 31, 2015 Installment shares	Mar. 31, 2015 shares	Apr. 29, 2017 USD ($) Equity_Plan $ / shares shares	Apr. 30, 2016 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity incentive plan \| Equity_Plan										2
Number of options granted										102,189
Maximum disposal restricted percentage of RSU										50.00%
Options granted weighted-average fair value per share \| $ / shares										$ 4.11	$ 2.86
Reservation of shares under Stock Purchase Plan										247,500
2007 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incentive plan, expiration period										2017-05
Shares available for grant under the Plan										205,983
2015 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incentive plan, expiration period										2025-05
Shares available for grant under the Plan										886
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant under the Plan										43,717
Employee Stock Purchase Plan discount rate										15.00%
Shares purchase under Employee Stock Purchase Plan										1,507	1,597
Non-Employee Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granting percentage of shares										25.00%
Director compensation amount, fiscal 2017 \| $										$ 55,000
Director compensation amount, fiscal 2018 \| $										65,000
Director compensation amount, fiscal 2019 \| $										75,000
Chairman of Board [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-employee director received restricted stock award value \| $										6,000
Chairs of Audit and Compensation Committees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-employee director received restricted stock award value \| $										$ 4,000
Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted				50,000			50,000		50,000
Chief Executive Officer [Member] \| 2007 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant under the Plan										500,000
Other Key Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted									35,000
Certain Key Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted						37,000
Chief Financial Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted	5,000
Certain Other Key Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted			52,189		52,189
Equity Incentive Plan [Member] \| Non-Employee Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option expiration period										10 years
Number of options granted										5,000
Number of stock options grant to each non-employee director										7,233	567
RSA [Member] \| Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stocks, granted							4,030		537
Restricted Stock And Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of annual vesting installments \| Installment				4
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense related to options \| $										$ 800,000
Unrecognized compensation expense to be recognized, Weighted average period										2 years 10 months 25 days
Stock Options [Member] \| 2007 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period										4 years
Option expiration period										10 years
Stock Options [Member] \| 2015 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period										4 years
Option expiration period										10 years
2014 Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of accelerated vesting shares		4,166
Number of vesting shares											9,300
Unrecognized compensation expense to be recognized, Weighted average period										9 months 18 days
Unrecognized compensation expense related to RSUs and RSAs \| $										$ 800,000
2014 Restricted Stock Units (RSUs) [Member] \| Third Anniversary [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of vesting shares											9,300
2014 Restricted Stock Units (RSUs) [Member] \| Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cumulative budgeted net sales target measurement period										2014 through 2016
2014 Restricted Stock Units (RSUs) [Member] \| Officer [Member] \| Net Sales Target [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock unit vested percentage										50.00%
2014 Restricted Stock Units (RSUs) [Member] \| Officer [Member] \| ORONA Target [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock unit vested percentage										25.00%
2014 Restricted Stock Units (RSUs) [Member] \| Officer [Member] \| Third Anniversary [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock unit vested percentage										25.00%
Time Based RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stocks, granted								80,000
Number of annual vesting installments \| Installment								4
Performance Based RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period								3 years
Restricted stocks, granted								155,000
Performance Based Restricted Stock Units RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of vesting shares										9,025	15,810

XML 58 R46.htm IDEA: XBRL DOCUMENT

Share-Based Compensation - Share-Based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Share-based Compensation [Abstract]
Stock Options	$ 94	$ 81
Restricted Stock Awards and Restricted Stock Units	74	230
Employee Stock Purchase Plan	3	3
Total	$ 171	$ 314

XML 59 R47.htm IDEA: XBRL DOCUMENT

Share-Based Compensation - Fair Value of Stock Options Granted (Detail)	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Risk Free Interest Rate	1.70%	1.50%
Expected Volatility	36.60%	24.60%
Expected Life (in years)	7 years 6 months	5 years
Dividend Yield	2.10%	1.90%

XML 60 R48.htm IDEA: XBRL DOCUMENT

Share-Based Compensation - Aggregated Information Regarding Stock Options Granted (Detail)	3 Months Ended
	Apr. 29, 2017 $ / shares shares
Share-based Compensation [Abstract]
Beginning balance, Number of Options \| shares	685,456
Granted, Number of Options \| shares	102,189
Exercised, Number of Options \| shares	(43,125)
Forfeited, Number of Options \| shares	0
Canceled, Number of Options \| shares	(19,700)
Ending balance, Number of Options \| shares	724,820
Beginning balance, Weighted Average Exercise Price \| $ / shares	$ 11.96
Granted, Weighted Average Exercise Price \| $ / shares	13.31
Exercised, Weighted Average Exercise Price \| $ / shares	11.50
Forfeited, Weighted Average Exercise Price \| $ / shares	0
Canceled, Weighted Average Exercise Price \| $ / shares	11.75
Ending balance, Weighted Average Exercise Price \| $ / shares	$ 12.19

XML 61 R49.htm IDEA: XBRL DOCUMENT

Share-Based Compensation - Summary of Options Outstanding (Detail) - $ / shares	3 Months Ended
	Apr. 29, 2017	Jan. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding, total	724,820	685,456
Outstanding, Weighted Average Exercise Price	$ 12.19
Exercisable, Weighted Average Exercise Price	$ 10.89
Outstanding Remaining Contractual Life	6 years 10 months 25 days
Number of shares exercisable, total	426,831
Exercisable Remaining Contractual Life	5 years 6 months
Range Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Range of Exercise prices, Lower Limit	$ 5.00
Outstanding Range of Exercise prices, Upper Limit	$ 10
Outstanding, Number of shares	188,056
Outstanding, Weighted Average Exercise Price	$ 7.84
Exercisable, Weighted Average Exercise Price	$ 7.84
Outstanding Remaining Contractual Life	3 years 7 months 6 days
Exercisable, Number of shares	188,056
Exercisable Remaining Contractual Life	3 years 7 months 6 days
Range Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Range of Exercise prices, Lower Limit	$ 10.01
Outstanding Range of Exercise prices, Upper Limit	$ 15
Outstanding, Number of shares	481,764
Outstanding, Weighted Average Exercise Price	$ 13.55
Exercisable, Weighted Average Exercise Price	$ 13.20
Outstanding Remaining Contractual Life	7 years 10 months 25 days
Exercisable, Number of shares	226,275
Exercisable Remaining Contractual Life	6 years 9 months 18 days
Range Five [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Range of Exercise prices, Lower Limit	$ 15.01
Outstanding Range of Exercise prices, Upper Limit	$ 20
Outstanding, Number of shares	55,000
Outstanding, Weighted Average Exercise Price	$ 15.07
Exercisable, Weighted Average Exercise Price	$ 15.01
Outstanding Remaining Contractual Life	8 years 10 months 25 days
Exercisable, Number of shares	12,500
Exercisable Remaining Contractual Life	8 years 10 months 25 days

XML 62 R50.htm IDEA: XBRL DOCUMENT

Share-Based Compensation - Aggregated Information Regarding RSUs and RSAs Granted (Detail) - Restricted Stock Award And Restricted Stock Unit [Member]	3 Months Ended
	Apr. 29, 2017 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning balance, Outstanding Restricted Stock Units and Restricted Stock Awards \| shares	213,868
Granted, Restricted Stock Units and Restricted Stock Awards \| shares	7,233
Vested, Restricted Stock Units and Restricted Stock Awards \| shares	(10,461)
Forfeited, Restricted Stock Units and Restricted Stock Awards \| shares	0
Ending balance, Outstanding Restricted Stock Units and Restricted Stock Awards \| shares	210,640
Beginning balance, Weighted Average Grant Date Fair Value \| $ / shares	$ 14.11
Granted, Weighted Average Grant Date Fair Value \| $ / shares	13.95
Vested, Weighted Average Grant Date Fair Value \| $ / shares	13.75
Forfeited, Weighted Average Grant Date Fair Value \| $ / shares	0
Ending balance, Weighted Average Grant Date Fair Value \| $ / shares	$ 14.10

XML 63 R51.htm IDEA: XBRL DOCUMENT

Inventories - Components of Inventories (Detail) - USD ($) $ in Thousands	Apr. 29, 2017	Jan. 31, 2017
Inventory Disclosure [Abstract]
Materials and Supplies	$ 12,082	$ 11,865
Work-In-Process	1,168	1,216
Finished Goods	11,184	10,270
Inventory, Gross	24,434	23,351
Inventory Reserve	(4,098)	(3,845)
Inventories	$ 20,336	$ 19,506

XML 64 R52.htm IDEA: XBRL DOCUMENT

Income Taxes - Projected Effective Tax Rate for Periods (Detail)	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Income Tax Disclosure [Abstract]
Effective tax rates for income from continuing operations	22.30%	31.80%

XML 65 R53.htm IDEA: XBRL DOCUMENT

Income Taxes - Additional Information (Detail) - USD ($)	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016	Jan. 31, 2017
Income Tax Disclosure [Abstract]
Income tax expense	$ 147,000	$ 476,000
Income tax benefit from expiration of the statue of limitations	71,000	$ 52,000
Income tax benefit from windfall of stock	14,000
Cumulative unrecognized tax benefits	673,000		$ 708,000
Developments affecting unrecognized tax benefits	$ 0

XML 66 R54.htm IDEA: XBRL DOCUMENT

Debt - Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets (Detail) $ in Thousands	Apr. 29, 2017 USD ($)
Less:
Current Portion	$ (1,104)
Long-Term Debt	7,941
Term Loan [Member]
Debt Instrument [Line Items]
USD Term Loan with a rate equal to LIBOR plus a margin of 1.0% to 1.5%, (2.031% as of April 29, 2017), and maturity date of January 31, 2022	9,200
Less:
Debt Issuance Costs, net of accumulated amortization	(155)
Current Portion	(1,104)
Long-Term Debt	$ 7,941

XML 67 R55.htm IDEA: XBRL DOCUMENT

Debt - Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets (Parenthetical) (Detail) - Term Loan [Member]	3 Months Ended
	Apr. 29, 2017
Debt Instrument [Line Items]
Debt instrument, maturity date	Jan. 31, 2022
LIBOR [Member]
Debt Instrument [Line Items]
Debt instrument, description of variable rate basis	LIBOR plus a margin of 1.0% to 1.5%, (2.031% as of April 29, 2017), and maturity date of January 31, 2022
Interest rate	2.031%
Minimum [Member] \| LIBOR [Member]
Debt Instrument [Line Items]
Interest rate	1.00%
Maximum [Member] \| LIBOR [Member]
Debt Instrument [Line Items]
Interest rate	1.50%

XML 68 R56.htm IDEA: XBRL DOCUMENT

Debt - Schedule of Required Principal Payments Remaining on Long Term Debt Outstanding (Detail) - Term Loan [Member] $ in Thousands	Apr. 29, 2017 USD ($)
Debt Instrument [Line Items]
Fiscal 2018	$ 1,104
Fiscal 2019	1,472
Fiscal 2020	1,840
Fiscal 2021	2,208
Fiscal 2022	2,576
Long term debt	$ 9,200

XML 69 R57.htm IDEA: XBRL DOCUMENT

Debt - Additional Information (Detail) - USD ($)	3 Months Ended
Debt - Additional Information (Detail) - USD ($)	Apr. 29, 2017	Feb. 28, 2017
Debt Instrument [Line Items]
Borrowings under revolving credit facility	$ 0
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Commitment fee rate	0.25%
Term Loan [Member]
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity	$ 9,200,000
LIBOR [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Interest rate	1.00%
LIBOR [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Interest rate	2.031%
Federal Funds Effective Swap Rate [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Interest rate	0.50%
Minimum [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Percentage added to variable rate	0.00%
Minimum [Member] \| LIBOR [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Interest rate	1.00%
Minimum [Member] \| LIBOR [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Interest rate	1.00%
Maximum [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Percentage added to variable rate	0.50%
Maximum [Member] \| LIBOR [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Interest rate	1.50%
Maximum [Member] \| LIBOR [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Interest rate	1.50%
Wells Fargo Bank [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Amount withdrawn under credit facility	$ 0
Bank of America, N.A. [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity		$ 10,000,000
Bank of America, N.A. [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity		$ 9,200,000

XML 70 R58.htm IDEA: XBRL DOCUMENT

Derivative Financial Instruments and Risk Management - Additional Information (Detail)		3 Months Ended
	Apr. 29, 2017 USD ($)	Apr. 29, 2017 USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of gains or losses reclassified to earnings		$ (211,000)
Cross Currency Interest Rate Contract [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of debt conversion	$ 8,600,000	$ 8,600,000
Maximum remaining maturity of foreign currency derivatives		5 years
Derivative fair value	393,600	$ 393,600
Amount of gains or losses reclassified to earnings		0
Cross Currency Interest Rate Contract [Member] \| Swap [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of debt conversion	8,900,000	$ 8,900,000
Cross Currency Interest Rate Contract [Member] \| Reclassification out of Accumulated Other Comprehensive Income [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain Reclassified from Accumulated OCI into Income (Effective Portion)	$ 108,200

XML 71 R59.htm IDEA: XBRL DOCUMENT

Derivative Financial Instruments and Risk Management - Schedule of Impact of the Derivative Instrument in the Condensed Consolidated Financial Statements (Detail) - Cash Flow Hedge [Member] - Cross Currency Interest Rate Contract [Member] - USD ($)	3 Months Ended	12 Months Ended
	Apr. 29, 2017	Jan. 31, 2017
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)	$ (392,636)	$ 0
Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	Other Income (Expense)
Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	$ (320,076)	$ 0

XML 72 R60.htm IDEA: XBRL DOCUMENT

Segment Information - Additional Information (Detail)	3 Months Ended
Segment Information - Additional Information (Detail)	Apr. 29, 2017 Segment
Segment Reporting [Abstract]
Number of reporting segments	2

XML 73 R61.htm IDEA: XBRL DOCUMENT

Segment Information - Net Sales and Segment Operating Profit for Each Reporting Segment (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Segment Reporting Information [Line Items]
Revenue	$ 24,458	$ 24,110
Corporate Expenses	1,856	1,651
Operating Income	707	1,547
Other Expense	(48)	(52)
Income Before Income Taxes	659	1,495
Income Tax Provision	147	476
Net Income	512	1,019
Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating Income	2,563	3,198
Operating Segments [Member] \| Product Identification [Member]
Segment Reporting Information [Line Items]
Revenue	18,646	16,606
Operating Income	2,492	1,996
Operating Segments [Member] \| T&M [Member]
Segment Reporting Information [Line Items]
Revenue	5,812	7,504
Operating Income	71	1,202
Corporate Expenses [Member]
Segment Reporting Information [Line Items]
Corporate Expenses	$ 1,856	$ 1,651

XML 74 R62.htm IDEA: XBRL DOCUMENT

Securities Available for Sale - Additional Information (Detail)	3 Months Ended
	Apr. 29, 2017 USD ($)
Schedule of Available-for-sale Securities [Line Items]
Impairment charges on available for sale security	$ 0
Minimum [Member]
Schedule of Available-for-sale Securities [Line Items]
Original maturity of short-term investments	90 days
Anticipated maturity period	6 months
Maximum [Member]
Schedule of Available-for-sale Securities [Line Items]
Anticipated maturity period	24 months

XML 75 R63.htm IDEA: XBRL DOCUMENT

Securities Available for Sale - Fair Value, Amortized Cost and Gross Unrealized Gains and Losses of the Securities (Detail) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 29, 2017	Jan. 31, 2017
Schedule of Available-for-sale Securities [Line Items]
Fair Value	$ 5,185	$ 6,723
State and Municipal Obligations [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	5,188	6,732
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(3)	(9)
Fair Value	$ 5,185	$ 6,723

XML 76 R64.htm IDEA: XBRL DOCUMENT

Fair Value - Summary of Financial Assets and Liabilities Measured at Fair Value (Detail) - USD ($) $ in Thousands	Apr. 29, 2017	Jan. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money Market Funds (included in Cash and Cash Equivalents)	$ 1,611	$ 2
State and Municipal Obligations (included in Securities Available for Sale)	5,185	6,723
Total assets	6,796	6,725
Swap Contracts (included in Other Liabilities)	393
Earnout liability (included in Other Liabilities)	1,322
Total liabilities	1,715
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money Market Funds (included in Cash and Cash Equivalents)	1,611	2
Total assets	1,611	2
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
State and Municipal Obligations (included in Securities Available for Sale)	5,185	6,723
Total assets	5,185	$ 6,723
Swap Contracts (included in Other Liabilities)	393
Total liabilities	393
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Earnout liability (included in Other Liabilities)	1,322
Total liabilities	$ 1,322

XML 77 R65.htm IDEA: XBRL DOCUMENT

Fair Value - Additional Information (Detail) - USD ($)	3 Months Ended
Fair Value - Additional Information (Detail) - USD ($)	Apr. 29, 2017	Feb. 28, 2017
Term Loan [Member]
Fair Value Inputs Assets Liabilities Quantitative Information [Line Items]
Credit facility, maximum borrowing capacity	$ 9,200,000
Bank of America, N.A. [Member] \| Term Loan [Member]
Fair Value Inputs Assets Liabilities Quantitative Information [Line Items]
Credit facility, maximum borrowing capacity		$ 9,200,000
Contingent Consideration Liability [Member]
Fair Value Inputs Assets Liabilities Quantitative Information [Line Items]
Estimated target period	7 years
Estimated earnout targets	$ 407,000
Estimated earnout targets	$ 1,280,000
Contingent Consideration Liability [Member] \| Minimum [Member]
Fair Value Inputs Assets Liabilities Quantitative Information [Line Items]
Fair value assumptions, risk-adjusted discount rate	1.77%
Probability of success	1.60%
Contingent Consideration Liability [Member] \| Maximum [Member]
Fair Value Inputs Assets Liabilities Quantitative Information [Line Items]
Fair value assumptions, risk-adjusted discount rate	3.35%
Probability of success	87.20%

XML 78 R66.htm IDEA: XBRL DOCUMENT

Fair Value - Schedule of Company's Long-Term Debt Including the Current Portion Not Reflected in Financial Statements at Fair Value (Detail) $ in Thousands	Mar. 29, 2017 USD ($)
Fair Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-Term debt and related current maturities	$ 9,200
Fair Value [Member] \| Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-Term debt and related current maturities	9,200
Carrying Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-Term debt and related current maturities	$ 9,200

XML 79 R67.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Loss - Changes in Balance of Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Schedule of Capitalization, Equity [Line Items]
Beginning Balance	$ (1,056)
Other Comprehensive Income (Loss)	(257)	$ 325
Ending Balance	(1,313)
Foreign Currency Translation Adjustments [Member]
Schedule of Capitalization, Equity [Line Items]
Beginning Balance	(1,048)
Other Comprehensive Income (Loss) before reclassification	(221)
Other Comprehensive Income (Loss)	(221)
Ending Balance	(1,269)
Unrealized Holding Gain/ (Loss) on Available for Sale Securities [Member]
Schedule of Capitalization, Equity [Line Items]
Beginning Balance	(8)
Other Comprehensive Income (Loss) before reclassification	12
Other Comprehensive Income (Loss)	12
Ending Balance	4
Net Unrealized Gain (Losses) on Cash Flow Hedges Translation Adjustments [Member]
Schedule of Capitalization, Equity [Line Items]
Other Comprehensive Income (Loss) before reclassification	(259)
Amounts reclassified from AOCI to Earnings	211
Other Comprehensive Income (Loss)	(48)
Ending Balance	(48)
Accumulated Other Comprehensive Income (Loss) [Member]
Schedule of Capitalization, Equity [Line Items]
Beginning Balance	(1,056)
Other Comprehensive Income (Loss) before reclassification	(468)
Amounts reclassified from AOCI to Earnings	211
Other Comprehensive Income (Loss)	(257)
Ending Balance	$ (1,313)

XML 80 R68.htm IDEA: XBRL DOCUMENT

Subsequent Events - Additional information (Detail) - Subsequent Event [Member] - USD ($)	May 01, 2017	Apr. 30, 2017
Stock Repurchase Agreement [Member]
Subsequent Event [Line Items]
Common stock, authorized to be repurchased, shares	826,305
Common stock repurchased, per share amount	$ 13.60
Common stock, authorized to be repurchased, value	$ 11,200,000
Common stock owned by trust, shares	36,000
Credit Agreement Amendment [Member]
Subsequent Event [Line Items]
Common stock, authorized to be repurchased, value	$ 12,000,000	$ 5,000,000

EXCEL 81 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 82 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 83 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 85 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 147 275 1 false 68 0 false 9 false false R1.htm 101 - Document - Document and Entity Information Sheet http://astro-med.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false R2.htm 103 - Statement - Condensed Consolidated Balance Sheets Sheet http://astro-med.com/taxonomy/role/StatementOfFinancialPositionClassified Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://astro-med.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 105 - Statement - Condensed Consolidated Statements of Income Sheet http://astro-med.com/taxonomy/role/StatementOfIncome Condensed Consolidated Statements of Income Statements 4 false false R5.htm 106 - Statement - Condensed Consolidated Statements of Comprehensive Income Sheet http://astro-med.com/taxonomy/role/StatementOfOtherComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income Statements 5 false false R6.htm 107 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://astro-med.com/taxonomy/role/StatementOfCashFlowsIndirect Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 108 - Disclosure - Overview Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations Overview Notes 7 false false R8.htm 109 - Disclosure - Basis of Presentation Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock Basis of Presentation Notes 8 false false R9.htm 110 - Disclosure - Principles of Consolidation Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock Principles of Consolidation Notes 9 false false R10.htm 111 - Disclosure - Acquisition Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsBusinessCombinationDisclosureTextBlock Acquisition Notes 10 false false R11.htm 112 - Disclosure - Net Income Per Common Share Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock Net Income Per Common Share Notes 11 false false R12.htm 113 - Disclosure - Intangible Assets Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsIntangibleAssetsDisclosureTextBlock Intangible Assets Notes 12 false false R13.htm 114 - Disclosure - Share-Based Compensation Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Share-Based Compensation Notes 13 false false R14.htm 115 - Disclosure - Inventories Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock Inventories Notes 14 false false R15.htm 116 - Disclosure - Income Taxes Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock Income Taxes Notes 15 false false R16.htm 117 - Disclosure - Debt Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock Debt Notes 16 false false R17.htm 118 - Disclosure - Derivative Financial Instruments and Risk Management Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock Derivative Financial Instruments and Risk Management Notes 17 false false R18.htm 119 - Disclosure - Segment Information Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock Segment Information Notes 18 false false R19.htm 120 - Disclosure - Recent Accounting Pronouncements Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock Recent Accounting Pronouncements Notes 19 false false R20.htm 121 - Disclosure - Securities Available for Sale Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock Securities Available for Sale Notes 20 false false R21.htm 122 - Disclosure - Fair Value Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Fair Value Notes 21 false false R22.htm 123 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsComprehensiveIncomeNoteTextBlock Accumulated Other Comprehensive Loss Notes 22 false false R23.htm 124 - Disclosure - Subsequent Events Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock Subsequent Events Notes 23 false false R24.htm 125 - Disclosure - Recent Accounting Pronouncements (Policies) Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlockPolicies Recent Accounting Pronouncements (Policies) Policies http://astro-med.com/taxonomy/role/NotesToFinancialStatementsNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock 24 false false R25.htm 126 - Disclosure - Acquisition (Tables) Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsBusinessCombinationDisclosureTextBlockTables Acquisition (Tables) Tables http://astro-med.com/taxonomy/role/NotesToFinancialStatementsBusinessCombinationDisclosureTextBlock 25 false false R26.htm 127 - Disclosure - Net Income Per Common Share (Tables) Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables Net Income Per Common Share (Tables) Tables http://astro-med.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock 26 false false R27.htm 128 - Disclosure - Intangible Assets (Tables) Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsIntangibleAssetsDisclosureTextBlockTables Intangible Assets (Tables) Tables http://astro-med.com/taxonomy/role/NotesToFinancialStatementsIntangibleAssetsDisclosureTextBlock 27 false false R28.htm 129 - Disclosure - Share-Based Compensation (Tables) Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Share-Based Compensation (Tables) Tables http://astro-med.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock 28 false false R29.htm 130 - Disclosure - Inventories (Tables) Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables Inventories (Tables) Tables http://astro-med.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock 29 false false R30.htm 131 - Disclosure - Income Taxes (Tables) Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables Income Taxes (Tables) Tables http://astro-med.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock 30 false false R31.htm 132 - Disclosure - Debt (Tables) Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables Debt (Tables) Tables http://astro-med.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock 31 false false R32.htm 133 - Disclosure - Derivative Financial Instruments and Risk Management (Tables) Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlockTables Derivative Financial Instruments and Risk Management (Tables) Tables http://astro-med.com/taxonomy/role/NotesToFinancialStatementsDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock 32 false false R33.htm 134 - Disclosure - Segment Information (Tables) Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables Segment Information (Tables) Tables http://astro-med.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock 33 false false R34.htm 135 - Disclosure - Securities Available for Sale (Tables) Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlockTables Securities Available for Sale (Tables) Tables http://astro-med.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock 34 false false R35.htm 136 - Disclosure - Fair Value (Tables) Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables Fair Value (Tables) Tables http://astro-med.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock 35 false false R36.htm 137 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://astro-med.com/taxonomy/role/NotesToFinancialStatementsComprehensiveIncomeNoteTextBlockTables Accumulated Other Comprehensive Loss (Tables) Tables http://astro-med.com/taxonomy/role/NotesToFinancialStatementsComprehensiveIncomeNoteTextBlock 36 false false R37.htm 138 - Disclosure - Overview - Additional Information (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureOverviewAdditionalInformation Overview - Additional Information (Detail) Details 37 false false R38.htm 139 - Disclosure - Acquisition - Additional Information (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureAcquisitionAdditionalInformation Acquisition - Additional Information (Detail) Details 38 false false R39.htm 140 - Disclosure - Acquisition - Purchase Price of Acquisition Allocated on Basis of Fair Value (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureAcquisitionPurchasePriceOfAcquisitionAllocatedOnBasisOfFairValue Acquisition - Purchase Price of Acquisition Allocated on Basis of Fair Value (Detail) Details 39 false false R40.htm 141 - Disclosure - Acquisition - Fair Value of the Acquired Identifiable Intangible Assets and Related Estimated Useful Lives (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureAcquisitionFairValueOfTheAcquiredIdentifiableIntangibleAssetsAndRelatedEstimatedUsefulLives Acquisition - Fair Value of the Acquired Identifiable Intangible Assets and Related Estimated Useful Lives (Detail) Details 40 false false R41.htm 142 - Disclosure - Net Income Per Common Share - Reconciliation of Shares Used in Calculating Basic and Diluted (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureNetIncomePerCommonShareReconciliationOfSharesUsedInCalculatingBasicAndDiluted Net Income Per Common Share - Reconciliation of Shares Used in Calculating Basic and Diluted (Detail) Details 41 false false R42.htm 143 - Disclosure - Net Income Per Common Share - Additional Information (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureNetIncomePerCommonShareAdditionalInformation Net Income Per Common Share - Additional Information (Detail) Details 42 false false R43.htm 144 - Disclosure - Intangible Assets - Fair Value of Acquired Identifiable Intangible Assets and Related Estimated Useful Lives (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureIntangibleAssetsFairValueOfAcquiredIdentifiableIntangibleAssetsAndRelatedEstimatedUsefulLives Intangible Assets - Fair Value of Acquired Identifiable Intangible Assets and Related Estimated Useful Lives (Detail) Details 43 false false R44.htm 145 - Disclosure - Intangible Assets - Additional Information (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureIntangibleAssetsAdditionalInformation Intangible Assets - Additional Information (Detail) Details 44 false false R45.htm 146 - Disclosure - Share-Based Compensation - Additional Information (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureShareBasedCompensationAdditionalInformation Share-Based Compensation - Additional Information (Detail) Details 45 false false R46.htm 147 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureShareBasedCompensationShareBasedCompensationExpense Share-Based Compensation - Share-Based Compensation Expense (Detail) Details 46 false false R47.htm 148 - Disclosure - Share-Based Compensation - Fair Value of Stock Options Granted (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureShareBasedCompensationFairValueOfStockOptionsGranted Share-Based Compensation - Fair Value of Stock Options Granted (Detail) Details 47 false false R48.htm 149 - Disclosure - Share-Based Compensation - Aggregated Information Regarding Stock Options Granted (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureShareBasedCompensationAggregatedInformationRegardingStockOptionsGranted Share-Based Compensation - Aggregated Information Regarding Stock Options Granted (Detail) Details 48 false false R49.htm 150 - Disclosure - Share-Based Compensation - Summary of Options Outstanding (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureShareBasedCompensationSummaryOfOptionsOutstanding Share-Based Compensation - Summary of Options Outstanding (Detail) Details 49 false false R50.htm 151 - Disclosure - Share-Based Compensation - Aggregated Information Regarding RSUs and RSAs Granted (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureShareBasedCompensationAggregatedInformationRegardingRSUsAndRSAsGranted Share-Based Compensation - Aggregated Information Regarding RSUs and RSAs Granted (Detail) Details 50 false false R51.htm 152 - Disclosure - Inventories - Components of Inventories (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureInventoriesComponentsOfInventories Inventories - Components of Inventories (Detail) Details 51 false false R52.htm 153 - Disclosure - Income Taxes - Projected Effective Tax Rate for Periods (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureIncomeTaxesProjectedEffectiveTaxRateForPeriods Income Taxes - Projected Effective Tax Rate for Periods (Detail) Details 52 false false R53.htm 154 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation Income Taxes - Additional Information (Detail) Details 53 false false R54.htm 155 - Disclosure - Debt - Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureDebtScheduleOfLongTermDebtInTheAccompanyingCondensedConsolidatedBalanceSheets Debt - Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets (Detail) Details 54 false false R55.htm 156 - Disclosure - Debt - Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets (Parenthetical) (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureDebtScheduleOfLongTermDebtInTheAccompanyingCondensedConsolidatedBalanceSheetsParenthetical Debt - Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets (Parenthetical) (Detail) Details 55 false false R56.htm 157 - Disclosure - Debt - Schedule of Required Principal Payments Remaining on Long Term Debt Outstanding (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureDebtScheduleOfRequiredPrincipalPaymentsRemainingOnLongTermDebtOutstanding Debt - Schedule of Required Principal Payments Remaining on Long Term Debt Outstanding (Detail) Details 56 false false R57.htm 158 - Disclosure - Debt - Additional Information (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureDebtAdditionalInformation Debt - Additional Information (Detail) Details 57 false false R58.htm 159 - Disclosure - Derivative Financial Instruments and Risk Management - Additional Information (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureDerivativeFinancialInstrumentsAndRiskManagementAdditionalInformation Derivative Financial Instruments and Risk Management - Additional Information (Detail) Details 58 false false R59.htm 160 - Disclosure - Derivative Financial Instruments and Risk Management - Schedule of Impact of the Derivative Instrument in the Condensed Consolidated Financial Statements (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureDerivativeFinancialInstrumentsAndRiskManagementScheduleOfImpactOfTheDerivativeInstrumentInTheCondensedConsolidatedFinancialStatements Derivative Financial Instruments and Risk Management - Schedule of Impact of the Derivative Instrument in the Condensed Consolidated Financial Statements (Detail) Details 59 false false R60.htm 161 - Disclosure - Segment Information - Additional Information (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureSegmentInformationAdditionalInformation Segment Information - Additional Information (Detail) Details 60 false false R61.htm 162 - Disclosure - Segment Information - Net Sales and Segment Operating Profit for Each Reporting Segment (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureSegmentInformationNetSalesAndSegmentOperatingProfitForEachReportingSegment Segment Information - Net Sales and Segment Operating Profit for Each Reporting Segment (Detail) Details 61 false false R62.htm 163 - Disclosure - Securities Available for Sale - Additional Information (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureSecuritiesAvailableForSaleAdditionalInformation Securities Available for Sale - Additional Information (Detail) Details 62 false false R63.htm 164 - Disclosure - Securities Available for Sale - Fair Value, Amortized Cost and Gross Unrealized Gains and Losses of the Securities (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureSecuritiesAvailableForSaleFairValueAmortizedCostAndGrossUnrealizedGainsAndLossesOfTheSecurities Securities Available for Sale - Fair Value, Amortized Cost and Gross Unrealized Gains and Losses of the Securities (Detail) Details 63 false false R64.htm 165 - Disclosure - Fair Value - Summary of Financial Assets and Liabilities Measured at Fair Value (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureFairValueSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValue Fair Value - Summary of Financial Assets and Liabilities Measured at Fair Value (Detail) Details 64 false false R65.htm 166 - Disclosure - Fair Value - Additional Information (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureFairValueAdditionalInformation Fair Value - Additional Information (Detail) Details 65 false false R66.htm 167 - Disclosure - Fair Value - Schedule of Company's Long-Term Debt Including the Current Portion Not Reflected in Financial Statements at Fair Value (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureFairValueScheduleOfCompanysLongTermDebtIncludingTheCurrentPortionNotReflectedInFinancialStatementsAtFairValue Fair Value - Schedule of Company's Long-Term Debt Including the Current Portion Not Reflected in Financial Statements at Fair Value (Detail) Details 66 false false R67.htm 168 - Disclosure - Accumulated Other Comprehensive Loss - Changes in Balance of Accumulated Other Comprehensive Loss (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureAccumulatedOtherComprehensiveLossChangesInBalanceOfAccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss - Changes in Balance of Accumulated Other Comprehensive Loss (Detail) Details 67 false false R68.htm 169 - Disclosure - Subsequent Events - Additional information (Detail) Sheet http://astro-med.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation Subsequent Events - Additional information (Detail) Details 68 false false All Reports Book All Reports alot-20170429.xml alot-20170429.xsd alot-20170429_cal.xml alot-20170429_def.xml alot-20170429_lab.xml alot-20170429_pre.xml true true ZIP 87 0001193125-17-197235-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-17-197235-xbrl.zip M4$L#!!0 ( $*.QTJ%'& X#.P '2T"P 1 86QO="TR,#$W,#0R.2YX M;6SLO6ESVT:V,/P]5?X/>'636W8506-?G$F> A?_73W6?[V?[[//.Z>A)$;^+]SX8\<+?/++Q2.)+O[/KV]^^-O_Q_/
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~~<#G08 MI FN]0(W6C9[O/*D.Z*G)S=N0(#9-6A8K'V[IDL=00T+75K%QM*6@ZK.Q# 6 MIDI<$R86'_OH,O_L.#P\+UDE/*?.-%Y"7(,MB]S3]7>T:G78 M*[$S9J>W4)^29P)_3^C'ZY?JS1X; 1 " 3OL !A;&]T+3(P,3~~
~~~~?+ 0!A;&]T+3(P,3~~~~

Large accelerated filer

Accelerated filer

Non-accelerated filer

☐ (Do not check if a smaller reporting company)

Smaller reporting company

Emerging growth company